Printing trees and the typed dependencies for file ./Medline/medline_sents_parsed.con.14
AdditionError: rel, (required-19, that-17)
AdditionError: rel, (contribute-59, that-54)
AdditionError: rel, (contribute-59, that-54)
AdditionError: rel, (contribute-59, that-54)
AdditionError: xcomp, (displayed-6, indicating-38)
AdditionError: xcomp, (displayed-6, indicating-38)
AdditionError: xcomp, (displayed-6, indicating-38)
AdditionError: xcomp, (displayed-6, indicating-38)
AdditionError: xcomp, (displayed-6, indicating-38)
AdditionError: xcomp, (displayed-6, indicating-38)
AdditionError: rel, (cause-28, which-25)
AdditionError: conj_and, (%-28, respectively-33)
AdditionError: conj_and, (%-28, respectively-33)
AdditionError: conj_and, (%-28, respectively-33)
AdditionError: conj_and, (%-28, respectively-33)
AdditionError: conj_and, (%-28, respectively-33)
AdditionError: conj_and, (%-28, respectively-33)
AdditionError: iobj, (had-17, %-19)
AdditionError: conj_than, (HCCs-8, negative-7)
AdditionError: pobj, (with-15, inhibition-17)
AdditionError: pobj, (with-15, inhibition-17)
AdditionError: pobj, (with-15, inhibition-17)
AdditionError: rel, (activates-30, which-28)
AdditionError: rel, (activates-30, which-28)
AdditionError: rel, (activates-30, which-28)
AdditionError: rel, (activates-30, which-28)
AdditionError: conj_and, (investigated-3, also-25)
AdditionError: iobj, (increased-18, inhibitors-20)
AdditionError: iobj, (increased-18, inhibitors-20)
AdditionError: iobj, (increased-18, inhibitors-20)
AdditionError: rel, (shown-37, which-34)
AdditionError: rel, (shown-37, which-34)
AdditionError: conj_and, (gave-14, lacked-34)
AdditionError: conj_and, (gave-14, failed-37)
AdditionError: conj_and, (gave-14, lacked-34)
AdditionError: conj_and, (gave-14, failed-37)
AdditionError: conj_and, (gave-14, lacked-34)
AdditionError: conj_and, (gave-14, failed-37)
AdditionError: conj_and, (gave-14, lacked-34)
AdditionError: conj_and, (gave-14, failed-37)
AdditionError: conj_and, (gave-14, lacked-34)
AdditionError: conj_and, (gave-14, failed-37)
AdditionError: conj_and, (gave-14, lacked-34)
AdditionError: conj_and, (gave-14, failed-37)
AdditionError: conj_and, (gave-14, lacked-34)
AdditionError: conj_and, (gave-14, failed-37)
AdditionError: conj_and, (gave-14, lacked-34)
AdditionError: conj_and, (gave-14, failed-37)
AdditionError: conj_and, (gave-14, lacked-34)
AdditionError: conj_and, (gave-14, failed-37)
AdditionError: conj_and, (gave-14, lacked-34)
AdditionError: conj_and, (gave-14, failed-37)
AdditionError: nsubj, (normal-27, expression-19)
AdditionError: conj_and, (internalized-17, catalytically-27)
AdditionError: neg, (bind-8, not-11)
AdditionError: rel, (have-37, which-35)
AdditionError: dobj, (found-2, expression-17)
AdditionError: dobj, (found-2, expression-17)
AdditionError: dobj, (found-2, expression-17)
AdditionError: conj_or, (investigated-7, not-16)
AdditionError: neg, (induced-25, not-16)
AdditionError: conj_or, (investigated-7, induced-25)
AdditionError: conj_or, (investigated-7, not-16)
AdditionError: neg, (induced-25, not-16)
AdditionError: conj_or, (investigated-7, induced-25)
AdditionError: conj_or, (adequate-50, slightly-52)
AdditionError: conj_or, (adequate-50, slightly-52)
AdditionError: conj_or, (adequate-50, slightly-52)
AdditionError: conj_or, (adequate-50, slightly-52)
AdditionError: rel, (encodes-18, which-17)
AdditionError: rel, (encodes-18, which-17)
AdditionError: ccomp, (delivered-24, inhibited-36)
AdditionError: ccomp, (delivered-24, suppressed-41)
AdditionError: ccomp, (delivered-24, inhibited-36)
AdditionError: ccomp, (delivered-24, suppressed-41)
AdditionError: ccomp, (delivered-24, inhibited-36)
AdditionError: ccomp, (delivered-24, suppressed-41)
AdditionError: ccomp, (delivered-24, inhibited-36)
AdditionError: ccomp, (delivered-24, suppressed-41)
AdditionError: rel, (produces-24, which-23)
AdditionError: rel, (produces-24, which-23)
AdditionError: nn, (<-17, p-16)
AdditionError: conj_and, (45.8-fold-20, respectively-54)
AdditionError: conj_and, (45.8-fold-20, respectively-54)
AdditionError: rel, (mediated-23, many-19)
AdditionError: rel, (mediated-23, many-19)
AdditionError: rel, (binds-41, where-39)
AdditionError: nsubj, (observed-18, we-17)
AdditionError: dobj, (observed-18, transactivation-19)
AdditionError: nsubj, (observed-18, we-17)
AdditionError: dobj, (observed-18, transactivation-19)
AdditionError: ccomp, (strictures-10, is-17)
AdditionError: dobj, (observed-2, enhancement-20)
AdditionError: dobj, (observed-2, enhancement-20)
AdditionError: poss, (patients-27, lymphoma-26)
AdditionError: poss, (patients-27, lymphoma-26)
AdditionError: iobj, (including-30, histiocytoma-33)
AdditionError: iobj, (including-30, histiocytoma-33)
AdditionError: iobj, (including-30, histiocytoma-33)
AdditionError: iobj, (including-30, histiocytoma-33)
AdditionError: iobj, (including-30, histiocytoma-33)
AdditionError: iobj, (including-30, histiocytoma-33)
AdditionError: nsubjpass, (treated-3, He-1)
AdditionError: dobj, (using-7, tryptase-8)
AdditionError: dobj, (using-7, tryptase-8)
AdditionError: cop, (present-16, were-14)
AdditionError: cop, (present-16, were-14)
AdditionError: cop, (present-16, were-14)
AdditionError: nsubjpass, (mediated-17, effects-11)
AdditionError: conj_and, (increased-4, pronounced-13)
AdditionError: conj_and, (increased-4, pronounced-13)
AdditionError: conj_and, (increased-4, pronounced-13)
AdditionError: conj_and, (increased-4, pronounced-13)
AdditionError: rel, (thought-16, which-14)
AdditionError: rel, (thought-16, which-14)
AdditionError: cop, (present-9, is-8)
AdditionError: ccomp, (respond-5, encountering-9)
AdditionError: xcomp, (loaded-15, indicating-23)
AdditionError: rel, (%-26, where-10)
AdditionError: conj_and, (%-26, respectively-38)
AdditionError: rel, (%-26, where-10)
AdditionError: conj_and, (%-26, respectively-38)
AdditionError: rel, (%-26, where-10)
AdditionError: conj_and, (%-26, respectively-38)
AdditionError: rel, (%-26, where-10)
AdditionError: conj_and, (%-26, respectively-38)
AdditionError: rel, (%-26, where-10)
AdditionError: conj_and, (%-26, respectively-38)
AdditionError: rel, (%-26, where-10)
AdditionError: conj_and, (%-26, respectively-38)
AdditionError: rel, (%-26, where-10)
AdditionError: conj_and, (%-26, respectively-38)
AdditionError: ccomp, (reduced-5, compared-12)
AdditionError: conj_and, (increase-6, respectively-29)
AdditionError: conj_and, (reduce-37, thus-41)
AdditionError: poss, (acuminatum-11, sarcoma-15)
AdditionError: poss, (acuminatum-11, sarcoma-15)
AdditionError: partmod, (cells-20, transformed-21)
AdditionError: partmod, (cells-20, transformed-21)
AdditionError: partmod, (cells-20, transformed-21)
AdditionError: conj_and, (prevents-4, inhibited-18)
AdditionError: conj_and, (prevents-4, inhibited-18)
AdditionError: conj_and, (prevents-4, inhibited-18)
AdditionError: ccomp, (confirmed-6, reduced-18)
AdditionError: rel, (correlated-30, which-29)
AdditionError: rel, (correlated-30, which-29)
AdditionError: rel, (correlated-30, which-29)
AdditionError: ccomp, (related-11, precedes-19)
AdditionError: rel, (positive-37, which-35)
AdditionError: rel, (associated-26, which-24)
AdditionError: rel, (associated-26, which-24)
AdditionError: conj_and, (induces-17, putatively-29)
AdditionError: nsubjpass, (correlated-37, mutations-22)
AdditionError: nsubjpass, (correlated-37, mutations-22)
AdditionError: nsubjpass, (correlated-37, mutations-22)
AdditionError: nsubjpass, (expressed-4, Matrix-1)
AdditionError: rel, (show-14, which-13)
AdditionError: rel, (show-14, which-13)
AdditionError: conj_and, (over-expressed-5, constitutively-7)
AdditionError: rel, (led-22, presentation-16)
AdditionError: rel, (led-22, presentation-16)
AdditionError: rel, (unclear-26, etiology-22)
AdditionError: conj_and, (increased-26, significantly-74)
AdditionError: conj_and, (increased-26, significantly-74)
AdditionError: conj_and, (increased-26, significantly-74)
AdditionError: conj_and, (increased-26, significantly-74)
AdditionError: ccomp, (based-4, inhibited-57)
AdditionError: ccomp, (based-4, inhibited-57)
AdditionError: rel, (cause-14, which-13)
AdditionError: prep, (involved-10, given-27)
AdditionError: prep, (involved-10, given-27)
AdditionError: ccomp, (reduced-5, treated-13)
AdditionError: ccomp, (reduced-5, treated-13)
AdditionError: ccomp, (reduced-5, treated-13)
AdditionError: ccomp, (reduced-5, treated-13)
AdditionError: conj_and, (expression-11, slightly-18)
AdditionError: conj_and, (expression-11, slightly-18)
AdditionError: conj_and, (expression-11, slightly-18)
AdditionError: nsubjpass, (implicated-37, overexpression-25)
AdditionError: nsubjpass, (implicated-37, overexpression-25)
AdditionError: xcomp, (reverse-23, indicating-34)
AdditionError: nsubj, (exist-4, differences-8)
AdditionError: conj_and, (disrupted-5, also-23)
AdditionError: rel, (influences-16, where-13)
AdditionError: rel, (influences-16, where-13)
AdditionError: ccomp, (learn-2, contribute-12)
AdditionError: ccomp, (learn-2, contribute-12)
AdditionError: iobj, (predicts-7, gene-12)
AdditionError: iobj, (predicts-7, gene-12)
AdditionError: rel, (stabilizes-6, which-5)
AdditionError: conj_and, (increased-13, then-19)
AdditionError: conj_and, (increased-13, then-19)
AdditionError: conj_and, (cloned-6, then-17)
AdditionError: conj_and, (cloned-6, stably-18)
AdditionError: conj_and, (cloned-6, then-17)
AdditionError: conj_and, (cloned-6, stably-18)
AdditionError: conj_and, (cloned-6, then-17)
AdditionError: conj_and, (cloned-6, stably-18)
AdditionError: conj_and, (chain-23, respectively-39)
AdditionError: conj_and, (chain-23, respectively-39)
AdditionError: conj_and, (chain-23, respectively-39)
AdditionError: conj_and, (chain-23, respectively-39)
AdditionError: conj_and, (chain-23, respectively-39)
AdditionError: conj_and, (chain-23, respectively-39)
AdditionError: conj_and, (chain-23, respectively-39)
AdditionError: conj_and, (had-11, showed-25)
AdditionError: conj_and, (had-11, showed-25)
AdditionError: conj_and, (had-11, showed-25)
AdditionError: conj_and, (had-11, showed-25)
AdditionError: conj_and, (had-11, showed-25)
AdditionError: conj_and, (had-11, showed-25)
AdditionError: conj_and, (overexpressed-29, >-36)
AdditionError: conj_and, (overexpressed-29, =-38)
AdditionError: conj_and, (overexpressed-29, >-36)
AdditionError: conj_and, (overexpressed-29, =-38)
AdditionError: conj_and, (overexpressed-29, >-36)
AdditionError: conj_and, (overexpressed-29, =-38)
AdditionError: conj_and, (overexpressed-29, >-36)
AdditionError: conj_and, (overexpressed-29, =-38)
AdditionError: nsubj, (higher-17, expression-8)
AdditionError: nsubj, (higher-17, expression-8)
AdditionError: rel, (provide-88, which-86)
AdditionError: iobj, (increased-17, times-19)
AdditionError: iobj, (increased-17, times-19)
AdditionError: ccomp, (found-21, compared-33)
AdditionError: conj_and, (%-22, respectively-52)
AdditionError: conj_and, (%-22, respectively-52)
AdditionError: conj_and, (%-22, respectively-52)
AdditionError: conj_and, (%-22, respectively-52)
AdditionError: conj_and, (%-22, respectively-52)
AdditionError: conj_and, (%-22, respectively-52)
AdditionError: conj_and, (%-22, respectively-52)
AdditionError: conj_and, (%-22, respectively-52)
AdditionError: ccomp, (preserved-32, rechallenged-39)
AdditionError: ccomp, (preserved-32, rechallenged-39)
AdditionError: ccomp, (preserved-32, rechallenged-39)
AdditionError: ccomp, (preserved-32, rechallenged-39)
AdditionError: conj_and, (plasma-14, lymphocytes-21)
AdditionError: prep_in, (lymphocytes-21, patients-23)
AdditionError: conj_and, (plasma-14, lymphocytes-21)
AdditionError: prep_in, (lymphocytes-21, patients-23)
AdditionError: conj_and, (plasma-14, lymphocytes-21)
AdditionError: prep_in, (lymphocytes-21, patients-23)
AdditionError: dobj, (caused-34, %-52)
AdditionError: dobj, (caused-34, %-52)
AdditionError: conj_and, (positive-4, positive-19)
AdditionError: conj_and, (positive-4, positive-19)
AdditionError: xcomp, (reduce-11, reversing-21)
AdditionError: xcomp, (reduce-11, reversing-21)
AdditionError: nsubj, (induce-5, inhibitors-2)
AdditionError: dobj, (induce-5, apoptosis-7)
AdditionError: nsubj, (induce-5, inhibitors-2)
AdditionError: dobj, (induce-5, apoptosis-7)
AdditionError: nsubj, (induce-5, inhibitors-2)
AdditionError: dobj, (induce-5, apoptosis-7)
AdditionError: rel, (contributes-17, where-15)
AdditionError: iobj, (Circulating-1, factor-5)
AdditionError: prep, (stained-25, except-31)
AdditionError: prep, (stained-25, except-31)
AdditionError: prep, (stained-25, except-31)
AdditionError: prep, (stained-25, except-31)
AdditionError: rel, (used-18, which-15)
AdditionError: ccomp, (diminished-21, compared-23)
AdditionError: nsubjpass, (detected-20, expression-14)
AdditionError: nsubj, (approved-13, Imatinib-4)
AdditionError: iobj, (infiltrating-45, tumor-48)
AdditionError: iobj, (infiltrating-45, tumor-48)
AdditionError: iobj, (infiltrating-45, tumor-48)
AdditionError: iobj, (infiltrating-45, tumor-48)
AdditionError: conj_and, (%-15, respectively-32)
AdditionError: rel, (creates-21, which-20)
AdditionError: rel, (creates-21, which-20)
AdditionError: cop, (absent-21, is-20)
AdditionError: cop, (absent-21, is-20)
AdditionError: conj_and, (P-20, respectively-29)
AdditionError: parataxis, (decreased-41, increased-56)
AdditionError: parataxis, (decreased-41, increased-56)
AdditionError: parataxis, (decreased-41, increased-56)
AdditionError: parataxis, (decreased-41, increased-56)
AdditionError: rel, (targets-46, which-45)
AdditionError: rel, (targets-46, which-45)
AdditionError: rel, (targets-46, which-45)
AdditionError: rel, (targets-46, which-45)
AdditionError: iobj, (inactivates-16, proteins-20)
AdditionError: iobj, (inactivates-16, proteins-20)
AdditionError: iobj, (inactivates-16, proteins-20)
AdditionError: iobj, (inactivates-16, proteins-20)
AdditionError: cop, (present-5, was-4)
AdditionError: cop, (present-5, was-4)
AdditionError: rel, (neutralized-22, which-20)
AdditionError: rel, (neutralized-22, which-20)
AdditionError: rel, (neutralized-22, which-20)
AdditionError: rel, (neutralized-22, which-20)
AdditionError: conj_and, (elevated-7, also-13)
AdditionError: conj_and, (elevated-7, also-13)
AdditionError: rel, (expressed-26, cells-25)
AdditionError: rel, (expressed-26, cells-25)
AdditionError: conj_and, (kinase-30, upstream-38)
AdditionError: conj_and, (kinase-30, upstream-38)
AdditionError: conj_and, (kinase-30, upstream-38)
AdditionError: conj_and, (kinase-30, upstream-38)
AdditionError: rel, (shown-35, which-32)
AdditionError: rel, (shown-35, which-32)
AdditionError: conj_but, (enhanced-7, eventually-10)
AdditionError: conj_but, (enhanced-7, eventually-10)
AdditionError: rel, (regulated-30, which-28)
AdditionError: rel, (regulated-30, which-28)
AdditionError: rel, (regulated-30, which-28)
AdditionError: rel, (regulated-30, which-28)
AdditionError: rel, (regulated-30, which-28)
AdditionError: rel, (regulated-30, which-28)
AdditionError: rel, (induce-23, which-22)
AdditionError: rel, (induce-23, which-22)
AdditionError: rel, (regulated-30, which-28)
AdditionError: rel, (regulated-30, which-28)
AdditionError: rel, (regulated-30, which-28)
AdditionError: rel, (regulated-30, which-28)
AdditionError: rel, (regulated-30, which-28)
AdditionError: rel, (regulated-30, which-28)
AdditionError: poss, (DG75-16, lymphoma-13)
AdditionError: rel, (restricted-17, expression-14)
AdditionError: ccomp, (upregulated-22, thought-47)
AdditionError: rel, (restricted-17, expression-14)
AdditionError: ccomp, (upregulated-22, thought-47)
AdditionError: rel, (restricted-17, expression-14)
AdditionError: ccomp, (upregulated-22, thought-47)
AdditionError: rel, (restricted-17, expression-14)
AdditionError: ccomp, (upregulated-22, thought-47)
AdditionError: rel, (restricted-17, expression-14)
AdditionError: ccomp, (upregulated-22, thought-47)
AdditionError: rel, (restricted-17, expression-14)
AdditionError: ccomp, (upregulated-22, thought-47)
AdditionError: conj_and, (analyzed-2, simultaneously-15)
AdditionError: conj_and, (analyzed-2, simultaneously-15)
AdditionError: rel, (considered-9, which-7)
AdditionError: ccomp, (explain-6, reduces-25)
AdditionError: rel, (requires-42, which-41)
AdditionError: rel, (had-5, cancers-4)
AdditionError: rel, (had-5, cancers-4)
AdditionError: rel, (dependent-24, which-20)
AdditionError: rel, (dependent-24, which-20)
AdditionError: rel, (dependent-24, which-20)
AdditionError: nsubj, (located-49, antigens-47)
AdditionError: dep, (H.pylori-46, located-49)
AdditionError: conj_and, (%-8, respectively-16)
AdditionError: conj_and, (%-8, respectively-16)
AdditionError: rel, (lead-15, whereby-5)
AdditionError: rel, (lead-15, whereby-5)
AdditionError: rel, (lead-15, whereby-5)
AdditionError: rel, (lead-15, whereby-5)
AdditionError: nsubjpass, (inactivated-16, p27-13)
AdditionError: prep_through, (inactivated-16, proteolysis-26)
AdditionError: nsubjpass, (inactivated-16, p27-13)
AdditionError: prep_through, (inactivated-16, proteolysis-26)
AdditionError: cop, (relapsed-12, were-5)
AdditionError: conj_and, (P-25, respectively-33)
AdditionError: cop, (relapsed-12, were-5)
AdditionError: conj_and, (P-25, respectively-33)
AdditionError: conj_and, (decreased-6, significantly-15)
AdditionError: conj_and, (decreased-6, significantly-15)
AdditionError: rel, (associated-14, which-12)
AdditionError: rel, (associated-14, which-12)
AdditionError: xcomp, (affect-13, suggesting-31)
AdditionError: ccomp, (killed-6, exposed-14)
AdditionError: ccomp, (killed-6, exposed-14)
AdditionError: ccomp, (killed-6, exposed-14)
AdditionError: conj_and, (subjected-11, informative-14)
AdditionError: conj_and, (subjected-11, informative-14)
AdditionError: dobj, (confirmed-6, expression-9)
AdditionError: rel, (cause-25, which-21)
AdditionError: rel, (decreased-13, expression-11)
AdditionError: rel, (decreased-13, expression-11)
AdditionError: rel, (lost-9, expression-7)
AdditionError: conj_and, (development-13, specifically-15)
AdditionError: ccomp, (discussed-4, occur-39)
AdditionError: conj_and, (development-13, specifically-15)
AdditionError: ccomp, (discussed-4, occur-39)
AdditionError: conj_and, (development-13, specifically-15)
AdditionError: ccomp, (discussed-4, occur-39)
AdditionError: conj_and, (development-13, specifically-15)
AdditionError: ccomp, (discussed-4, occur-39)
AdditionError: nsubjpass, (overexpressed-5, mRNA-2)
AdditionError: nsubjpass, (overexpressed-5, mRNA-2)
AdditionError: nsubjpass, (reduced-18, Levels-1)
AdditionError: nsubjpass, (reduced-18, Levels-1)
AdditionError: nsubjpass, (reduced-18, Levels-1)
AdditionError: nsubjpass, (reduced-18, Levels-1)
AdditionError: nsubjpass, (reduced-18, Levels-1)
AdditionError: ccomp, (prevented-30, tested-34)
AdditionError: rel, (induced-41, synthesis-39)
AdditionError: rel, (induced-41, synthesis-39)
AdditionError: rel, (induced-41, synthesis-39)
AdditionError: rel, (induced-41, synthesis-39)
AdditionError: rel, (induced-41, synthesis-39)
AdditionError: conj_and, (increased-10, thereby-15)
AdditionError: conj_and, (how-12, when-15)
AdditionError: ccomp, (detected-15, compared-20)
AdditionError: ccomp, (detected-15, compared-20)
AdditionError: rel, (associated-30, polymorphisms-23)
AdditionError: rel, (associated-30, polymorphisms-23)
AdditionError: rel, (influence-89, which-88)
AdditionError: rel, (influence-89, which-88)
AdditionError: rel, (influence-89, which-88)
AdditionError: rel, (influence-89, which-88)
AdditionError: rel, (influence-89, which-88)
AdditionError: conj_and, (associate-15, activated-19)
AdditionError: conj_and, (associate-15, activated-19)
AdditionError: conj_and, (associate-15, activated-19)
AdditionError: conj_and, (associate-15, activated-19)
AdditionError: conj_and, (drugs-12, also-14)
AdditionError: conj_and, (cascades-26, mainly-28)
AdditionError: conj_and, (cascades-26, mainly-28)
AdditionError: conj_and, (suppressed-21, also-43)
AdditionError: conj_and, (suppressed-21, also-43)
AdditionError: conj_and, (suppressed-21, also-43)
AdditionError: conj_and, (suppressed-21, also-43)
AdditionError: rel, (occurred-31, when-28)
AdditionError: rel, (occurred-31, when-28)
AdditionError: quantmod, (one-4, more-6)
AdditionError: quantmod, (one-4, more-6)
AdditionError: ccomp, (increased-8, compared-28)
AdditionError: nsubjpass, (induced-16, expression-14)
AdditionError: conj_but, (expressed-5, induced-16)
AdditionError: nsubjpass, (induced-16, expression-14)
AdditionError: conj_but, (expressed-5, induced-16)
AdditionError: nsubjpass, (induced-16, expression-14)
AdditionError: conj_but, (expressed-5, induced-16)
AdditionError: nsubjpass, (induced-16, expression-14)
AdditionError: conj_but, (expressed-5, induced-16)
AdditionError: conj_and, (overexpressed-5, often-17)
AdditionError: conj_and, (overexpressed-5, often-17)
AdditionError: conj_and, (results-16, thus-26)
AdditionError: rel, (suppressed-12, which-11)
AdditionError: conj_and, (U-0126-17, respectively-26)
AdditionError: conj_and, (U-0126-17, respectively-26)
AdditionError: conj_and, (U-0126-17, respectively-26)
AdditionError: conj_and, (U-0126-17, respectively-26)
AdditionError: conj_and, (U-0126-17, respectively-26)
AdditionError: conj_and, (U-0126-17, respectively-26)
AdditionError: conj_and, (U-0126-17, respectively-26)
AdditionError: conj_and, (U-0126-17, respectively-26)
AdditionError: conj_and, (U-0126-17, respectively-26)
AdditionError: poss, (D1-9, Wilms-50)
AdditionError: poss, (D1-9, Wilms-50)
AdditionError: poss, (D1-9, Wilms-50)
AdditionError: poss, (D1-9, Wilms-50)
AdditionError: conj_and, (inhibit-10, thus-21)
AdditionError: quantmod, (1-7, more-9)
AdditionError: nsubj, (up-regulated-19, beta-estradiol-18)
AdditionError: dobj, (up-regulated-19, expression-24)
AdditionError: nsubj, (up-regulated-19, beta-estradiol-18)
AdditionError: dobj, (up-regulated-19, expression-24)
AdditionError: rel, (associated-18, which-16)
AdditionError: rel, (associated-18, which-16)
AdditionError: conj_and, (member-4, overexpressed-15)
AdditionError: rel, (established-10, which-7)
AdditionError: rel, (established-10, which-7)
AdditionError: rel, (established-10, which-7)
AdditionError: rel, (established-10, which-7)
AdditionError: rel, (established-10, which-7)
AdditionError: ccomp, (observed-26, introduced-30)
AdditionError: conj_and, (positive-5, also-17)
AdditionError: conj_and, (positive-5, positive-18)
AdditionError: conj_and, (positive-5, also-17)
AdditionError: conj_and, (positive-5, positive-18)
AdditionError: conj_and, (positive-5, also-17)
AdditionError: conj_and, (positive-5, positive-18)
AdditionError: rel, (linked-29, where-26)
AdditionError: rel, (linked-29, where-26)
AdditionError: ccomp, (decreased-6, compared-20)
AdditionError: ccomp, (decreased-6, compared-20)
AdditionError: ccomp, (decreased-6, compared-20)
AdditionError: conj_and, (expression-55, consequently-57)
AdditionError: conj_and, (expression-55, consequently-57)
AdditionError: conj_and, (expression-55, consequently-57)
AdditionError: conj_and, (expression-55, consequently-57)
AdditionError: conj_and, (investigated-4, also-24)
AdditionError: rel, (restricted-24, where-20)
AdditionError: conj_and, (influx-119, consequently-135)
AdditionError: conj_and, (influx-119, consequently-135)
AdditionError: conj_and, (influx-119, consequently-135)
AdditionError: iobj, (given-97, g/kg-100)
AdditionError: iobj, (given-97, g/kg-100)
AdditionError: rel, (contribute-15, which-13)
AdditionError: rel, (contribute-15, which-13)
AdditionError: dobj, (increased-7, MMP-1-12)
AdditionError: dobj, (increased-7, secretion-16)
AdditionError: dobj, (increased-7, MMP-1-12)
AdditionError: dobj, (increased-7, secretion-16)
AdditionError: dobj, (increased-7, MMP-1-12)
AdditionError: dobj, (increased-7, secretion-16)
AdditionError: rel, (contribute-15, which-13)
AdditionError: rel, (contribute-15, which-13)
AdditionError: rel, (contribute-15, which-13)
AdditionError: rel, (contribute-15, which-13)
AdditionError: prep_as, (established-18, mechanism-23)
AdditionError: prep_as, (established-18, mechanism-23)
AdditionError: prep_as, (established-18, mechanism-23)
AdditionError: prep_as, (established-18, mechanism-23)
AdditionError: prep_as, (established-18, mechanism-23)
AdditionError: prep_as, (established-18, mechanism-23)
AdditionError: prep_as, (established-18, mechanism-23)
AdditionError: prep_as, (established-18, mechanism-23)
AdditionError: ccomp, (lower-21, compared-30)
AdditionError: ccomp, (lower-21, compared-30)
AdditionError: conj_and, (determine-5, also-30)
AdditionError: conj_and, (determine-5, also-30)
AdditionError: poss, (neuroblastoma-23, tumour-27)
AdditionError: poss, (neuroblastoma-23, tumour-27)
AdditionError: poss, (neuroblastoma-23, tumour-27)
AdditionError: poss, (neuroblastoma-23, tumour-27)
AdditionError: conj_and, (hyperplasia-17, occasionally-19)
AdditionError: rel, (observed-16, overexpression-13)
AdditionError: xcomp, (made-6, administrating-20)
AdditionError: xcomp, (made-6, administrating-20)
AdditionError: rel, (account-27, which-25)
AdditionError: rel, (account-27, which-25)
AdditionError: conj_and, (increase-8, decrease-13)
AdditionError: conj_and, (increase-8, decrease-13)
AdditionError: cop, (weak-12, is-11)
AdditionError: cop, (weak-12, is-11)
AdditionError: ccomp, (investigated-2, affected-6)
AdditionError: iobj, (activate-4, metalloproteinase-6)
AdditionError: neg, (present-24, not-34)
AdditionError: conj_and, (receptors-13, particularly-15)
AdditionError: conj_and, (receptors-13, particularly-15)
AdditionError: rel, (expressed-16, tumors-15)
AdditionError: rel, (overexpressed-8, tumors-7)
AdditionError: rel, (expressed-16, tumors-15)
AdditionError: poss, (cells-42, lymphoma-41)
AdditionError: poss, (cells-42, lymphoma-41)
AdditionError: poss, (cells-42, lymphoma-41)
AdditionError: rel, (lack-19, which-17)
AdditionError: rel, (lack-19, which-17)
AdditionError: rel, (lack-19, which-17)
AdditionError: rel, (lack-19, which-17)
AdditionError: rel, (stimulates-72, which-71)
AdditionError: rel, (stimulates-72, which-71)
AdditionError: rel, (stimulates-72, which-71)
AdditionError: rel, (reduced-20, which-18)
AdditionError: conj_and, (caused-5, also-21)
AdditionError: conj_and, (caused-5, significantly-22)
AdditionError: conj_and, (caused-5, also-21)
AdditionError: conj_and, (caused-5, significantly-22)
AdditionError: conj_and, (inhibited-11, also-14)
AdditionError: rel, (inhibitor-21, product-17)
AdditionError: conj_and, (stimulate-11, hence-18)
AdditionError: conj_and, (%-24, respectively-49)
AdditionError: conj_and, (%-24, respectively-49)
AdditionError: conj_and, (%-24, respectively-49)
AdditionError: conj_and, (%-24, respectively-49)
AdditionError: conj_and, (%-24, respectively-49)
AdditionError: conj_and, (%-24, respectively-49)
AdditionError: conj_and, (%-24, respectively-49)
AdditionError: rel, (consistent-16, which-13)
AdditionError: nsubjpass, (upregulated-6, expression-4)
AdditionError: conj_and, (expressed-4, often-14)
AdditionError: acomp, (overexpressed-18, manifold-19)
AdditionError: acomp, (overexpressed-18, manifold-19)
AdditionError: acomp, (overexpressed-18, manifold-19)
AdditionError: acomp, (overexpressed-18, manifold-19)
AdditionError: quantmod, (one-29, more-31)
AdditionError: iobj, (delayed-20, depression-21)
AdditionError: rel, (associated-29, which-27)
AdditionError: rel, (associated-29, which-27)
AdditionError: rel, (associated-29, which-27)
AdditionError: nsubjpass, (performed-10, Immunohistochemistry-4)
AdditionError: dep, (DESIGN-2, performed-10)
AdditionError: rel, (encodes-21, which-20)
AdditionError: conj_and, (associated-14, therefore-24)
AdditionError: conj_and, (associated-14, therefore-24)
AdditionError: conj_and, (associated-14, therefore-24)
AdditionError: conj_and, (associated-14, therefore-24)
AdditionError: nn, (interleukin-25, chemokines-42)
AdditionError: nn, (interleukin-25, chemokines-42)
AdditionError: nn, (interleukin-25, chemokines-42)
AdditionError: nn, (interleukin-25, chemokines-42)
AdditionError: nn, (interleukin-25, chemokines-42)
AdditionError: nn, (interleukin-25, chemokines-42)
AdditionError: cop, (undetectable-18, was-17)
AdditionError: conj_or, (undetectable-18, faintly-21)
AdditionError: cop, (undetectable-18, was-17)
AdditionError: conj_or, (undetectable-18, faintly-21)
AdditionError: cop, (undetectable-18, was-17)
AdditionError: conj_or, (undetectable-18, faintly-21)
AdditionError: cop, (undetectable-18, was-17)
AdditionError: conj_or, (undetectable-18, faintly-21)
AdditionError: advcl, (comprised-14, shown-20)
AdditionError: conj_and, (binds-5, increases-15)
AdditionError: conj_and, (stimulates-6, only-22)
AdditionError: rel, (encode-17, which-16)
AdditionError: rel, (encode-17, which-16)
AdditionError: rel, (encode-17, which-16)
AdditionError: rel, (shown-33, which-30)
AdditionError: rel, (shown-33, which-30)
AdditionError: rel, (shown-33, which-30)
AdditionError: rel, (shown-33, which-30)
AdditionError: conj_and, (showed-14, dramatically-30)
AdditionError: ccomp, (grown-18, compared-22)
AdditionError: ccomp, (grown-18, compared-22)
AdditionError: rel, (associates-30, which-27)
AdditionError: rel, (associates-30, which-27)
AdditionError: rel, (associates-30, which-27)
AdditionError: rel, (associates-30, which-27)
AdditionError: ccomp, (inhibited-29, cultured-39)
AdditionError: ccomp, (inhibited-29, cultured-39)
AdditionError: rel, (carries-40, which-39)
AdditionError: conj_and, (coupled-20, responsible-24)
AdditionError: conj_and, (coupled-20, responsible-24)
AdditionError: conj_and, (coupled-20, responsible-24)
AdditionError: ccomp, (increased-3, grown-10)
AdditionError: rel, (consistent-23, which-21)
AdditionError: conj_and, (P-36, respectively-44)
AdditionError: dobj, (induce-17, production-19)
AdditionError: dobj, (induce-17, production-19)
AdditionError: dobj, (induce-17, production-19)
AdditionError: dobj, (induce-17, production-19)
AdditionError: nsubjpass, (observed-29, increase-17)
AdditionError: nsubjpass, (observed-29, increase-17)
AdditionError: conj_and, (elevated-3, therefore-11)
AdditionError: conj_and, (elevated-3, therefore-11)
AdditionError: ccomp, (appeared-9, testing-12)
AdditionError: conj_and, (resulted-14, further-26)
AdditionError: conj_and, (resulted-14, further-26)
AdditionError: nsubj, (rapid-17, upregulation-2)
AdditionError: rel, (associated-8, which-6)
AdditionError: rel, (associated-8, which-6)
AdditionError: rel, (associated-8, which-6)
AdditionError: ccomp, (observed-7, combined-11)
AdditionError: conj_and, (synthesized-11, examined-13)
AdditionError: conj_or, (enhanced-23, respectively-33)
AdditionError: conj_or, (enhanced-23, respectively-33)
AdditionError: rel, (dependent-20, which-18)
AdditionError: rel, (dependent-20, which-18)
AdditionError: conj_and, (shown-8, selectively-39)
AdditionError: rel, (occurred-46, which-45)
AdditionError: rel, (occurred-46, which-45)
AdditionError: rel, (occurred-46, which-45)
AdditionError: ccomp, (clarify-2, confer-9)
AdditionError: pobj, (taken-16, area-23)
AdditionError: pobj, (taken-16, area-23)
AdditionError: rel, (established-20, which-17)
AdditionError: rel, (established-20, which-17)
AdditionError: rel, (established-20, which-17)
AdditionError: dobj, (blocked-11, activity-19)
AdditionError: dobj, (blocked-11, expression-23)
AdditionError: conj_and, (allowed-5, also-16)
AdditionError: rel, (have-31, where-20)
AdditionError: nsubjpass, (upregulated-14, pathway-11)
AdditionError: dep, (PURPOSE-1, upregulated-14)
AdditionError: iobj, (render-26, EGFR-27)
AdditionError: nsubjpass, (upregulated-14, pathway-11)
AdditionError: dep, (PURPOSE-1, upregulated-14)
AdditionError: iobj, (render-26, EGFR-27)
AdditionError: nsubjpass, (upregulated-14, pathway-11)
AdditionError: dep, (PURPOSE-1, upregulated-14)
AdditionError: iobj, (render-26, EGFR-27)
AdditionError: rel, (stimulate-25, which-21)
AdditionError: rel, (stimulate-25, which-21)
AdditionError: rel, (stimulate-25, which-21)
AdditionError: rel, (stimulate-25, which-21)
AdditionError: poss, (interleukin-6-5, herpesvirus-4)
AdditionError: poss, (interleukin-6-5, herpesvirus-4)
AdditionError: rel, (reduced-11, expression-8)
AdditionError: rel, (reduced-11, expression-8)
AdditionError: rel, (reduced-11, expression-8)
AdditionError: rel, (reduced-11, expression-8)
AdditionError: ccomp, (elevated-10, compared-19)
AdditionError: ccomp, (elevated-10, compared-19)
AdditionError: iobj, (down-regulates-31, proteins-34)
AdditionError: iobj, (down-regulates-31, proteins-34)
AdditionError: iobj, (down-regulates-31, proteins-34)
AdditionError: iobj, (down-regulates-31, proteins-34)
AdditionError: rel, (overexpress-11, tumors-10)
AdditionError: ccomp, (increased-9, injected-16)
AdditionError: conj_and, (stimulates-5, thereby-26)
AdditionError: conj_and, (stimulates-5, thereby-26)
AdditionError: ccomp, (down-regulated-23, compared-33)
AdditionError: rel, (down-regulated-10, where-7)
AdditionError: rel, (down-regulated-10, where-7)
AdditionError: rel, (down-regulated-10, where-7)
AdditionError: conj_and, (present-19, also-21)
AdditionError: conj_and, (present-19, also-21)
AdditionError: rel, (express-21, which-19)
AdditionError: rel, (induces-23, which-22)
AdditionError: ccomp, (migrate-16, compared-21)
AdditionError: conj_but, (showed-8, negative-20)
AdditionError: conj_but, (showed-8, negative-20)
AdditionError: conj_but, (showed-8, negative-20)
AdditionError: conj_but, (showed-8, negative-20)
AdditionError: conj_but, (showed-8, negative-20)
AdditionError: conj_but, (showed-8, negative-20)
AdditionError: conj_but, (showed-8, negative-20)
AdditionError: conj_but, (showed-8, negative-20)
AdditionError: nsubjpass, (observed-5, activation-2)
AdditionError: nsubjpass, (observed-5, activation-2)
AdditionError: dobj, (evaluated-3, expression-6)
AdditionError: dobj, (evaluated-3, expression-6)
AdditionError: dobj, (evaluated-3, expression-6)
AdditionError: dobj, (evaluated-3, expression-6)
AdditionError: dobj, (evaluated-3, expression-6)
AdditionError: dobj, (evaluated-3, expression-6)
AdditionError: dobj, (evaluated-3, expression-6)
AdditionError: dobj, (evaluated-3, expression-6)
AdditionError: dobj, (evaluated-3, expression-6)
AdditionError: dobj, (evaluated-3, expression-6)
AdditionError: dobj, (evaluated-3, expression-6)
AdditionError: dobj, (evaluated-3, expression-6)
AdditionError: dobj, (evaluated-3, expression-6)
AdditionError: dobj, (evaluated-3, expression-6)
AdditionError: dobj, (evaluated-3, expression-6)
AdditionError: dobj, (evaluated-3, expression-6)
AdditionError: dobj, (evaluated-3, expression-6)
AdditionError: dobj, (evaluated-3, expression-6)
AdditionError: dobj, (evaluated-3, expression-6)
AdditionError: dobj, (evaluated-3, expression-6)
AdditionError: dobj, (evaluated-3, expression-6)
AdditionError: conj_and, (positive-7, focally-17)
AdditionError: conj_and, (positive-7, focally-17)
AdditionError: conj_and, (positive-7, focally-17)
AdditionError: conj_and, (positive-7, focally-17)
AdditionError: conj_and, (positive-7, focally-17)
AdditionError: conj_and, (positive-7, focally-17)
AdditionError: conj_and, (positive-7, focally-17)
AdditionError: conj_and, (positive-7, focally-17)
AdditionError: xcomp, (frequent-7, indicating-22)
AdditionError: xcomp, (induced-8, showing-33)
AdditionError: xcomp, (induced-8, showing-33)
AdditionError: rel, (exhibit-16, tumors-15)
AdditionError: rel, (exhibit-16, tumors-15)
AdditionError: cop, (increased-15, was-5)
AdditionError: nsubj, (resulted-3, treatment-2)
AdditionError: conj_and, (inhibits-2, capable-24)
AdditionError: conj_and, (inhibits-2, capable-24)
AdditionError: conj_and, (inhibits-2, capable-24)
AdditionError: conj_and, (%-16, respectively-24)
AdditionError: conj_and, (%-16, respectively-24)
AdditionError: nsubj, (evaluated-3, We-1)
AdditionError: dobj, (evaluated-3, expression-8)
AdditionError: nsubj, (evaluated-3, We-1)
AdditionError: dobj, (evaluated-3, expression-8)
AdditionError: rel, (regarded-32, which-30)
AdditionError: nsubj, (useful-13, detection-7)
AdditionError: prep_with, (compared-17, transplantation-19)
AdditionError: prep_with, (compared-17, transplantation-19)
AdditionError: iobj, (sequesters-8, inhibitors-11)
AdditionError: iobj, (sequesters-8, inhibitors-11)
AdditionError: iobj, (sequesters-8, inhibitors-11)
AdditionError: iobj, (sequesters-8, inhibitors-11)
AdditionError: rel, (defined-15, roles-5)
AdditionError: conj, (were-38, highly-40)
AdditionError: iobj, (up-regulate-32, inhibitors-35)
AdditionError: iobj, (up-regulate-32, inhibitors-35)
AdditionError: iobj, (up-regulate-32, inhibitors-35)
AdditionError: iobj, (up-regulate-32, inhibitors-35)
AdditionError: iobj, (up-regulate-32, inhibitors-35)
AdditionError: iobj, (up-regulate-32, inhibitors-35)
AdditionError: iobj, (up-regulate-32, inhibitors-35)
AdditionError: iobj, (up-regulate-32, inhibitors-35)
AdditionError: preconj, (Smad2-23, either-20)
AdditionError: preconj, (Smad2-23, either-20)
AdditionError: ccomp, (suppressed-15, transfected-19)
AdditionError: ccomp, (suppressed-15, pretreated-24)
AdditionError: nn, (antibody-35, inhibitor-54)
AdditionError: ccomp, (suppressed-15, transfected-19)
AdditionError: ccomp, (suppressed-15, pretreated-24)
AdditionError: nn, (antibody-35, inhibitor-54)
AdditionError: rel, (elevated-29, where-24)
AdditionError: rel, (elevated-29, where-24)
AdditionError: conj_and, (negative-29, focally-34)
AdditionError: conj_and, (negative-29, focally-34)
AdditionError: ccomp, (activated-7, coexpressed-13)
AdditionError: pobj, (after-39, months-42)
AdditionError: pobj, (after-39, months-42)
AdditionError: conj_and, (metalloproteinases-10, also-12)
AdditionError: conj_and, (metalloproteinases-10, also-12)
AdditionError: rel, (inhibitor-34, which-31)
AdditionError: rel, (inhibitor-34, which-31)
AdditionError: rel, (inhibitor-34, which-31)
AdditionError: rel, (inhibitor-34, which-31)
AdditionError: rel, (inhibitor-34, which-31)
AdditionError: rel, (inhibitor-34, which-31)
AdditionError: rel, (up-regulated-29, that-27)
AdditionError: rel, (up-regulated-29, that-27)
AdditionError: rel, (up-regulated-29, that-27)
AdditionError: rel, (up-regulated-29, that-27)
AdditionError: rel, (up-regulated-29, that-27)
AdditionError: rel, (up-regulated-29, that-27)
AdditionError: rel, (implicated-18, that-15)
AdditionError: rel, (implicated-18, that-15)
AdditionError: rel, (implicated-18, that-15)
AdditionError: rel, (implicated-18, that-15)
AdditionError: conj_and, (accelerates-12, drastically-20)
AdditionError: conj_and, (accelerates-12, drastically-20)
AdditionError: rel, (available-9, where-5)
AdditionError: rel, (available-9, where-5)
AdditionError: rel, (responded-10, that-9)
AdditionError: conj_and, (upregulated-15, active-18)
AdditionError: conj_and, (upregulated-15, active-18)
AdditionError: conj_but, (had-10, significantly-19)
AdditionError: iobj, (rendering-31, it-32)
AdditionError: rel, (correlates-17, which-16)
AdditionError: conj_but, (decreased-9, associated-26)
AdditionError: conj_but, (decreased-9, associated-26)
AdditionError: conj_but, (decreased-9, associated-26)
AdditionError: conj_and, (regulates-10, overexpressed-15)
AdditionError: conj_and, (regulates-10, overexpressed-15)
AdditionError: rel, (lacks-7, that-6)
AdditionError: pobj, (observed-8, addition-12)
AdditionError: nsubj, (increased-29, ACTH-16)
AdditionError: dobj, (increased-29, expression-31)
AdditionError: nsubj, (increased-29, ACTH-16)
AdditionError: dobj, (increased-29, expression-31)
AdditionError: rel, (appears-12, which-11)
AdditionError: conj_and, (block-31, also-47)
AdditionError: conj_and, (block-31, also-47)
AdditionError: conj_and, (block-31, also-47)
AdditionError: conj_and, (block-31, also-47)
AdditionError: conj_and, (block-31, also-47)
AdditionError: conj_and, (block-31, also-47)
AdditionError: conj_and, (block-31, also-47)
AdditionError: conj_and, (block-31, also-47)
AdditionError: rel, (lost-15, expression-13)
AdditionError: rel, (lost-15, expression-13)
AdditionError: rel, (have-22, tumors-19)
AdditionError: rel, (have-22, tumors-19)
AdditionError: conj_and, (P-28, respectively-36)
AdditionError: conj_and, (P-28, respectively-36)
AdditionError: conj_and, (region-24, as-46)
AdditionError: conj_therefore, (important-23, candidates-32)
AdditionError: conj_therefore, (important-23, candidates-32)
AdditionError: rel, (cause-12, that-11)
AdditionError: dobj, (provide-24, alternative-33)
AdditionError: dobj, (provide-24, alternative-33)
AdditionError: dobj, (provide-24, alternative-33)
AdditionError: dobj, (provide-24, alternative-33)
AdditionError: dobj, (provide-24, alternative-33)
AdditionError: ccomp, (elevated-16, compared-36)
AdditionError: ccomp, (elevated-16, compared-36)
AdditionError: ccomp, (elevated-16, compared-36)
AdditionError: dobj, (analysed-9, levels-11)
AdditionError: dobj, (analysed-9, levels-11)
AdditionError: dobj, (analysed-9, levels-11)
AdditionError: dobj, (analysed-9, levels-11)
AdditionError: dobj, (analysed-9, levels-11)
AdditionError: dobj, (analysed-9, levels-11)
AdditionError: conj_vs., (months-27, respectively-38)
AdditionError: conj_vs., (months-27, respectively-38)
AdditionError: dobj, (blocking-5, functions-7)
AdditionError: dobj, (blocking-5, functions-7)
AdditionError: dobj, (blocking-5, functions-7)
AdditionError: dobj, (blocking-5, functions-7)
AdditionError: conj_and, (%-27, respectively-32)
AdditionError: conj_and, (result-26, thus-35)
AdditionError: rel, (positive-41, results-16)
AdditionError: rel, (positive-41, results-16)
AdditionError: rel, (correlates-22, which-21)
AdditionError: rel, (correlates-22, which-21)
AdditionError: iobj, (induce-17, cytokines-19)
AdditionError: iobj, (induce-17, cytokines-19)
AdditionError: iobj, (induce-17, cytokines-19)
AdditionError: iobj, (induce-17, cytokines-19)
AdditionError: iobj, (induce-17, cytokines-19)
AdditionError: iobj, (induce-17, cytokines-19)
AdditionError: iobj, (induce-17, cytokines-19)
AdditionError: rel, (inhibits-12, whereby-8)
AdditionError: ccomp, (investigated-7, influences-11)
AdditionError: ccomp, (investigated-7, influences-11)
AdditionError: ccomp, (designed-4, given-19)
AdditionError: nsubj, (showed-22, tissues-3)
AdditionError: cop, (associated-14, is-6)
AdditionError: iobj, (using-3, inhibitor-6)
AdditionError: conj_and, (produce-25, potentially-36)
AdditionError: conj_and, (produce-25, potentially-36)
AdditionError: rel, (resistant-33, products-31)
AdditionError: rel, (resistant-33, products-31)
AdditionError: rel, (resistant-33, products-31)
AdditionError: rel, (resistant-33, products-31)
AdditionError: rel, (resistant-33, products-31)
AdditionError: rel, (overexpressed-19, lesion-18)
AdditionError: rel, (overexpressed-19, lesion-18)
AdditionError: iobj, (administered-8, times-11)
AdditionError: cop, (absent-13, was-12)
AdditionError: conj_and, (antagonizes-23, synergistically-35)
AdditionError: conj_and, (causes-12, also-19)
AdditionError: conj_and, (causes-12, also-19)
AdditionError: conj_and, (causes-12, also-19)
AdditionError: nsubj, (resulted-7, vaccination-3)
AdditionError: nsubj, (resulted-7, vaccination-3)
AdditionError: poss, (cancer-22, disease-26)
AdditionError: ccomp, (elevated-15, compared-23)
AdditionError: iobj, (carrying-27, alpha-32)
AdditionError: iobj, (carrying-27, alpha-32)
AdditionError: iobj, (carrying-27, alpha-32)
AdditionError: conj_and, (associated-8, typically-15)
AdditionError: conj_and, (associated-8, typically-15)
AdditionError: conj_and, (associated-8, typically-15)
AdditionError: iobj, (bearing-9, oncogenes-18)
AdditionError: iobj, (bearing-9, oncogenes-18)
AdditionError: iobj, (bearing-9, oncogenes-18)
AdditionError: ccomp, (increased-12, compared-21)
AdditionError: ccomp, (increased-12, compared-21)
AdditionError: ccomp, (increased-12, compared-21)
AdditionError: ccomp, (increased-12, compared-21)
AdditionError: ccomp, (increased-12, compared-21)
AdditionError: rel, (demonstrate-25, tumors-24)
AdditionError: rel, (demonstrate-25, tumors-24)
AdditionError: rel, (demonstrate-25, tumors-24)
AdditionError: rel, (demonstrate-25, tumors-24)
AdditionError: rel, (demonstrate-25, tumors-24)
AdditionError: rel, (demonstrate-25, tumors-24)
AdditionError: nsubj, (contribute-3, Platelets-1)
AdditionError: rel, (show-20, karyotypes-17)
AdditionError: rel, (show-20, karyotypes-17)
AdditionError: nsubj, (increased-37, levels-32)
AdditionError: conj_and, (decreased-14, increased-37)
AdditionError: nsubj, (increased-37, levels-32)
AdditionError: conj_and, (decreased-14, increased-37)
AdditionError: rel, (correlate-29, which-28)
AdditionError: rel, (correlate-29, which-28)
AdditionError: rel, (correlate-29, which-28)
AdditionError: rel, (correlate-29, which-28)
AdditionError: rel, (expressed-25, that-24)
AdditionError: neg, (received-48, not-44)
AdditionError: rel, (compared-6, where-4)
AdditionError: ccomp, (decreased-26, included-30)
AdditionError: ccomp, (decreased-26, included-30)
AdditionError: ccomp, (decreased-26, included-30)
AdditionError: rel, (approved-22, which-19)
AdditionError: rel, (approved-22, which-19)
AdditionError: rel, (linked-37, whereby-8)
AdditionError: rel, (linked-37, whereby-8)
AdditionError: rel, (linked-37, whereby-8)
AdditionError: rel, (linked-37, whereby-8)
AdditionError: rel, (linked-37, whereby-8)
AdditionError: rel, (linked-37, whereby-8)
AdditionError: conj_and, (decreased-10, then-30)
AdditionError: conj_and, (decreased-10, then-30)
AdditionError: conj_and, (decreased-10, then-30)
AdditionError: conj_and, (decreased-10, then-30)
AdditionError: conj_and, (decreased-10, then-30)
AdditionError: conj_and, (decreased-10, then-30)
AdditionError: conj_and, (decreased-10, then-30)
AdditionError: conj_and, (decreased-10, then-30)
AdditionError: conj_and, (decreased-10, then-30)
AdditionError: conj_and, (decreased-10, then-30)
AdditionError: conj_and, (decreased-10, then-30)
AdditionError: conj_and, (decreased-10, then-30)
AdditionError: rel, (involved-23, which-21)
AdditionError: rel, (involved-23, which-21)
AdditionError: rel, (increase-23, which-21)
AdditionError: rel, (increase-23, which-21)
AdditionError: rel, (increase-23, which-21)
AdditionError: rel, (increase-23, which-21)
AdditionError: rel, (increase-23, which-21)
AdditionError: rel, (increase-23, which-21)
AdditionError: rel, (increase-23, which-21)
AdditionError: rel, (increase-23, which-21)
AdditionError: prep_in, (included-4, combination-36)
AdditionError: prep_in, (included-4, combination-36)
AdditionError: prep_in, (included-4, combination-36)
AdditionError: dobj, (have-16, risk-23)
AdditionError: nn, (response-38, development-54)
AdditionError: nn, (response-38, development-54)
AdditionError: nn, (response-38, development-54)
AdditionError: conj_and, (IL-6-39, especially-43)
AdditionError: conj_and, (IL-6-39, especially-43)
AdditionError: conj_and, (IL-6-39, especially-43)
AdditionError: conj_and, (IL-6-39, especially-43)
AdditionError: conj_and, (IL-6-39, especially-43)
AdditionError: conj_and, (IL-6-39, especially-43)
AdditionError: dobj, (circumventing-26, effects-28)
AdditionError: conj_and, (enhance-60, vivo-82)
AdditionError: conj_and, (enhance-60, vivo-82)
AdditionError: conj_and, (enhance-60, vivo-82)
AdditionError: conj_and, (enhance-60, vivo-82)
AdditionError: conj_and, (overexpressed-17, highly-19)
AdditionError: conj_and, (overexpressed-17, highly-19)
AdditionError: conj_and, (overexpressed-17, highly-19)
AdditionError: conj_and, (overexpressed-17, highly-19)
AdditionError: rel, (progressed-15, which-14)
AdditionError: rel, (progressed-15, which-14)
AdditionError: rel, (express-12, tumors-11)
AdditionError: rel, (express-12, tumors-11)
AdditionError: neg, (altered-8, not-10)
AdditionError: rel, (activated-12, when-11)
AdditionError: rel, (activated-12, when-11)
AdditionError: rel, (activated-12, when-11)
AdditionError: iobj, (predicting-14, survival-17)
AdditionError: rel, (induce-8, which-7)
AdditionError: rel, (induce-8, which-7)
AdditionError: rel, (induce-8, which-7)
AdditionError: rel, (induce-8, which-7)
AdditionError: conj_and, (secreted-8, proliferated-17)
AdditionError: conj_and, (secreted-8, proliferated-17)
AdditionError: conj_and, (secreted-8, proliferated-17)
AdditionError: rel, (regulated-18, activation-15)
AdditionError: rel, (regulated-18, activation-15)
AdditionError: iobj, (overexpress-7, p73-10)
AdditionError: iobj, (overexpress-7, p73-10)
AdditionError: iobj, (overexpress-7, p73-10)
AdditionError: iobj, (overexpress-7, p73-10)
AdditionError: ccomp, (defined-8, showed-18)
AdditionError: poss, (registry-29, lymphoma-28)
AdditionError: poss, (registry-29, lymphoma-28)
AdditionError: ccomp, (defined-8, showed-18)
AdditionError: poss, (registry-29, lymphoma-28)
AdditionError: poss, (registry-29, lymphoma-28)
AdditionError: rel, (contributes-34, which-32)
AdditionError: rel, (contributes-34, which-32)
AdditionError: conj_and, (blocked-7, dramatically-19)
AdditionError: conj_and, (blocked-7, dramatically-19)
AdditionError: conj_and, (blocked-7, dramatically-19)
AdditionError: nsubjpass, (induced-4, blisters-2)
AdditionError: conj_and, (demonstrate-5, also-27)
AdditionError: rel, (makes-14, which-13)
AdditionError: rel, (silenced-32, expression-29)
AdditionError: conj_and, (increased-6, then-18)
AdditionError: conj_and, (increased-6, then-18)
AdditionError: rel, (resulted-27, which-26)
AdditionError: rel, (resulted-27, which-26)
AdditionError: rel, (resulted-27, which-26)
AdditionError: rel, (resulted-27, which-26)
AdditionError: pred, (overexpression-5, melphalan-7)
AdditionError: nsubjpass, (incubated-6, lines-4)
AdditionError: nsubjpass, (incubated-6, lines-4)
AdditionError: nsubjpass, (incubated-6, lines-4)
AdditionError: nsubjpass, (incubated-6, lines-4)
AdditionError: ccomp, (increased-41, compared-46)
AdditionError: ccomp, (increased-41, compared-46)
AdditionError: ccomp, (increased-41, compared-46)
AdditionError: ccomp, (increased-41, compared-46)
AdditionError: ccomp, (increased-41, compared-46)
AdditionError: ccomp, (increased-41, compared-46)
AdditionError: ccomp, (increased-41, compared-46)
AdditionError: ccomp, (increased-41, compared-46)
AdditionError: neg, (due-22, not-18)
AdditionError: parataxis, (greatest-7, inhibited-48)
AdditionError: parataxis, (greatest-7, inhibited-48)
AdditionError: parataxis, (greatest-7, inhibited-48)
AdditionError: parataxis, (greatest-7, inhibited-48)
AdditionError: parataxis, (greatest-7, inhibited-48)
AdditionError: parataxis, (greatest-7, inhibited-48)
AdditionError: rel, (present-10, which-8)
AdditionError: cop, (present-4, was-3)
AdditionError: iobj, (making-19, it-20)
AdditionError: conj_and, (suppressed-4, also-21)
AdditionError: conj_and, (suppressed-4, also-21)
AdditionError: conj_and, (plays-8, importantly-19)
AdditionError: conj_and, (plays-8, importantly-19)
AdditionError: rel, (suppresses-34, product-33)
AdditionError: rel, (suppresses-34, product-33)
AdditionError: rel, (suppresses-34, product-33)
AdditionError: xcomp, (up-regulated-8, enhancing-38)
AdditionError: xcomp, (up-regulated-8, enhancing-38)
AdditionError: xcomp, (up-regulated-8, enhancing-38)
AdditionError: conj_and, (signaling-12, separately-17)
AdditionError: conj_and, (signaling-12, separately-17)
AdditionError: conj_and, (signaling-12, separately-17)
AdditionError: conj_and, (abnormal-16, thus-19)
AdditionError: conj_and, (abnormal-16, predisposed-21)
AdditionError: conj_and, (%-13, respectively-22)
AdditionError: conj_and, (associated-32, thus-45)
AdditionError: conj_and, (associated-32, thus-45)
AdditionError: conj_and, (was-6, isolated-28)
AdditionError: dobj, (isolated-28, lymphocytes-30)
AdditionError: prep_in, (isolated-28, patients-33)
AdditionError: conj_and, (was-6, isolated-28)
AdditionError: dobj, (isolated-28, lymphocytes-30)
AdditionError: prep_in, (isolated-28, patients-33)
AdditionError: conj_and, (was-6, isolated-28)
AdditionError: dobj, (isolated-28, lymphocytes-30)
AdditionError: prep_in, (isolated-28, patients-33)
AdditionError: conj_and, (was-6, isolated-28)
AdditionError: dobj, (isolated-28, lymphocytes-30)
AdditionError: prep_in, (isolated-28, patients-33)
AdditionError: conj_and, (detected-14, detected-29)
AdditionError: conj_and, (detected-14, detected-29)
AdditionError: conj_and, (detected-14, detected-29)
AdditionError: conj_and, (detected-14, detected-29)
AdditionError: conj_and, (detected-14, detected-29)
AdditionError: conj_and, (detected-14, detected-29)
AdditionError: quantmod, (two-5, more-7)
AdditionError: rel, (regulates-15, which-14)
AdditionError: rel, (regulates-15, which-14)
AdditionError: iobj, (requires-26, GTPases-29)
AdditionError: iobj, (requires-26, GTPases-29)
AdditionError: prep_in, (found-8, tumors-13)
AdditionError: nsubj, (induced-16, cells-11)
AdditionError: ccomp, (suggests-7, induced-16)
AdditionError: dobj, (induced-16, apoptosis-17)
AdditionError: ccomp, (inhibited-24, induced-28)
AdditionError: ccomp, (inhibited-24, induced-28)
AdditionError: conj_and, (levels-12, consequently-15)
AdditionError: conj_and, (levels-12, consequently-15)
AdditionError: conj_and, (levels-12, consequently-15)
AdditionError: conj_and, (levels-12, consequently-15)
AdditionError: nsubj, (are-6, drugs-5)
AdditionError: dep, (FINDINGS-2, are-6)
AdditionError: nsubj, (are-6, drugs-5)
AdditionError: dep, (FINDINGS-2, are-6)
AdditionError: nsubj, (are-6, drugs-5)
AdditionError: dep, (FINDINGS-2, are-6)
AdditionError: nsubj, (are-6, drugs-5)
AdditionError: dep, (FINDINGS-2, are-6)
AdditionError: conj_and, (overexpressed-4, constitutively-6)
AdditionError: conj_and, (overexpressed-4, constitutively-6)
AdditionError: iobj, (had-17, DSS-21)
AdditionError: rel, (independent-33, where-29)
AdditionError: rel, (independent-33, where-29)
AdditionError: rel, (express-27, tumors-26)
AdditionError: rel, (express-27, tumors-26)
AdditionError: rel, (express-27, tumors-26)
AdditionError: conj_and, (indicate-3, further-34)
AdditionError: conj_and, (inhibited-3, also-15)
AdditionError: conj_and, (inhibited-3, markedly-16)
AdditionError: rel, (expressed-8, which-7)
AdditionError: ccomp, (independent-27, extended-32)
AdditionError: conj_and, (inhibit-4, greatly-15)
AdditionError: conj_and, (inhibit-4, greatly-15)
AdditionError: conj_and, (inhibit-4, greatly-15)
AdditionError: conj_and, (inhibit-4, greatly-15)
AdditionError: rel, (shown-32, proliferation-29)
AdditionError: rel, (shown-32, proliferation-29)
AdditionError: rel, (catalyzes-40, which-39)
AdditionError: rel, (factor-15, which-11)
AdditionError: dobj, (enhances-33, growth-40)
AdditionError: conj_and, (sequenced-2, then-13)
AdditionError: rel, (associated-42, where-37)
AdditionError: rel, (associated-42, where-37)
AdditionError: rel, (associated-42, where-37)
AdditionError: rel, (recognized-15, which-13)
AdditionError: rel, (recognized-15, which-13)
AdditionError: rel, (recognized-15, which-13)
AdditionError: neg, (overexpressed-26, not-11)
AdditionError: neg, (overexpressed-26, not-11)
AdditionError: rel, (attributed-21, which-19)
AdditionError: rel, (overexpress-19, tumors-18)
AdditionError: rel, (overexpress-19, tumors-18)
AdditionError: conj_and, (%-19, respectively-27)
AdditionError: conj_and, (%-19, respectively-27)
AdditionError: rel, (%-21, when-13)
AdditionError: iobj, (upregulate-15, cytokines-24)
AdditionError: prep_in, (upregulate-15, islets-39)
AdditionError: iobj, (upregulate-15, cytokines-24)
AdditionError: prep_in, (upregulate-15, islets-39)
AdditionError: partmod, (apoptosis-6, induced-7)
AdditionError: rel, (restored-25, expression-23)
AdditionError: rel, (restored-44, expression-41)
AdditionError: rel, (restored-25, expression-23)
AdditionError: rel, (restored-44, expression-41)
AdditionError: rel, (restored-25, expression-23)
AdditionError: rel, (restored-44, expression-41)
AdditionError: rel, (restored-25, expression-23)
AdditionError: rel, (restored-44, expression-41)
AdditionError: cop, (decreased-6, was-4)
AdditionError: iobj, (rendering-19, it-20)
AdditionError: iobj, (rendering-19, it-20)
AdditionError: rel, (repress-20, whereby-17)
AdditionError: dobj, (repress-20, expression-27)
AdditionError: rel, (repress-20, whereby-17)
AdditionError: dobj, (repress-20, expression-27)
AdditionError: ccomp, (described-14, promoter-28)
AdditionError: ccomp, (described-14, promoter-28)
AdditionError: ccomp, (described-14, promoter-28)
AdditionError: num, (%-7, 47.8-6)
AdditionError: appos, (218-4, %-7)
AdditionError: num, (cases-12, 456-11)
AdditionError: prep_out_of, (218-4, cases-12)
AdditionError: amod, (biopsy-15, prostatic-14)
AdditionError: nsubjpass, (conducted-17, biopsy-15)
AdditionError: auxpass, (conducted-17, was-16)
AdditionError: dep, (RESULTS-1, conducted-17)
AdditionError: dep, (TUR-P-20, to-22)
AdditionError: advmod, (elevated-24, abnormally-23)
AdditionError: amod, (levels-32, elevated-24)
AdditionError: nn, (antigen-28, serum-25)
AdditionError: nn, (antigen-28, prostate-26)
AdditionError: amod, (antigen-28, specific-27)
AdditionError: nn, (levels-32, antigen-28)
AdditionError: appos, (antigen-28, PSA-30)
AdditionError: num, (ng/ml-35, 4.0-34)
AdditionError: num, (ng/ml-35, more-37)
AdditionError: xcomp, (conducted-17, revealing-39)
AdditionError: quantmod, (22-41, only-40)
AdditionError: num, (cases-46, 22-41)
AdditionError: num, (%-44, 10.1-43)
AdditionError: dep, (22-41, %-44)
AdditionError: dobj, (revealing-39, cases-46)
AdditionError: amod, (cancer-49, prostatic-48)
AdditionError: num, (%-7, 47.8-6)
AdditionError: appos, (218-4, %-7)
AdditionError: num, (cases-12, 456-11)
AdditionError: prep_out_of, (218-4, cases-12)
AdditionError: amod, (biopsy-15, prostatic-14)
AdditionError: nsubjpass, (conducted-17, biopsy-15)
AdditionError: auxpass, (conducted-17, was-16)
AdditionError: dep, (RESULTS-1, conducted-17)
AdditionError: dep, (TUR-P-20, to-22)
AdditionError: advmod, (elevated-24, abnormally-23)
AdditionError: amod, (levels-32, elevated-24)
AdditionError: nn, (antigen-28, serum-25)
AdditionError: nn, (antigen-28, prostate-26)
AdditionError: amod, (antigen-28, specific-27)
AdditionError: nn, (levels-32, antigen-28)
AdditionError: appos, (antigen-28, PSA-30)
AdditionError: num, (ng/ml-35, 4.0-34)
AdditionError: num, (ng/ml-35, more-37)
AdditionError: xcomp, (conducted-17, revealing-39)
AdditionError: quantmod, (22-41, only-40)
AdditionError: num, (cases-46, 22-41)
AdditionError: num, (%-44, 10.1-43)
AdditionError: dep, (22-41, %-44)
AdditionError: dobj, (revealing-39, cases-46)
AdditionError: amod, (cancer-49, prostatic-48)
AdditionError: num, (%-7, 47.8-6)
AdditionError: appos, (218-4, %-7)
AdditionError: num, (cases-12, 456-11)
AdditionError: prep_out_of, (218-4, cases-12)
AdditionError: amod, (biopsy-15, prostatic-14)
AdditionError: nsubjpass, (conducted-17, biopsy-15)
AdditionError: auxpass, (conducted-17, was-16)
AdditionError: dep, (RESULTS-1, conducted-17)
AdditionError: dep, (TUR-P-20, to-22)
AdditionError: advmod, (elevated-24, abnormally-23)
AdditionError: amod, (levels-32, elevated-24)
AdditionError: nn, (antigen-28, serum-25)
AdditionError: nn, (antigen-28, prostate-26)
AdditionError: amod, (antigen-28, specific-27)
AdditionError: nn, (levels-32, antigen-28)
AdditionError: appos, (antigen-28, PSA-30)
AdditionError: num, (ng/ml-35, 4.0-34)
AdditionError: num, (ng/ml-35, more-37)
AdditionError: xcomp, (conducted-17, revealing-39)
AdditionError: quantmod, (22-41, only-40)
AdditionError: num, (cases-46, 22-41)
AdditionError: num, (%-44, 10.1-43)
AdditionError: dep, (22-41, %-44)
AdditionError: dobj, (revealing-39, cases-46)
AdditionError: amod, (cancer-49, prostatic-48)
AdditionError: ccomp, (induced-8, treated-13)
AdditionError: conj_and, (%-32, respectively-37)
AdditionError: rel, (promotes-28, whereby-20)
AdditionError: rel, (promotes-28, whereby-20)
AdditionError: poss, (sera-5, patients-3)
AdditionError: poss, (sera-5, patients-3)
AdditionError: poss, (sera-5, patients-3)
AdditionError: poss, (sera-5, patients-3)
AdditionError: poss, (sera-5, patients-3)
AdditionError: poss, (sera-5, patients-3)
AdditionError: poss, (sera-5, patients-3)
AdditionError: ccomp, (decreased-20, induced-25)
AdditionError: conj_and, (activity-7, ultimately-22)
AdditionError: conj_and, (activity-7, ultimately-22)
AdditionError: conj_and, (activity-7, ultimately-22)
AdditionError: conj_and, (activity-7, ultimately-22)
AdditionError: conj_and, (transfecting-35, then-47)
AdditionError: conj_and, (transfecting-35, then-47)
AdditionError: rel, (results-16, whereby-12)
AdditionError: rel, (results-16, whereby-12)
AdditionError: xcomp, (result-18, indicating-33)
AdditionError: xcomp, (result-18, indicating-33)
AdditionError: partmod, (cells-16, cultured-17)
AdditionError: partmod, (cells-16, cultured-17)
AdditionError: partmod, (cells-16, cultured-17)
AdditionError: partmod, (cells-16, cultured-17)
AdditionError: partmod, (cells-16, cultured-17)
AdditionError: partmod, (cells-16, cultured-17)
AdditionError: rel, (independent-27, that-25)
AdditionError: conj_but, (independent-27, instead-34)
AdditionError: rel, (independent-27, that-25)
AdditionError: conj_but, (independent-27, instead-34)
AdditionError: rel, (independent-27, that-25)
AdditionError: conj_but, (independent-27, instead-34)
AdditionError: rel, (independent-27, that-25)
AdditionError: conj_but, (independent-27, instead-34)
AdditionError: rel, (independent-27, that-25)
AdditionError: conj_but, (independent-27, instead-34)
AdditionError: xcomp, (inhibitor-10, inhibiting-14)
AdditionError: dobj, (inhibiting-14, activity-16)
AdditionError: conj_and, (activated-14, determine-26)
AdditionError: conj_and, (activated-14, determine-26)
AdditionError: conj_and, (dehydrogenase-2, responsible-19)
AdditionError: conj_and, (dehydrogenase-2, responsible-19)
AdditionError: conj_and, (dehydrogenase-2, responsible-19)
AdditionError: conj_and, (dehydrogenase-2, responsible-19)
AdditionError: conj_and, (dehydrogenase-2, responsible-19)
AdditionError: conj_or, (ERK/MAPK-22, respectively-27)
AdditionError: conj_or, (ERK/MAPK-22, respectively-27)
AdditionError: conj_or, (ERK/MAPK-22, respectively-27)
AdditionError: cop, (described-30, are-7)
AdditionError: cop, (described-30, are-7)
AdditionError: cop, (described-30, are-7)
AdditionError: cop, (described-30, are-7)
AdditionError: cop, (described-30, are-7)
AdditionError: poss, (tumors-3, Patients-1)
AdditionError: poss, (tumors-3, Patients-1)
AdditionError: poss, (tumors-3, Patients-1)
AdditionError: poss, (tumors-3, Patients-1)
AdditionError: conj_and, (elevated-17, normal-22)
AdditionError: conj_and, (elevated-17, normal-22)
AdditionError: nsubj, (inducible-10, mRNA-5)
AdditionError: nsubj, (inducible-10, mRNA-5)
AdditionError: nsubj, (demonstrated-25, studies-8)
AdditionError: nsubjpass, (indicated-6, antibody-4)
AdditionError: rel, (down-regulates-24, which-23)
AdditionError: conj_and, (co-activator-26, consequently-42)
AdditionError: rel, (down-regulates-24, which-23)
AdditionError: conj_and, (co-activator-26, consequently-42)
AdditionError: conj_and, (tumors-17, predominantly-19)
AdditionError: conj_and, (tumors-17, predominantly-19)
AdditionError: conj_and, (tumors-17, predominantly-19)
AdditionError: conj_and, (tumors-17, predominantly-19)
AdditionError: conj_and, (tumors-17, predominantly-19)
AdditionError: conj_and, (tumors-17, predominantly-19)
AdditionError: nsubj, (depend-33, lymphomas-22)
AdditionError: nsubj, (depend-33, lymphomas-22)
AdditionError: nsubj, (depend-33, lymphomas-22)
AdditionError: nsubj, (depend-33, lymphomas-22)
AdditionError: nsubj, (depend-33, lymphomas-22)
AdditionError: nsubj, (depend-33, lymphomas-22)
AdditionError: conj_and, (BCR-ABL-18, respectively-22)
AdditionError: conj_and, (BCR-ABL-18, respectively-22)
AdditionError: conj_and, (displayed-6, showed-13)
AdditionError: conj_and, (displayed-6, showed-13)
AdditionError: conj_but, (excellent-27, positively-33)
AdditionError: rel, (showed-28, tumors-27)
AdditionError: conj_and, (4.5--25, respectively-32)
AdditionError: conj_and, (4.5--25, respectively-32)
AdditionError: conj_and, (4.5--25, respectively-32)
AdditionError: conj_and, (4.5--25, respectively-32)
AdditionError: conj_and, (4.5--25, respectively-32)
AdditionError: conj_and, (4.5--25, respectively-32)
AdditionError: conj_and, (4.5--25, respectively-32)
AdditionError: conj_and, (4.5--25, respectively-32)
AdditionError: conj_and, (4.5--25, respectively-32)
AdditionError: prep_for, (homozygous-13, polymorphism-16)
AdditionError: prep_for, (homozygous-13, polymorphism-16)
AdditionError: prep_for, (homozygous-13, polymorphism-16)
AdditionError: rel, (known-25, which-22)
AdditionError: poss, (follow-up-20, years-17)
AdditionError: poss, (follow-up-20, years-17)
AdditionError: poss, (follow-up-20, years-17)
AdditionError: poss, (diarrhea-32, travelers-30)
AdditionError: poss, (diarrhea-32, travelers-30)
AdditionError: rel, (inactivates-24, which-23)
AdditionError: rel, (postulated-19, which-12)
AdditionError: ccomp, (moving-6, important-14)
AdditionError: ccomp, (moving-6, important-14)
AdditionError: ccomp, (moving-6, important-14)
AdditionError: ccomp, (moving-6, important-14)
AdditionError: nsubj, (increase-18, subunit-12)
AdditionError: rcmod, (subunit-12, increase-18)
AdditionError: ccomp, (moving-6, important-14)
AdditionError: ccomp, (moving-6, important-14)
AdditionError: ccomp, (moving-6, important-14)
AdditionError: ccomp, (moving-6, important-14)
AdditionError: prep_for, (necessary-17, progression-21)
AdditionError: rel, (be-36, which-34)
AdditionError: rel, (classified-71, WHO-70)
AdditionError: rel, (classified-71, WHO-70)
AdditionError: rel, (classified-71, WHO-70)
AdditionError: rel, (classified-71, WHO-70)
AdditionError: rel, (classified-71, WHO-70)
AdditionError: rel, (classified-71, WHO-70)
AdditionError: rel, (classified-71, WHO-70)
AdditionError: rel, (classified-71, WHO-70)
AdditionError: rel, (classified-71, WHO-70)
AdditionError: nsubj, (treated-12, we-11)
AdditionError: dep, (DESIGN-2, treated-12)
AdditionError: dobj, (treated-12, patients-14)
AdditionError: rel, (dependent-20, which-18)
AdditionError: rel, (dependent-20, which-18)
AdditionError: rel, (dependent-20, which-18)
AdditionError: rel, (dependent-20, which-18)
AdditionError: rel, (dependent-20, which-18)
AdditionError: rel, (dependent-20, which-18)
AdditionError: rel, (dependent-20, which-18)
AdditionError: rel, (dependent-20, which-18)
AdditionError: rel, (required-28, which-25)
AdditionError: rel, (required-28, which-25)
AdditionError: rel, (required-28, which-25)
AdditionError: rel, (required-28, which-25)
AdditionError: rel, (required-28, which-25)
AdditionError: rel, (required-28, which-25)
AdditionError: neg, (increases-7, not-3)
AdditionError: iobj, (induce-5, cytokine-8)
AdditionError: ccomp, (found-3, tested-17)
AdditionError: rel, (implicated-15, which-12)
AdditionError: quantmod, (one-31, more-33)
AdditionError: quantmod, (one-31, more-33)
AdditionError: quantmod, (one-31, more-33)
AdditionError: quantmod, (one-31, more-33)
AdditionError: quantmod, (one-31, more-33)
AdditionError: quantmod, (one-31, more-33)
AdditionError: ccomp, (correlated-15, evaluated-26)
AdditionError: rel, (leads-6, which-5)
AdditionError: conj_and, (leads-6, thereby-13)
AdditionError: rel, (leads-6, which-5)
AdditionError: conj_and, (leads-6, thereby-13)
AdditionError: rel, (leads-6, which-5)
AdditionError: conj_and, (leads-6, thereby-13)
AdditionError: rel, (leads-6, which-5)
AdditionError: conj_and, (leads-6, thereby-13)
AdditionError: rel, (leads-6, which-5)
AdditionError: conj_and, (leads-6, thereby-13)
AdditionError: rel, (leads-6, which-5)
AdditionError: conj_and, (leads-6, thereby-13)
AdditionError: rel, (leads-6, which-5)
AdditionError: conj_and, (leads-6, thereby-13)
AdditionError: rel, (leads-6, which-5)
AdditionError: conj_and, (leads-6, thereby-13)
AdditionError: rel, (proceeds-15, which-14)
AdditionError: iobj, (using-17, mesylate-23)
AdditionError: conj_and, (1p-31, respectively-35)
AdditionError: conj_and, (1p-31, respectively-35)
AdditionError: conj_and, (1p-31, respectively-35)
AdditionError: conj_and, (1p-31, respectively-35)
AdditionError: conj_and, (1p-31, respectively-35)
AdditionError: conj_and, (1p-31, respectively-35)
AdditionError: conj_and, (protein-19, respectively-29)
AdditionError: conj_and, (protein-19, respectively-29)
AdditionError: conj_and, (protein-19, respectively-29)
AdditionError: conj_and, (protein-19, respectively-29)
AdditionError: quantmod, (2.5--9, 4.3-fold-11)
AdditionError: conj_and, (arzoxifene-5, especially-7)
AdditionError: rel, (increased-17, expression-15)
AdditionError: rel, (increased-17, expression-15)
AdditionError: rel, (increased-17, expression-15)
AdditionError: rel, (increased-17, expression-15)
AdditionError: rel, (increased-17, expression-15)
AdditionError: conj_and, (induces-2, independently-13)
AdditionError: conj_and, (induces-2, independently-13)
AdditionError: conj_and, (induces-2, independently-13)
AdditionError: rel, (lack-18, that-17)
AdditionError: rel, (lack-18, that-17)
AdditionError: rel, (lack-18, that-17)
AdditionError: rel, (lack-18, that-17)
AdditionError: rel, (lack-18, that-17)
AdditionError: rel, (plays-36, which-35)
AdditionError: rel, (plays-36, which-35)
AdditionError: rel, (plays-36, which-35)
AdditionError: rel, (plays-36, which-35)
AdditionError: conj_and, (increased-8, progressed-28)
AdditionError: dobj, (increased-11, expression-36)
AdditionError: dobj, (increased-11, expression-36)
AdditionError: dobj, (increased-11, expression-36)
AdditionError: dobj, (increased-11, expression-36)
AdditionError: dobj, (increased-11, expression-36)
AdditionError: dobj, (increased-11, expression-36)
AdditionError: dobj, (increased-11, expression-36)
AdditionError: dobj, (increased-11, expression-36)
AdditionError: conj_and, (underwent-6, had-17)
AdditionError: conj_and, (underwent-6, administered-28)
AdditionError: conj_and, (underwent-6, had-17)
AdditionError: conj_and, (underwent-6, administered-28)
AdditionError: conj_and, (underwent-6, had-17)
AdditionError: conj_and, (underwent-6, administered-28)
AdditionError: conj_and, (underwent-6, had-17)
AdditionError: conj_and, (underwent-6, administered-28)
AdditionError: conj_and, (mRNAs-53, seemingly-70)
AdditionError: conj_and, (mRNAs-53, seemingly-70)
AdditionError: conj_and, (mRNAs-53, seemingly-70)
AdditionError: conj_and, (mRNAs-53, seemingly-70)
AdditionError: conj_and, (mRNAs-53, seemingly-70)
AdditionError: conj_and, (mRNAs-53, seemingly-70)
AdditionError: conj_and, (mRNAs-53, seemingly-70)
AdditionError: conj_and, (mRNAs-53, seemingly-70)
AdditionError: rel, (verified-23, where-18)
AdditionError: rel, (verified-23, where-18)
AdditionError: rel, (verified-23, where-18)
AdditionError: rel, (verified-23, where-18)
AdditionError: rel, (verified-23, where-18)
AdditionError: rel, (verified-23, where-18)
AdditionError: conj_and, (attributed-9, therefore-19)
AdditionError: nn, (constants-17, dissociation-16)
AdditionError: nn, (constants-17, dissociation-16)
AdditionError: nn, (constants-17, dissociation-16)
AdditionError: nn, (constants-17, dissociation-16)
AdditionError: rel, (involved-11, which-9)
AdditionError: rel, (involved-11, which-9)
AdditionError: nsubj, (reported-3, We-1)
AdditionError: advmod, (reported-3, previously-2)
AdditionError: complm, (initiated-17, that-4)
AdditionError: nsubjpass, (initiated-17, hypermethylation-5)
AdditionError: det, (island-10, the-7)
AdditionError: nn, (island-10, GSTP1-8)
AdditionError: nn, (island-10, CpG-9)
AdditionError: nn, (promoter-11, island-10)
AdditionError: nn, (cells-15, prostate-13)
AdditionError: nn, (cells-15, cancer-14)
AdditionError: auxpass, (initiated-17, is-16)
AdditionError: ccomp, (reported-3, initiated-17)
AdditionError: det, (combination-20, a-19)
AdditionError: amod, (silencing-24, transcriptional-22)
AdditionError: nn, (silencing-24, gene-23)
AdditionError: dep, (silencing-24, by-26)
AdditionError: pobj, (by-26, removal-27)
AdditionError: det, (sites-31, the-29)
AdditionError: nn, (sites-31, Sp1-30)
AdditionError: prep_of, (combination-20, seeds-34)
AdditionError: conj_and, (silencing-24, seeds-34)
AdditionError: nsubj, (acts-51, methylation-36)
AdditionError: rel, (acts-51, that-37)
AdditionError: auxpass, (removed-43, being-41)
AdditionError: advmod, (removed-43, constantly-42)
AdditionError: prep_because_of, (removed-43, demethylation-46)
AdditionError: partmod, (demethylation-46, associated-47)
AdditionError: rcmod, (methylation-36, acts-51)
AdditionError: det, (catalyst-54, a-53)
AdditionError: det, (spread-57, the-56)
AdditionError: det, (island-63, the-61)
AdditionError: nn, (island-63, CpG-62)
AdditionError: ccomp, (located-4, exhibit-18)
AdditionError: conj_and, (inhibit-43, thereby-46)
AdditionError: conj_and, (inhibit-43, thereby-46)
AdditionError: conj_and, (inhibit-43, thereby-46)
AdditionError: rel, (discriminated-23, which-22)
AdditionError: rel, (discriminated-23, which-22)
AdditionError: rel, (discriminated-23, which-22)
AdditionError: rel, (discriminated-23, which-22)
AdditionError: rel, (discriminated-23, which-22)
AdditionError: rel, (discriminated-23, which-22)
AdditionError: rel, (discriminated-23, which-22)
AdditionError: rel, (discriminated-23, which-22)
AdditionError: rel, (discriminated-23, which-22)
AdditionError: rel, (discriminated-23, which-22)
AdditionError: rel, (expressed-5, tumors-4)
AdditionError: rel, (expressed-5, tumors-4)
AdditionError: rel, (inhibits-10, which-9)
AdditionError: conj_and, (decrease-37, concomitantly-41)
AdditionError: rel, (inhibits-10, which-9)
AdditionError: conj_and, (decrease-37, concomitantly-41)
AdditionError: rel, (inhibits-10, which-9)
AdditionError: conj_and, (decrease-37, concomitantly-41)
AdditionError: rel, (inhibits-10, which-9)
AdditionError: conj_and, (decrease-37, concomitantly-41)
AdditionError: rel, (expressed-21, which-19)
AdditionError: rel, (inhibits-10, which-9)
AdditionError: conj_and, (decrease-37, concomitantly-41)
AdditionError: xcomp, (belongs-5, preventing-30)
AdditionError: nsubj, (impaired-36, number-30)
AdditionError: conj_or, (known-3, restored-27)
AdditionError: conj_and, (purified-11, previously-33)
AdditionError: conj_and, (purified-11, previously-33)
AdditionError: conj_and, (decreased-9, subsequently-19)
AdditionError: rel, (detected-49, when-44)
AdditionError: rel, (detected-49, when-44)
AdditionError: rel, (detected-49, when-44)
AdditionError: rel, (detected-49, when-44)
AdditionError: rel, (detected-49, when-44)
AdditionError: rel, (detected-49, when-44)
AdditionError: rel, (failed-72, where-67)
AdditionError: rel, (failed-72, where-67)
AdditionError: rel, (failed-72, where-67)
AdditionError: rel, (failed-72, where-67)
AdditionError: rel, (induced-40, where-35)
AdditionError: predet, (patients-29, all-27)
AdditionError: conj_and, (%-20, respectively-25)
AdditionError: rel, (present-9, where-5)
AdditionError: cop, (normal-20, was-19)
AdditionError: rel, (lack-14, tumors-13)
AdditionError: rel, (contain-33, tumors-32)
AdditionError: rel, (lack-14, tumors-13)
AdditionError: rel, (contain-33, tumors-32)
AdditionError: iobj, (increased-19, isoenzymes-23)
AdditionError: iobj, (increased-19, isoenzymes-23)
AdditionError: iobj, (increased-19, isoenzymes-23)
AdditionError: nsubjpass, (indicated-3, Polychemotherapy-1)
AdditionError: nsubjpass, (indicated-3, Polychemotherapy-1)
AdditionError: nsubjpass, (indicated-3, Polychemotherapy-1)
AdditionError: conj_and, (depressed-17, frequently-22)
AdditionError: poss, (cases-19, lymphoma-18)
AdditionError: poss, (cases-19, lymphoma-18)
AdditionError: poss, (cirrhosis-7, disease-17)
AdditionError: pred, (MTW9-2, showed-23)
AdditionError: pred, (MTW9-2, showed-23)
AdditionError: conj_and, (confirmed-3, also-23)
AdditionError: conj_and, (confirmed-3, also-23)
AdditionError: conj_and, (confirmed-3, also-23)
AdditionError: conj_and, (confirmed-3, also-23)
AdditionError: conj_and, (cells-16, namely-18)
AdditionError: conj_and, (cells-16, presumably-58)
AdditionError: xcomp, (thermolabile-5, implicating-40)
AdditionError: xcomp, (thermolabile-5, implicating-40)
AdditionError: conj_and, (extracted-7, then-17)
AdditionError: rel, (was-29, where-23)
AdditionError: rel, (have-23, where-21)
AdditionError: conj_and, (elevated-12, sharply-21)
AdditionError: conj_and, (elevated-12, sharply-21)
AdditionError: rel, (contained-14, which-13)
AdditionError: rel, (contained-14, which-13)
AdditionError: nsubj, (were-18, tumors-2)
AdditionError: nsubj, (were-18, tumors-2)
AdditionError: nsubjpass, (elevated-5, levels-3)
AdditionError: nsubjpass, (elevated-5, levels-3)
AdditionError: rel, (given-8, when-7)
AdditionError: rel, (given-8, when-7)
AdditionError: rel, (given-8, when-7)
AdditionError: rel, (given-8, when-7)
AdditionError: conj_and, (purified-8, generated-21)
AdditionError: conj_and, (purified-8, generated-21)
AdditionError: ccomp, (compared-10, had-17)
AdditionError: ccomp, (compared-10, had-17)
AdditionError: rel, (dependent-11, growth-9)
AdditionError: rel, (dependent-11, growth-9)
AdditionError: conj_and, (contain-3, thus-10)
AdditionError: ccomp, (derived-29, injected-32)
AdditionError: ccomp, (derived-29, produced-38)
AdditionError: ccomp, (decreased-23, compared-32)
AdditionError: ccomp, (decreased-23, compared-32)
AdditionError: nsubj, (virus-specific-3, EB-2)
AdditionError: conj_and, (increased-7, also-19)
AdditionError: conj_and, (increased-7, also-19)
AdditionError: iobj, (administered-59, 14C-putrescine-60)
AdditionError: nsubjpass, (evaluated-4, They-1)
AdditionError: nsubjpass, (evaluated-4, They-1)
AdditionError: conj_and, (elevated-15, increased-24)
AdditionError: conj_or, (expression-9, only-16)
AdditionError: conj_or, (expression-9, only-16)
AdditionError: rel, (had-10, who-9)
AdditionError: rel, (incompetence-18, findings-15)
AdditionError: poss, (syndrome-2, lymphoma-10)
AdditionError: conj_but, (caused-9, apparently-16)
AdditionError: conj_but, (caused-9, apparently-16)
AdditionError: rel, (present-22, which-20)
AdditionError: rel, (present-22, which-20)
AdditionError: rel, (present-22, which-20)
AdditionError: rel, (correlate-67, where-60)
AdditionError: ccomp, (active-30, administered-32)
AdditionError: ccomp, (active-30, administered-32)
AdditionError: rel, (lacked-13, lymphoblasts-12)
AdditionError: rel, (lacked-13, lymphoblasts-12)
AdditionError: nsubjpass, (observed-26, levels-19)
AdditionError: nsubjpass, (reduced-21, Synthesis-1)
AdditionError: nsubjpass, (reduced-21, Synthesis-1)
AdditionError: nsubjpass, (reduced-21, Synthesis-1)
AdditionError: nsubjpass, (reduced-21, Synthesis-1)
AdditionError: conj_and, (suppresses-54, also-73)
AdditionError: xcomp, (act-110, suppress-114)
AdditionError: conj_and, (suppresses-54, also-73)
AdditionError: xcomp, (act-110, suppress-114)
AdditionError: conj_and, (suppresses-54, also-73)
AdditionError: xcomp, (act-110, suppress-114)
AdditionError: conj_and, (suppresses-54, also-73)
AdditionError: xcomp, (act-110, suppress-114)
AdditionError: conj_and, (suppresses-54, also-73)
AdditionError: xcomp, (act-110, suppress-114)
AdditionError: conj_and, (suppresses-54, also-73)
AdditionError: xcomp, (act-110, suppress-114)
AdditionError: conj_and, (suppresses-54, also-73)
AdditionError: xcomp, (act-110, suppress-114)
AdditionError: conj_and, (suppresses-54, also-73)
AdditionError: xcomp, (act-110, suppress-114)
AdditionError: conj_and, (suppresses-54, also-73)
AdditionError: xcomp, (act-110, suppress-114)
AdditionError: rel, (showed-7, which-6)
AdditionError: quantmod, (2-10, more-12)
AdditionError: quantmod, (2-10, more-12)
AdditionError: conj_and, (continued-25, static-31)
AdditionError: conj_and, (prevented-9, significantly-16)
AdditionError: conj_and, (LTC4-9, respectively-16)
AdditionError: conj_and, (LTC4-9, respectively-16)
AdditionError: conj_and, (LTC4-9, respectively-16)
AdditionError: conj_and, (given-7, then-15)
AdditionError: nsubjpass, (increased-11, activity-2)
AdditionError: conj_and, (decarboxylase-18, respectively-29)
AdditionError: conj_and, (decarboxylase-18, respectively-29)
AdditionError: conj_and, (decarboxylase-18, respectively-29)
AdditionError: conj_and, (decarboxylase-18, respectively-29)
AdditionError: conj_and, (decarboxylase-18, respectively-29)
AdditionError: conj_and, (decarboxylase-18, respectively-29)
AdditionError: ccomp, (increased-14, compared-19)
AdditionError: partmod, (alpha-6, given-8)
AdditionError: partmod, (alpha-6, given-8)
AdditionError: conj_and, (stimulated-9, also-26)
AdditionError: conj_and, (stimulated-9, also-26)
AdditionError: conj_and, (stimulated-9, also-26)
AdditionError: conj_and, (stimulated-9, also-26)
AdditionError: conj_and, (stimulated-9, also-26)
AdditionError: conj_and, (stimulated-9, also-26)
AdditionError: rel, (contribute-19, which-17)
AdditionError: rel, (contribute-19, which-17)
AdditionError: rel, (administered-66, where-63)
AdditionError: ccomp, (administered-66, grown-71)
AdditionError: conj_but, (seem-13, merely-21)
AdditionError: rel, (defective-25, which-22)
AdditionError: ccomp, (repressed-26, transferred-30)
AdditionError: ccomp, (repressed-26, transferred-30)
AdditionError: conj_and, (increases-28, later-30)
AdditionError: conj_and, (increases-28, later-30)
AdditionError: rel, (enzymes-16, which-12)
AdditionError: conj_and, (encoded-14, present-20)
AdditionError: conj_and, (encoded-14, present-20)
AdditionError: nsubjpass, (demonstrated-18, increase-2)
AdditionError: xcomp, (high-7, suggesting-19)
AdditionError: rel, (accumulated-14, why-12)
AdditionError: ccomp, (induced-9, injected-13)
AdditionError: ccomp, (found-9, injected-17)
AdditionError: prep_in, (found-87, chains-91)
AdditionError: conj_+/-, (%-42, respectively-52)
AdditionError: rel, (grade-48, diagnosis-43)
AdditionError: rel, (abundant-28, where-20)
AdditionError: rel, (blocks-21, that-20)
AdditionError: ccomp, (extinguished-27, fused-33)
AdditionError: ccomp, (increased-7, compared-13)
AdditionError: poss, (leukemia-9, lymphoma-13)
AdditionError: poss, (leukemia-9, lymphoma-13)
AdditionError: cop, (inhibited-10, was-8)
AdditionError: ccomp, (inhibited-7, applied-25)
AdditionError: nsubjpass, (studied-51, effect-2)
AdditionError: ccomp, (reduced-22, treated-26)
AdditionError: pred, (levels-6, increased-11)
AdditionError: conj_and, (%-26, respectively-31)
AdditionError: pred, (Exclusion-1, reduced-6)
AdditionError: rel, (predicted-20, sequence-18)
AdditionError: rel, (predicted-20, sequence-18)
AdditionError: rel, (predicted-20, sequence-18)
AdditionError: rel, (derived-36, that-34)
AdditionError: rel, (derived-36, that-34)
AdditionError: rel, (derived-36, that-34)
AdditionError: rel, (derived-36, that-34)
AdditionError: rel, (derived-36, that-34)
AdditionError: xcomp, (found-21, internalize-24)
AdditionError: nsubj, (resulted-19, passage-3)
AdditionError: nsubj, (resulted-19, passage-3)
AdditionError: rel, (allow-10, which-9)
AdditionError: rel, (allow-10, which-9)
AdditionError: rel, (allow-10, which-9)
AdditionError: rel, (allow-10, which-9)
AdditionError: cop, (maximal-5, was-4)
AdditionError: conj_and, (%-22, respectively-29)
AdditionError: conj_and, (%-22, respectively-29)
AdditionError: ccomp, (increased-11, compared-20)
AdditionError: ccomp, (evident-19, comparing-21)
AdditionError: ccomp, (evident-19, comparing-21)
AdditionError: ccomp, (observed-11, injected-22)
AdditionError: ccomp, (observed-11, injected-22)
AdditionError: conj_and, (sensitive-18, also-30)
AdditionError: nsubj, (gave-27, stimulation-3)
AdditionError: xcomp, (gave-27, examine-31)
AdditionError: nsubj, (gave-27, stimulation-3)
AdditionError: xcomp, (gave-27, examine-31)
AdditionError: nsubjpass, (tested-12, effusions-2)
AdditionError: nsubjpass, (determined-45, effects-14)
AdditionError: nsubjpass, (determined-45, effects-14)
AdditionError: ccomp, (varied-7, compared-13)
AdditionError: prep_to, (gave-24, colonies-28)
AdditionError: ccomp, (varied-7, compared-13)
AdditionError: prep_to, (gave-24, colonies-28)
AdditionError: iobj, (using-27, derivative-30)
AdditionError: iobj, (using-27, derivative-30)
AdditionError: conj_and, (days-2, is-10)
AdditionError: nn, (encephalitis-58, pseudoileus-88)
AdditionError: nn, (encephalitis-58, pseudoileus-88)
AdditionError: conj_and, (intercalated-5, permanently-15)
AdditionError: pred, (inhibitor-3, prevented-12)
AdditionError: pred, (inhibitor-3, prevented-12)
AdditionError: ccomp, (elevated-4, low-18)
AdditionError: ccomp, (enhanced-4, invade-8)
AdditionError: conj_and, (esters-9, significantly-17)
AdditionError: conj_and, (esters-9, significantly-17)
AdditionError: conj_and, (esters-9, significantly-17)
AdditionError: conj_and, (antibodies-5, preoperatively-11)
AdditionError: iobj, (predicting-25, response-26)
AdditionError: iobj, (predicting-25, response-26)
AdditionError: dobj, (showed-15, increase-27)
AdditionError: nsubjpass, (elevated-27, levels-24)
AdditionError: conj_and, (low-4, elevated-27)
AdditionError: nsubjpass, (elevated-27, levels-24)
AdditionError: conj_and, (low-4, elevated-27)
AdditionError: nsubjpass, (elevated-27, levels-24)
AdditionError: conj_and, (low-4, elevated-27)
AdditionError: nsubjpass, (elevated-27, levels-24)
AdditionError: conj_and, (low-4, elevated-27)
AdditionError: rel, (coupled-25, which-23)
AdditionError: conj_and, (mixed-18, then-26)
AdditionError: nsubj, (abrogated-13, Decontamination-1)
AdditionError: conj_and, (elevated-33, elevated-43)
AdditionError: conj_and, (elevated-33, elevated-43)
AdditionError: conj_and, (%-22, respectively-34)
AdditionError: conj_and, (%-22, respectively-34)
AdditionError: conj_and, (%-22, respectively-34)
AdditionError: conj_and, (%-22, respectively-34)
AdditionError: conj_and, (%-22, respectively-34)
AdditionError: nsubj, (had-13, patients-11)
AdditionError: rcmod, (patients-11, had-13)
AdditionError: dobj, (had-13, carcinoma-15)
AdditionError: ccomp, (abolished-32, reduced-37)
AdditionError: ccomp, (determined-13, found-22)
AdditionError: conj_away, (localized-11, segregates-29)
AdditionError: nsubj, (caused-22, injections-2)
AdditionError: nsubjpass, (tested-25, they-23)
AdditionError: nsubjpass, (tested-25, they-23)
AdditionError: rel, (determined-9, which-7)
AdditionError: rel, (determined-9, which-7)
AdditionError: ccomp, (occurred-23, reduced-29)
AdditionError: ccomp, (occurred-23, reduced-29)
AdditionError: rel, (expresses-13, which-12)
AdditionError: conj_or, (%-7, respectively-28)
AdditionError: conj_and, (gene-9, sometimes-19)
AdditionError: conj_and, (gene-9, sometimes-19)
AdditionError: conj_and, (gene-9, sometimes-19)
AdditionError: conj_and, (demonstrate-9, further-32)
AdditionError: conj_and, (demonstrate-9, further-32)
AdditionError: conj_and, (increase-34, then-51)
AdditionError: conj_and, (increase-34, then-51)
AdditionError: conj_+/-, (difference-26, respectively-79)
AdditionError: conj_+/-, (difference-26, respectively-79)
AdditionError: rel, (defines-11, which-10)
AdditionError: rel, (defines-11, which-10)
AdditionError: dobj, (had-21, levels-24)
AdditionError: amod, (inducibility-17, unrelated-9)
AdditionError: conj_and, (induction-3, vivo-28)
AdditionError: rel, (present-39, when-38)
AdditionError: conj_and, (generation-10, presumably-13)
AdditionError: conj_perhaps, (unusual-3, gene-34)
AdditionError: conj_and, (decarboxylase-17, respectively-28)
AdditionError: conj_and, (decarboxylase-17, respectively-28)
AdditionError: conj_and, (decarboxylase-17, respectively-28)
AdditionError: conj_and, (decarboxylase-17, respectively-28)
AdditionError: conj_and, (nM-18, respectively-27)
AdditionError: conj_and, (positive-18, negative-31)
AdditionError: conj_and, (positive-18, negative-31)
AdditionError: conj_and, (positive-18, negative-31)
AdditionError: dobj, (showed-16, dependence-29)
AdditionError: dobj, (showed-16, dependence-29)
AdditionError: conj_or, (%-41, respectively-52)
AdditionError: iobj, (given-34, micrograms/kg-36)
AdditionError: poss, (lines-15, lymphoma-13)
AdditionError: ccomp, (elevated-8, disseminated-30)
AdditionError: ccomp, (elevated-8, disseminated-30)
AdditionError: rel, (has-11, which-10)
AdditionError: nsubjpass, (induced-58, it-55)
AdditionError: parataxis, (according-21, induced-58)
AdditionError: nsubj, (increased-26, activity-19)
AdditionError: nsubjpass, (detected-40, pseudocholinesterase-30)
AdditionError: nsubjpass, (detected-40, pseudocholinesterase-30)
AdditionError: nsubjpass, (detected-40, pseudocholinesterase-30)
AdditionError: nsubjpass, (detected-40, pseudocholinesterase-30)
AdditionError: conj_and, (decreases-21, eventually-27)
AdditionError: poss, (lines-10, lymphoma-8)
AdditionError: quantmod, (2.5-51, equal-49)
AdditionError: quantmod, (2.5-51, equal-49)
AdditionError: ccomp, (striking-6, compared-11)
AdditionError: rel, (lack-6, cancers-5)
AdditionError: rel, (lack-6, cancers-5)
AdditionError: rel, (restricted-26, sites-21)
AdditionError: rel, (restricted-26, sites-21)
AdditionError: rel, (restricted-26, sites-21)
AdditionError: rel, (restricted-26, sites-21)
AdditionError: rel, (restricted-26, sites-21)
AdditionError: rel, (restricted-26, sites-21)
AdditionError: poss, (leukemia-24, lymphoma-48)
AdditionError: poss, (leukemia-24, disease-53)
AdditionError: poss, (leukemia-24, lymphoma-48)
AdditionError: poss, (leukemia-24, disease-53)
AdditionError: poss, (leukemia-24, lymphoma-48)
AdditionError: poss, (leukemia-24, disease-53)
AdditionError: poss, (leukemia-24, lymphoma-48)
AdditionError: poss, (leukemia-24, disease-53)
AdditionError: poss, (leukemia-24, lymphoma-48)
AdditionError: poss, (leukemia-24, disease-53)
AdditionError: poss, (leukemia-24, lymphoma-48)
AdditionError: poss, (leukemia-24, disease-53)
AdditionError: poss, (leukemia-24, lymphoma-48)
AdditionError: poss, (leukemia-24, disease-53)
AdditionError: poss, (leukemia-24, lymphoma-48)
AdditionError: poss, (leukemia-24, disease-53)
AdditionError: poss, (leukemia-24, lymphoma-48)
AdditionError: poss, (leukemia-24, disease-53)
AdditionError: poss, (leukemia-24, lymphoma-48)
AdditionError: poss, (leukemia-24, disease-53)
AdditionError: poss, (leukemia-24, lymphoma-48)
AdditionError: poss, (leukemia-24, disease-53)
AdditionError: poss, (leukemia-24, lymphoma-48)
AdditionError: poss, (leukemia-24, disease-53)
AdditionError: poss, (leukemia-24, lymphoma-48)
AdditionError: poss, (leukemia-24, disease-53)
AdditionError: poss, (leukemia-24, lymphoma-48)
AdditionError: poss, (leukemia-24, disease-53)
AdditionError: poss, (leukemia-24, lymphoma-48)
AdditionError: poss, (leukemia-24, disease-53)
AdditionError: poss, (leukemia-24, lymphoma-48)
AdditionError: poss, (leukemia-24, disease-53)
AdditionError: poss, (leukemia-24, lymphoma-48)
AdditionError: poss, (leukemia-24, disease-53)
AdditionError: poss, (leukemia-24, lymphoma-48)
AdditionError: poss, (leukemia-24, disease-53)
AdditionError: poss, (leukemia-24, lymphoma-48)
AdditionError: poss, (leukemia-24, disease-53)
AdditionError: poss, (leukemia-24, lymphoma-48)
AdditionError: poss, (leukemia-24, disease-53)
AdditionError: poss, (leukemia-24, lymphoma-48)
AdditionError: poss, (leukemia-24, disease-53)
AdditionError: poss, (leukemia-24, lymphoma-48)
AdditionError: poss, (leukemia-24, disease-53)
AdditionError: ccomp, (modified-13, compared-31)
AdditionError: ccomp, (modified-13, compared-31)
AdditionError: ccomp, (modified-13, compared-31)
AdditionError: ccomp, (modified-13, compared-31)
AdditionError: ccomp, (modified-13, compared-31)
AdditionError: nsubj, (responsible-4, astrocytoma-2)
AdditionError: ccomp, (elevated-12, compared-22)
AdditionError: rel, (showed-12, when-10)
AdditionError: rel, (showed-12, when-10)
AdditionError: rel, (showed-12, when-10)
AdditionError: conj_and, (suggesting-24, thus-32)
AdditionError: conj_and, (suggesting-24, thus-32)
AdditionError: rel, (affected-40, family-38)
AdditionError: nsubj, (retained-22, all-21)
AdditionError: dobj, (retained-22, activity-25)
AdditionError: conj_and, (elevated-12, also-33)
AdditionError: conj_and, (elevated-12, slightly-34)
AdditionError: conj_and, (elevated-12, also-33)
AdditionError: conj_and, (elevated-12, slightly-34)
AdditionError: conj_and, (elevated-12, also-33)
AdditionError: conj_and, (elevated-12, slightly-34)
AdditionError: rel, (higher-44, which-41)
AdditionError: rel, (higher-44, which-41)
AdditionError: rel, (greatest-60, where-54)
AdditionError: prep_to, (bind-7, variety-10)
AdditionError: prep_to, (bind-7, variety-10)
AdditionError: prep_to, (bind-7, variety-10)
AdditionError: ccomp, (present-17, used-22)
AdditionError: pred, (tests-2, produced-4)
AdditionError: pred, (tests-2, produced-4)
AdditionError: pred, (tests-2, produced-4)
AdditionError: conj_and, (%-68, respectively-76)
AdditionError: conj_and, (%-68, respectively-76)
AdditionError: conj_and, (%-68, respectively-76)
AdditionError: conj_and, (%-68, respectively-76)
AdditionError: conj_and, (%-68, respectively-76)
AdditionError: conj_or, (abolished-22, markedly-24)
AdditionError: nsubjpass, (isolated-7, gene-5)
AdditionError: nsubjpass, (isolated-7, gene-5)
AdditionError: partmod, (patients-4, treated-18)
AdditionError: partmod, (patients-4, treated-18)
AdditionError: partmod, (patients-4, treated-18)
AdditionError: partmod, (patients-4, treated-18)
AdditionError: poss, (activity-12, adenosine-14)
AdditionError: nsubj, (showed-36, B-35)
AdditionError: parataxis, (divided-8, showed-36)
AdditionError: dobj, (showed-36, elevation-38)
AdditionError: nsubj, (showed-36, B-35)
AdditionError: parataxis, (divided-8, showed-36)
AdditionError: dobj, (showed-36, elevation-38)
AdditionError: dobj, (include-10, HCG-14)
AdditionError: dobj, (include-10, HCG-14)
AdditionError: rel, (bind-8, whereby-4)
AdditionError: rel, (lack-31, which-30)
AdditionError: rel, (involved-69, whereby-64)
AdditionError: rel, (followed-26, which-24)
AdditionError: poss, (cells-8, lymphoma-6)
AdditionError: quantmod, (three-8, more-10)
AdditionError: poss, (Burkitt-33, non-Burkitt-36)
AdditionError: poss, (Burkitt-33, non-Burkitt-36)
AdditionError: rel, (encoded-20, which-18)
AdditionError: ccomp, (decreased-12, induced-19)
AdditionError: rel, (retain-15, which-14)
AdditionError: conj_and, (differentiation-24, namely-26)
AdditionError: xcomp, (reported-17, decrease-19)
AdditionError: nsubj, (present-4, lymphocytes-2)
AdditionError: quantmod, (9-23, more-25)
AdditionError: conj_and, (inhibits-31, therefore-37)
AdditionError: conj_and, (stimulated-5, hence-9)
AdditionError: poss, (aniridia-14, tumor-18)
AdditionError: quantmod, (more-20, less-22)
AdditionError: rel, (required-30, which-28)
AdditionError: rel, (extended-8, life-span-5)
AdditionError: conj_and, (Tp40+-15, Tp120+-27)
AdditionError: conj_and, (Tp40+-15, Tp120+-27)
AdditionError: nsubjpass, (observed-18, lysis-3)
AdditionError: conj_and, (breakthrough-19, easier-71)
AdditionError: poss, (TGF-27, TIF-30)
AdditionError: poss, (TGF-27, TIF-30)
AdditionError: prep, (inhibited-20, if-37)
AdditionError: dobj, (inhibited-20, growth-42)
AdditionError: prep, (inhibited-20, if-37)
AdditionError: dobj, (inhibited-20, growth-42)
AdditionError: nsubjpass, (studied-35, levels-2)
AdditionError: conj_and, (increased-6, significantly-49)
AdditionError: conj_and, (increased-6, significantly-49)
AdditionError: ccomp, (increased-12, compared-21)
AdditionError: ccomp, (increased-12, compared-21)
AdditionError: poss, (leukemia-9, lymphoma-13)
AdditionError: poss, (leukemia-9, lymphoma-13)
AdditionError: poss, (leukemia-9, lymphoma-13)
AdditionError: poss, (leukemia-9, lymphoma-13)
AdditionError: cop, (negative-14, were-13)
AdditionError: ccomp, (close-5, indicator-17)
AdditionError: ccomp, (close-5, used-21)
AdditionError: xcomp, (confirmed-4, lesions-9)
AdditionError: xcomp, (confirmed-4, had-14)
AdditionError: conj_but, (lesions-9, had-14)
AdditionError: ccomp, (justified-32, associated-45)
AdditionError: xcomp, (confirmed-4, lesions-9)
AdditionError: xcomp, (confirmed-4, had-14)
AdditionError: conj_but, (lesions-9, had-14)
AdditionError: ccomp, (justified-32, associated-45)
AdditionError: rel, (died-9, which-8)
AdditionError: rel, (necessary-22, undermethylation-20)
AdditionError: rel, (necessary-22, undermethylation-20)
AdditionError: ccomp, (observed-18, incubated-25)
AdditionError: ccomp, (observed-18, incubated-25)
AdditionError: ccomp, (enhanced-8, incubated-17)
AdditionError: rel, (identical-50, sequence-48)
AdditionError: rel, (exceeded-28, levels-26)
AdditionError: ccomp, (insufficient-9, delivered-25)
AdditionError: ccomp, (able-5, injected-25)
AdditionError: ccomp, (able-5, injected-25)
AdditionError: conj_and, (developed-15, induced-38)
AdditionError: conj_and, (developed-15, induced-38)
AdditionError: nsubjpass, (activated-38, which-36)
AdditionError: rel, (activated-38, which-36)
AdditionError: rcmod, (lymphocytes-27, activated-38)
AdditionError: poss, (sera-9, patients-7)
AdditionError: poss, (sera-9, patients-7)
AdditionError: poss, (sera-9, patients-7)
AdditionError: poss, (sera-9, patients-7)
AdditionError: poss, (sera-9, patients-7)
AdditionError: poss, (sera-9, patients-7)
AdditionError: poss, (cells-10, lymphoma-9)
AdditionError: rel, (experienced-22, who-21)
AdditionError: rel, (experienced-22, who-21)
AdditionError: conj_and, (analogs-25, respectively-35)
AdditionError: prep_of, (sera-8, subjects-10)
AdditionError: prep_of, (sera-8, subjects-10)
AdditionError: ccomp, (reduced-23, compared-25)
AdditionError: ccomp, (observed-32, compared-42)
AdditionError: rel, (derived-9, genome-7)
AdditionError: rel, (derived-9, genome-7)
AdditionError: poss, (cultures-8, disease-6)
AdditionError: poss, (cultures-8, disease-6)
AdditionError: rel, (frequent-30, where-26)
AdditionError: rel, (event-42, where-37)
AdditionError: rel, (activated-46, where-37)
AdditionError: iobj, (show-6, pattern-12)
AdditionError: iobj, (show-6, pattern-12)
AdditionError: iobj, (show-6, pattern-12)
AdditionError: iobj, (show-6, pattern-12)
AdditionError: iobj, (show-6, pattern-12)
AdditionError: iobj, (show-6, pattern-12)
AdditionError: quantmod, (90-24, equal-22)
AdditionError: rel, (increases-36, that-35)
AdditionError: ccomp, (increased-10, compared-12)
AdditionError: rel, (contains-37, which-36)
AdditionError: rel, (contains-37, which-36)
AdditionError: conj_negcc, (capable-14, IgG1-24)
AdditionError: conj_negcc, (capable-14, IgG1-24)
AdditionError: ccomp, (complete-9, seen-24)
AdditionError: conj_or, (decreased-18, deficient-20)
AdditionError: conj_or, (decreased-18, deficient-20)
AdditionError: prep, (administered-41, before-43)
AdditionError: prep, (administered-41, after-45)
AdditionError: prep, (administered-41, before-43)
AdditionError: prep, (administered-41, after-45)
AdditionError: poss, (origin-78, cells-75)
AdditionError: nsubj, (occurred-19, Loss-1)
AdditionError: nsubj, (occurred-19, Loss-1)
AdditionError: nsubj, (occurred-19, Loss-1)
AdditionError: nsubj, (occurred-19, Loss-1)
AdditionError: ccomp, (observed-4, expressed-10)
AdditionError: rel, (function-28, proportions-24)
AdditionError: rel, (function-28, proportions-24)
AdditionError: dobj, (degree-33, increase-54)
AdditionError: conj_and, (promote-6, perhaps-18)
AdditionError: conj_and, (promote-6, perhaps-18)
AdditionError: nsubjpass, (reduced-6, expression-2)
AdditionError: nsubjpass, (reduced-6, expression-2)
AdditionError: conj_and, (%-23, respectively-33)
AdditionError: conj_and, (%-23, respectively-33)
AdditionError: dobj, (determine-7, effect-9)
AdditionError: dobj, (determine-7, effect-9)
AdditionError: dobj, (determine-7, effect-9)
AdditionError: dobj, (determine-7, effect-9)
AdditionError: dobj, (determine-7, effect-9)
AdditionError: rel, (were-23, whereby-19)
AdditionError: rel, (were-23, whereby-19)
AdditionError: rel, (parallel-24, which-21)
AdditionError: rel, (parallel-24, which-21)
AdditionError: rel, (parallel-24, which-21)
AdditionError: pred, (deletion-2, reduced-4)
AdditionError: poss, (aniridia-11, tumor-18)
AdditionError: conj_and, (positive-13, positive-19)
AdditionError: conj_and, (positive-13, positive-19)
AdditionError: conj_and, (positive-13, positive-19)
AdditionError: conj_and, (positive-13, positive-19)
AdditionError: iobj, (using-22, lines-28)
AdditionError: iobj, (using-22, lines-28)
AdditionError: nsubj, (reactive-4, Myoblasts-1)
AdditionError: rel, (mutagen-sensitive-25, which-23)
AdditionError: rel, (=-18, where-14)
AdditionError: rel, (induces-56, where-41)
AdditionError: ccomp, (=-18, elevated-71)
AdditionError: rel, (=-18, where-14)
AdditionError: rel, (induces-56, where-41)
AdditionError: ccomp, (=-18, elevated-71)
AdditionError: rel, (=-18, where-14)
AdditionError: rel, (induces-56, where-41)
AdditionError: ccomp, (=-18, elevated-71)
AdditionError: ccomp, (generated-15, incubated-26)
AdditionError: ccomp, (generated-15, incubated-26)
AdditionError: rel, (neutralize-9, which-7)
AdditionError: rel, (type-50, which-46)
AdditionError: rel, (type-50, which-46)
AdditionError: rel, (type-50, which-46)
AdditionError: rel, (type-50, which-46)
AdditionError: rel, (type-50, which-46)
AdditionError: rel, (type-50, which-46)
AdditionError: rel, (resistant-26, that-24)
AdditionError: nsubj, (revealed-4, studies-3)
AdditionError: dobj, (revealed-4, increase-6)
AdditionError: conj_and, (normal-11, suppressed-16)
AdditionError: conj_and, (normal-11, was-22)
AdditionError: conj_and, (normal-11, suppressed-16)
AdditionError: conj_and, (normal-11, was-22)
AdditionError: rel, (prompted-16, which-15)
AdditionError: rel, (prompted-16, which-15)
AdditionError: rel, (prompted-16, which-15)
AdditionError: rel, (prompted-16, which-15)
AdditionError: conj_and, (0.098-26, respectively-31)
AdditionError: quantmod, (20-31, equal-29)
AdditionError: rel, (defines-23, which-22)
AdditionError: conj_or, (antigen-27, respectively-34)
AdditionError: nsubjpass, (elevated-10, levels-8)
AdditionError: nsubjpass, (elevated-10, levels-8)
AdditionError: nsubjpass, (elevated-10, levels-8)
AdditionError: rel, (synthesize-17, which-16)
AdditionError: tmod, (shorter-37, years-57)
AdditionError: poss, (antigen-27, antigen-33)
AdditionError: poss, (antigen-27, antigen-33)
AdditionError: poss, (antigen-27, antigen-33)
AdditionError: poss, (antigen-27, antigen-33)
AdditionError: poss, (antigen-27, antigen-33)
AdditionError: poss, (antigen-27, antigen-33)
AdditionError: ccomp, (enhanced-33, compared-39)
AdditionError: conj_and, (increased-21, then-31)
AdditionError: conj_and, (increase-37, presumably-43)
AdditionError: ccomp, (observed-11, cultured-16)
AdditionError: rel, (inhibits-24, which-23)
AdditionError: rel, (inhibits-24, which-23)
AdditionError: rel, (inhibits-24, which-23)
AdditionError: rel, (compared-6, when-5)
AdditionError: rel, (deficient-10, which-8)
AdditionError: rel, (deficient-10, which-8)
AdditionError: rel, (deficient-10, which-8)
AdditionError: conj_and, (II-24, respectively-35)
AdditionError: conj_and, (II-24, respectively-35)
AdditionError: rel, (seen-19, which-16)
AdditionError: conj_and, (%-11, respectively-21)
AdditionError: rel, (appeared-11, where-8)
AdditionError: rel, (had-17, who-16)
AdditionError: iobj, (describes-3, woman-6)
AdditionError: ccomp, (higher-8, compared-20)
AdditionError: cop, (increased-14, was-2)
AdditionError: ccomp, (found-47, used-58)
AdditionError: ccomp, (found-47, used-58)
AdditionError: ccomp, (found-47, used-58)
AdditionError: ccomp, (found-47, used-58)
AdditionError: ccomp, (found-47, used-58)
AdditionError: quantmod, (30-23, equal-21)
AdditionError: rel, (refractory-42, which-40)
AdditionError: rel, (refractory-42, which-40)
AdditionError: rel, (refractory-42, which-40)
AdditionError: rel, (refractory-42, which-40)
AdditionError: rel, (refractory-42, which-40)
AdditionError: rel, (refractory-42, which-40)
AdditionError: rel, (increases-5, which-4)
AdditionError: conj_and, (%-33, respectively-41)
AdditionError: conj_and, (%-33, respectively-41)
AdditionError: rel, (has-14, that-13)
AdditionError: rel, (involved-28, whereby-23)
AdditionError: ccomp, (significant-26, was-33)
AdditionError: ccomp, (resistant-15, incubated-20)
AdditionError: rel, (expressed-13, blasts-12)
AdditionError: rel, (exerts-27, where-25)
AdditionError: conj, (inhibit-11, purified-16)
AdditionError: prep_from, (purified-16, liver-19)
AdditionError: ccomp, (increased-18, compared-20)
AdditionError: ccomp, (increased-18, compared-20)
AdditionError: ccomp, (increased-18, compared-20)
AdditionError: ccomp, (increased-18, compared-20)
AdditionError: ccomp, (increased-18, compared-20)
AdditionError: ccomp, (increased-18, compared-20)
AdditionError: dobj, (occurred-16, staining-22)
AdditionError: rel, (suggested-23, which-22)
AdditionError: rel, (indicated-8, scans-7)
AdditionError: rel, (known-39, where-36)
AdditionError: partmod, (rats-6, grafted-7)
AdditionError: poss, (menorrhagia-14, IUD-16)
AdditionError: poss, (T-lymphocytes-12, patients-10)
AdditionError: ccomp, (tumorigenic-49, tested-51)
AdditionError: ccomp, (tumorigenic-49, tested-51)
AdditionError: ccomp, (tumorigenic-49, tested-51)
AdditionError: ccomp, (tumorigenic-49, tested-51)
AdditionError: ccomp, (tumorigenic-49, tested-51)
AdditionError: pred, (activities-33, release-38)
AdditionError: neg, (seen-36, not-44)
AdditionError: neg, (seen-36, not-44)
AdditionError: nsubj, (is-2, correlation-5)
AdditionError: nsubj, (is-2, correlation-5)
AdditionError: rel, (localized-47, which-45)
AdditionError: iobj, (using-29, antibody-35)
AdditionError: iobj, (using-29, antibody-35)
AdditionError: rel, (evident-26, which-24)
AdditionError: nsubjpass, (reduced-5, level-3)
AdditionError: nsubjpass, (reduced-5, level-3)
AdditionError: nsubjpass, (reduced-5, level-3)
AdditionError: nn, (chain-7, lambda-6)
AdditionError: conj_and, (exhibited-8, often-18)
AdditionError: conj_and, (exhibited-8, often-18)
AdditionError: conj_and, (exhibited-8, often-18)
AdditionError: conj_and, (exhibited-8, often-18)
AdditionError: ccomp, (observed-26, compared-29)
AdditionError: ccomp, (observed-26, compared-29)
AdditionError: ccomp, (observed-26, compared-29)
AdditionError: ccomp, (observed-26, compared-29)
AdditionError: ccomp, (observed-26, compared-29)
AdditionError: ccomp, (observed-26, compared-29)
AdditionError: rel, (ng/ml-19, concentration-14)
AdditionError: rel, (different-45, which-42)
AdditionError: conj_and, (has-36, has-52)
AdditionError: neg, (responsible-26, not-20)
AdditionError: neg, (responsible-26, not-20)
AdditionError: neg, (responsible-26, not-20)
AdditionError: ccomp, (increased-35, shifted-40)
AdditionError: rel, (cultured-15, when-14)
AdditionError: rel, (cultured-15, when-14)
AdditionError: conj_and, (were-7, associated-23)
AdditionError: conj_and, (were-7, positive-30)
AdditionError: conj_and, (were-7, associated-23)
AdditionError: conj_and, (were-7, positive-30)
AdditionError: ccomp, (increased-5, supplemented-12)
AdditionError: ccomp, (increased-5, supplemented-12)
AdditionError: conj_and, (phosphorylase-19, respectively-25)
AdditionError: conj_and, (phosphorylase-19, respectively-25)
AdditionError: conj_and, (yielded-25, drug-37)
AdditionError: conj_and, (yielded-25, drug-37)
AdditionError: iobj, (activating-23, Ca++--25)
AdditionError: iobj, (activating-23, kinase-29)
AdditionError: iobj, (activating-23, Ca++--25)
AdditionError: iobj, (activating-23, kinase-29)
AdditionError: cop, (urothelium-specific-15, be-14)
AdditionError: dobj, (resulted-19, growth-39)
AdditionError: poss, (lines-20, lymphoma-18)
AdditionError: ccomp, (observed-13, infected-23)
AdditionError: rel, (appear-39, which-36)
AdditionError: ccomp, (resulted-6, stimulated-17)
AdditionError: conj_and, (enhance-30, also-35)
AdditionError: conj_and, (enhance-30, also-35)
AdditionError: conj_and, (enhance-30, also-35)
AdditionError: nn, (hybridomas-36, T-34)
AdditionError: nn, (hybridomas-36, T-34)
AdditionError: nn, (hybridomas-36, T-34)
AdditionError: nn, (hybridomas-36, T-34)
AdditionError: conj_and, (restored-39, greatly-41)
AdditionError: rel, (had-43, cells-35)
AdditionError: nsubjpass, (observed-16, decrease-11)
AdditionError: nsubjpass, (observed-16, decrease-11)
AdditionError: nsubj, (exhibited-16, Mice-1)
AdditionError: dobj, (exhibited-16, decrease-18)
AdditionError: nsubj, (exhibited-16, Mice-1)
AdditionError: dobj, (exhibited-16, decrease-18)
AdditionError: rel, (added-7, when-6)
AdditionError: prep_in, (decreased-7, males-9)
AdditionError: prep_in, (decreased-7, males-9)
AdditionError: rel, (higher-24, where-19)
AdditionError: iobj, (treated-8, U-76)
AdditionError: iobj, (treated-8, U-76)
AdditionError: iobj, (treated-8, U-76)
AdditionError: iobj, (treated-8, U-76)
AdditionError: conj_and, (resulted-27, subsequently-36)
AdditionError: conj_and, (expressed-16, expressed-29)
AdditionError: conj_and, (expressed-16, expressed-29)
AdditionError: rel, (inhibited-16, growth-14)
AdditionError: ccomp, (increased-29, compared-36)
AdditionError: ccomp, (increased-29, compared-36)
AdditionError: cop, (lost-5, Are-1)
AdditionError: nsubj, (appeared-22, doses-16)
AdditionError: nsubj, (expression-11, %-16)
AdditionError: conj_but, (inhibitor-10, ineffective-24)
AdditionError: ccomp, (seen-6, induces-18)
AdditionError: conj_and, (%-16, respectively-21)
AdditionError: conj_and, (%-16, respectively-21)
AdditionError: ccomp, (tended-14, analysed-41)
AdditionError: rel, (shares-27, which-26)
AdditionError: rel, (shares-27, which-26)
AdditionError: conj_and, (inactive-14, thereby-23)
AdditionError: ccomp, (negative-33, used-46)
AdditionError: ccomp, (negative-33, used-46)
AdditionError: ccomp, (negative-33, used-46)
AdditionError: conj_and, (high-7, markedly-26)
AdditionError: ccomp, (pronounced-10, given-14)
AdditionError: conj_and, (carcinoma-15, respectively-26)
AdditionError: conj_and, (carcinoma-15, respectively-26)
AdditionError: conj_and, (carcinoma-15, respectively-26)
AdditionError: conj_x, (mg-26, twice-28)
AdditionError: conj_x, (mg-26, twice-28)
AdditionError: conj_x, (mg-26, twice-28)
AdditionError: conj_x, (mg-26, twice-28)
AdditionError: ccomp, (inhibited-5, incubated-11)
AdditionError: conj_and, (inhibited-3, class-specifically-18)
AdditionError: conj_but, (enhances-2, paradoxically-9)
AdditionError: rel, (blocked-35, which-32)
AdditionError: rel, (increased-24, which-22)
AdditionError: ccomp, (behaved-21, hybridized-32)
AdditionError: rel, (expressed-48, that-47)
AdditionError: rel, (expressed-48, that-47)
AdditionError: rel, (expressed-48, that-47)
AdditionError: rel, (expressed-48, that-47)
AdditionError: ccomp, (increased-4, added-9)
AdditionError: poss, (lines-6, lymphoma-5)
AdditionError: poss, (lines-6, lymphoma-5)
AdditionError: poss, (lines-6, lymphoma-5)
AdditionError: poss, (lines-6, lymphoma-5)
AdditionError: poss, (lines-6, lymphoma-5)
AdditionError: poss, (lines-6, lymphoma-5)
AdditionError: ccomp, (examined-6, months-12)
AdditionError: rel, (have-33, who-32)
AdditionError: rel, (have-33, who-32)
AdditionError: rel, (have-33, who-32)
AdditionError: rel, (have-33, who-32)
AdditionError: rel, (=-26, where-24)
AdditionError: nsubjpass, (detected-7, PMR-4)
AdditionError: prep_for, (detected-7, cancer-10)
AdditionError: nsubjpass, (detected-7, PMR-4)
AdditionError: prep_for, (detected-7, cancer-10)
AdditionError: dobj, (paralleled-12, maturation-15)
AdditionError: dobj, (paralleled-12, maturation-15)
AdditionError: iobj, (inducing-15, inhibitor-18)
AdditionError: iobj, (inducing-15, inhibitor-18)
AdditionError: rel, (observed-10, lesions-8)
AdditionError: rel, (1-phosphate-18, which-14)
AdditionError: rel, (1-phosphate-18, which-14)
AdditionError: conj_and, (present-19, present-39)
AdditionError: conj_and, (present-19, present-39)
AdditionError: conj_and, (present-19, present-39)
AdditionError: conj_and, (present-19, present-39)
AdditionError: conj_and, (present-19, present-39)
AdditionError: conj_and, (present-19, present-39)
AdditionError: ccomp, (found-12, compared-32)
AdditionError: prep_of, (cells-3, patients-5)
AdditionError: rel, (features-28, all-23)
AdditionError: conj_and, (negative-21, also-25)
AdditionError: conj_and, (negative-21, also-25)
AdditionError: conj_and, (negative-21, also-25)
AdditionError: conj_and, (negative-21, also-25)
AdditionError: conj_and, (negative-21, also-25)
AdditionError: conj_and, (negative-21, also-25)
AdditionError: conj_and, (negative-21, also-25)
AdditionError: conj_and, (negative-21, also-25)
AdditionError: conj_and, (negative-21, also-25)
AdditionError: conj_and, (negative-21, also-25)
AdditionError: nsubj, (contrasted-28, inhibition-3)
AdditionError: ccomp, (contrasted-28, given-45)
AdditionError: conj_and, (hyperalbuminemia-43, possibly-45)
AdditionError: conj_and, (hyperalbuminemia-43, possibly-45)
AdditionError: conj_and, (hyperalbuminemia-43, possibly-45)
AdditionError: conj_and, (hyperalbuminemia-43, possibly-45)
AdditionError: conj_and, (reactive-7, also-14)
AdditionError: conj_and, (reactive-7, also-14)
AdditionError: pobj, (transfection-13, plasmid-17)
AdditionError: pobj, (transfection-13, plasmid-17)
AdditionError: pobj, (transfection-13, plasmid-17)
AdditionError: pobj, (transfection-13, plasmid-17)
AdditionError: conj_and, (increased-7, rapidly-19)
AdditionError: acomp, (resulted-34, apparent-45)
AdditionError: dobj, (produced-10, virions-18)
AdditionError: xcomp, (produced-10, suggesting-20)
AdditionError: conj_and, (decreased-12, absent-22)
AdditionError: conj_and, (elevated-19, gradually-22)
AdditionError: neg, (induce-10, not-7)
AdditionError: prep_from, (cells-31, patients-33)
AdditionError: quantmod, (35-14, equal-12)
AdditionError: rel, (translated-34, that-30)
AdditionError: dep, (MDS-30, RAEB-32)
AdditionError: rel, (have-46, who-43)
AdditionError: dep, (MDS-30, RAEB-32)
AdditionError: rel, (have-46, who-43)
AdditionError: dep, (MDS-30, RAEB-32)
AdditionError: rel, (have-46, who-43)
AdditionError: dep, (MDS-30, RAEB-32)
AdditionError: rel, (have-46, who-43)
AdditionError: dep, (MDS-30, RAEB-32)
AdditionError: rel, (have-46, who-43)
AdditionError: dep, (MDS-30, RAEB-32)
AdditionError: rel, (have-46, who-43)
AdditionError: rel, (resectable-27, 272-22)
AdditionError: rel, (resectable-27, 272-22)
AdditionError: rel, (cotransfected-6, when-5)
AdditionError: rel, (cotransfected-6, when-5)
AdditionError: ccomp, (elevated-15, compared-26)
AdditionError: nsubj, (decreased-7, levels-2)
AdditionError: ccomp, (recovered-30, decreased-7)
AdditionError: nsubj, (decreased-7, levels-2)
AdditionError: ccomp, (recovered-30, decreased-7)
AdditionError: xcomp, (seems-21, result-24)
AdditionError: nsubjpass, (found-11, expression-2)
AdditionError: nsubjpass, (found-11, expression-2)
AdditionError: conj_and, (restricted-8, therefore-18)
AdditionError: prep_in, (have-20, vivo-25)
AdditionError: prep_in, (have-20, vivo-25)
AdditionError: conj_and, (alleles-6, hence-8)
AdditionError: poss, (cases-7, lymphoma-13)
AdditionError: poss, (cases-7, lymphoma-13)
AdditionError: cop, (germ-line-33, were-32)
AdditionError: cop, (germ-line-33, were-32)
AdditionError: cop, (germ-line-33, were-32)
AdditionError: cop, (germ-line-33, were-32)
AdditionError: conj_and, (alpha-1-10, also-12)
AdditionError: conj_and, (alpha-1-10, also-12)
AdditionError: conj_and, (elevated-11, related-14)
AdditionError: rel, (has-34, that-33)
AdditionError: conj_and, (1.6-24, respectively-31)
AdditionError: neg, (expressed-19, not-31)
AdditionError: neg, (expressed-19, not-31)
AdditionError: neg, (expressed-19, not-31)
AdditionError: neg, (expressed-19, not-31)
AdditionError: nsubj, (had-25, patients-23)
AdditionError: advcl, (had-5, had-25)
AdditionError: dobj, (had-25, reduction-28)
AdditionError: conj_and, (PHI-17, especially-21)
AdditionError: conj_and, (PHI-17, especially-21)
AdditionError: rel, (found-11, which-8)
AdditionError: rel, (found-11, which-8)
AdditionError: prep_in, (mitogen-10, patients-12)
AdditionError: conj_and, (pSV2-AS-28, respectively-32)
AdditionError: conj_and, (pSV2-AS-28, respectively-32)
AdditionError: conj_and, (pSV2-AS-28, respectively-32)
AdditionError: conj_and, (pSV2-AS-28, respectively-32)
AdditionError: conj_and, (pSV2-AS-28, respectively-32)
AdditionError: rel, (increase-42, striking-34)
AdditionError: rel, (increase-42, consistent-36)
AdditionError: conj_and, (decreased-6, then-20)
AdditionError: conj_and, (decreased-6, gradually-21)
AdditionError: ccomp, (increased-11, compared-20)
AdditionError: ccomp, (increased-11, compared-20)
AdditionError: nsubjpass, (cultured-28, they-26)
AdditionError: advcl, (entered-18, cultured-28)
AdditionError: nsubjpass, (cultured-28, they-26)
AdditionError: advcl, (entered-18, cultured-28)
AdditionError: quantmod, (two-77, more-79)
AdditionError: rel, (is-30, where-28)
AdditionError: rel, (is-30, where-28)
AdditionError: rel, (carries-59, that-58)
AdditionError: rel, (carries-59, that-58)
AdditionError: rel, (carries-59, that-58)
AdditionError: rel, (carries-59, that-58)
AdditionError: nsubj, (negative-5, tumors-2)
AdditionError: ccomp, (revealed-9, compared-37)
AdditionError: poss, (leukemia-21, disease-25)
AdditionError: poss, (leukemia-21, disease-25)
AdditionError: poss, (leukemia-21, disease-25)
AdditionError: nsubj, (involves-16, amplification-12)
AdditionError: ccomp, (show-10, involves-16)
AdditionError: dobj, (involves-16, increase-18)
AdditionError: nsubj, (involves-16, amplification-12)
AdditionError: ccomp, (show-10, involves-16)
AdditionError: dobj, (involves-16, increase-18)
AdditionError: conj_and, (contain-16, followed-39)
AdditionError: cop, (correlated-44, was-25)
AdditionError: cop, (correlated-44, was-25)
AdditionError: cop, (correlated-44, was-25)
AdditionError: cop, (correlated-44, was-25)
AdditionError: cop, (correlated-44, was-25)
AdditionError: cop, (correlated-44, was-25)
AdditionError: cop, (correlated-44, was-25)
AdditionError: cop, (correlated-44, was-25)
AdditionError: cop, (correlated-44, was-25)
AdditionError: cop, (correlated-44, was-25)
AdditionError: cop, (correlated-44, was-25)
AdditionError: cop, (correlated-44, was-25)
AdditionError: rel, (combined-25, when-24)
AdditionError: rel, (compared-57, when-56)
AdditionError: rel, (compared-57, when-56)
AdditionError: rel, (compared-57, when-56)
AdditionError: rel, (compared-57, when-56)
AdditionError: rel, (compared-57, when-56)
AdditionError: rel, (compared-57, when-56)
AdditionError: rel, (compared-57, when-56)
AdditionError: rel, (compared-57, when-56)
AdditionError: rel, (expressed-12, which-10)
AdditionError: rel, (expressed-12, which-10)
AdditionError: rel, (expressed-12, which-10)
AdditionError: rel, (expressed-12, which-10)
AdditionError: rel, (expressed-12, which-10)
AdditionError: rel, (expressed-12, which-10)
AdditionError: nsubj, (negative-5, adenomas-2)
AdditionError: nsubj, (occurred-21, staining-20)
AdditionError: parataxis, (negative-5, occurred-21)
AdditionError: nsubj, (negative-5, adenomas-2)
AdditionError: nsubj, (occurred-21, staining-20)
AdditionError: parataxis, (negative-5, occurred-21)
AdditionError: poss, (translocation-20, lymphoma-15)
AdditionError: rel, (inhibits-22, which-20)
AdditionError: rel, (inhibits-22, which-20)
AdditionError: quantmod, (20-15, equal-13)
AdditionError: ccomp, (stabilized-5, cotransfected-7)
AdditionError: dobj, (increased-3, activity-6)
AdditionError: rel, (mature-18, where-8)
AdditionError: rel, (mature-18, where-8)
AdditionError: ccomp, (occurs-26, blocked-35)
AdditionError: nsubjpass, (evaluated-39, weight-17)
AdditionError: nsubjpass, (evaluated-39, weight-17)
AdditionError: nsubjpass, (noted-15, decrease-25)
AdditionError: nsubjpass, (noted-15, decrease-25)
AdditionError: poss, (Hodgkin-7, non-Hodgkin-10)
AdditionError: nsubjpass, (investigated-24, course-2)
AdditionError: nsubjpass, (investigated-24, course-2)
AdditionError: ccomp, (reappeared-2, relapsed-5)
AdditionError: rel, (occur-15, where-13)
AdditionError: ccomp, (study-7, influenced-15)
AdditionError: ccomp, (study-7, influenced-15)
AdditionError: conj_and, (induce-11, induce-172)
AdditionError: conj_and, (induce-11, thereby-184)
AdditionError: conj_and, (induce-172, thereby-184)
AdditionError: conj_and, (induce-11, induce-172)
AdditionError: conj_and, (induce-11, thereby-184)
AdditionError: conj_and, (induce-172, thereby-184)
AdditionError: conj_and, (induce-11, induce-172)
AdditionError: conj_and, (induce-11, thereby-184)
AdditionError: conj_and, (induce-172, thereby-184)
AdditionError: conj_and, (induce-11, induce-172)
AdditionError: conj_and, (induce-11, thereby-184)
AdditionError: conj_and, (induce-172, thereby-184)
AdditionError: conj_and, (onset-27, respectively-67)
AdditionError: iobj, (using-50, meromyosin-52)
AdditionError: prep, (higher-15, than-36)
AdditionError: poss, (lymphocytes-29, lines-43)
AdditionError: poss, (lymphocytes-29, lines-43)
AdditionError: poss, (lymphocytes-29, lines-43)
AdditionError: poss, (lymphocytes-29, lines-43)
AdditionError: poss, (lymphocytes-29, lines-43)
AdditionError: poss, (lymphocytes-29, lines-43)
AdditionError: nsubjpass, (induced-12, state-10)
AdditionError: ccomp, (reported-5, induced-12)
AdditionError: nsubjpass, (induced-12, state-10)
AdditionError: ccomp, (reported-5, induced-12)
AdditionError: nsubjpass, (induced-12, state-10)
AdditionError: ccomp, (reported-5, induced-12)
AdditionError: nsubjpass, (induced-12, state-10)
AdditionError: ccomp, (reported-5, induced-12)
AdditionError: conj_and, (resulted-9, compared-47)
AdditionError: conj_and, (elevated-7, frequently-15)
AdditionError: nsubj, (appeared-18, cells-17)
AdditionError: nsubjpass, (observed-10, staining-6)
AdditionError: prep_in, (observed-10, spaces-15)
AdditionError: nsubjpass, (observed-10, staining-6)
AdditionError: prep_in, (observed-10, spaces-15)
AdditionError: dobj, (describes-4, use-17)
AdditionError: dobj, (describes-4, use-17)
AdditionError: dobj, (describes-4, use-17)
AdditionError: cop, (showed-46, were-35)
AdditionError: poss, (titer-28, sarcoma-32)
AdditionError: conj_and, (overexpression-20, frequently-23)
AdditionError: dobj, (inside-12, tumor-14)
AdditionError: dobj, (inside-12, tumor-14)
AdditionError: dobj, (inside-12, tumor-14)
AdditionError: dobj, (inside-12, tumor-14)
AdditionError: conj_but, (tumorigenic-34, totally-37)
AdditionError: rel, (augmented-28, both-23)
AdditionError: rel, (augmented-28, both-23)
AdditionError: quantmod, (one-25, more-27)
AdditionError: conj_and, (induced-14, grew-21)
AdditionError: quantmod, (little-34, no-36)
AdditionError: rel, (initiate-33, where-22)
AdditionError: rel, (initiate-33, where-22)
AdditionError: rel, (exhibited-10, protein-9)
AdditionError: rel, (exhibited-10, protein-9)
AdditionError: poss, (mononucleosis-28, lymphoma-46)
AdditionError: nsubjpass, (controlled-8, defect-5)
AdditionError: ccomp, (asked-2, controlled-8)
AdditionError: poss, (lymphoma-13, lymphoma-17)
AdditionError: poss, (lymphoma-13, lymphoma-17)
AdditionError: poss, (lymphoma-13, lymphoma-17)
AdditionError: ccomp, (pronounced-45, suppressed-50)
AdditionError: rel, (contributes-10, which-9)
AdditionError: rel, (directed-28, which-26)
AdditionError: rel, (directed-28, which-26)
AdditionError: rel, (directed-28, which-26)
AdditionError: rel, (directed-28, which-26)
AdditionError: rel, (directed-28, which-26)
AdditionError: rel, (directed-28, which-26)
AdditionError: conj_and, (specific-12, also-14)
AdditionError: conj_and, (specific-12, also-14)
AdditionError: rel, (incubated-15, when-14)
AdditionError: conj_and, (reductase-11, particularly-19)
AdditionError: conj_and, (reductase-11, particularly-19)
AdditionError: conj_and, (reductase-11, particularly-19)
AdditionError: rel, (demonstrates-20, which-19)
AdditionError: rel, (demonstrates-20, which-19)
AdditionError: rel, (demonstrates-20, which-19)
AdditionError: nsubj, (resulted-25, treatment-11)
AdditionError: nsubj, (resulted-25, treatment-11)
AdditionError: nsubj, (resulted-25, treatment-11)
AdditionError: prep_following, (decreased-5, treatment-11)
AdditionError: prepc_of, (capable-17, differentiating-19)
AdditionError: ccomp, (able-30, injected-39)
AdditionError: ccomp, (able-30, injected-39)
AdditionError: ccomp, (able-30, injected-39)
AdditionError: ccomp, (able-30, injected-39)
AdditionError: ccomp, (able-30, injected-39)
AdditionError: ccomp, (able-30, injected-39)
AdditionError: ccomp, (able-30, injected-39)
AdditionError: ccomp, (able-30, injected-39)
AdditionError: conj_and, (effective-10, alone-24)
AdditionError: rel, (eluted-26, where-19)
AdditionError: ccomp, (decreased-33, was-40)
AdditionError: nsubjpass, (examined-12, Induction-1)
AdditionError: rel, (used-31, which-28)
AdditionError: prep_in, (increases-6, cells-19)
AdditionError: prep_in, (increases-6, cells-19)
AdditionError: iobj, (bearing-30, tumors-32)
AdditionError: iobj, (bearing-30, tumors-32)
AdditionError: iobj, (bearing-30, tumors-32)
AdditionError: iobj, (bearing-30, tumors-32)
AdditionError: ccomp, (reduced-14, compared-20)
AdditionError: ccomp, (reduced-14, compared-20)
AdditionError: rel, (increased-13, activities-11)
error on token alignment
token: ., current:229
[(0, 4), (6, 16), (18, 21), (23, 32), (34, 41), (43, 43), (44, 52), (54, 56), (58, 67), (68, 68), (70, 73), (75, 78), (80, 89), (91, 94), (96, 104), (106, 108), (110, 125), (127, 131), (133, 137), (138, 138), (140, 149), (151, 163), (165, 168), (170, 178), (180, 189), (191, 196), (198, 199), (201, 203), (205, 209), (211, 212), (214, 217), (219, 223), (225, 228)]
[u'Cells', u'transfected', u'with', u'secretable', u'IL-1beta', u'-LRB-', u'mIL-1beta', u'and', u'ssIL-1beta', u'-RRB-', u'were', u'more', u'aggressive', u'than', u'wild-type', u'and', u'mock-transfected', u'tumor', u'cells', u';', u'ssIL-1beta', u'transfectants', u'even', u'exhibited', u'metastatic', u'tumors', u'in', u'the', u'lungs', u'of', u'mice', u'after', u'i.v.', u'.']
orignal sentence: Cells transfected with secretable IL-1beta (mIL-1beta and ssIL-1beta) were more aggressive than wild-type and mock-transfected tumor cells; ssIL-1beta transfectants even exhibited metastatic tumors in the lungs of mice after i.v.
error on token alignment
token: ., current:229
[(0, 4), (6, 16), (18, 21), (23, 32), (34, 41), (43, 43), (44, 52), (54, 56), (58, 67), (68, 68), (70, 73), (75, 78), (80, 89), (91, 94), (96, 104), (106, 108), (110, 125), (127, 131), (133, 137), (138, 138), (140, 149), (151, 163), (165, 168), (170, 178), (180, 189), (191, 196), (198, 199), (201, 203), (205, 209), (211, 212), (214, 217), (219, 223), (225, 228)]
[u'Cells', u'transfected', u'with', u'secretable', u'IL-1beta', u'-LRB-', u'mIL-1beta', u'and', u'ssIL-1beta', u'-RRB-', u'were', u'more', u'aggressive', u'than', u'wild-type', u'and', u'mock-transfected', u'tumor', u'cells', u';', u'ssIL-1beta', u'transfectants', u'even', u'exhibited', u'metastatic', u'tumors', u'in', u'the', u'lungs', u'of', u'mice', u'after', u'i.v.', u'.']
orignal sentence: Cells transfected with secretable IL-1beta (mIL-1beta and ssIL-1beta) were more aggressive than wild-type and mock-transfected tumor cells; ssIL-1beta transfectants even exhibited metastatic tumors in the lungs of mice after i.v.
error on token alignment
token: ., current:229
[(0, 4), (6, 16), (18, 21), (23, 32), (34, 41), (43, 43), (44, 52), (54, 56), (58, 67), (68, 68), (70, 73), (75, 78), (80, 89), (91, 94), (96, 104), (106, 108), (110, 125), (127, 131), (133, 137), (138, 138), (140, 149), (151, 163), (165, 168), (170, 178), (180, 189), (191, 196), (198, 199), (201, 203), (205, 209), (211, 212), (214, 217), (219, 223), (225, 228)]
[u'Cells', u'transfected', u'with', u'secretable', u'IL-1beta', u'-LRB-', u'mIL-1beta', u'and', u'ssIL-1beta', u'-RRB-', u'were', u'more', u'aggressive', u'than', u'wild-type', u'and', u'mock-transfected', u'tumor', u'cells', u';', u'ssIL-1beta', u'transfectants', u'even', u'exhibited', u'metastatic', u'tumors', u'in', u'the', u'lungs', u'of', u'mice', u'after', u'i.v.', u'.']
orignal sentence: Cells transfected with secretable IL-1beta (mIL-1beta and ssIL-1beta) were more aggressive than wild-type and mock-transfected tumor cells; ssIL-1beta transfectants even exhibited metastatic tumors in the lungs of mice after i.v.
error on token alignment
token: ., current:229
[(0, 4), (6, 16), (18, 21), (23, 32), (34, 41), (43, 43), (44, 52), (54, 56), (58, 67), (68, 68), (70, 73), (75, 78), (80, 89), (91, 94), (96, 104), (106, 108), (110, 125), (127, 131), (133, 137), (138, 138), (140, 149), (151, 163), (165, 168), (170, 178), (180, 189), (191, 196), (198, 199), (201, 203), (205, 209), (211, 212), (214, 217), (219, 223), (225, 228)]
[u'Cells', u'transfected', u'with', u'secretable', u'IL-1beta', u'-LRB-', u'mIL-1beta', u'and', u'ssIL-1beta', u'-RRB-', u'were', u'more', u'aggressive', u'than', u'wild-type', u'and', u'mock-transfected', u'tumor', u'cells', u';', u'ssIL-1beta', u'transfectants', u'even', u'exhibited', u'metastatic', u'tumors', u'in', u'the', u'lungs', u'of', u'mice', u'after', u'i.v.', u'.']
orignal sentence: Cells transfected with secretable IL-1beta (mIL-1beta and ssIL-1beta) were more aggressive than wild-type and mock-transfected tumor cells; ssIL-1beta transfectants even exhibited metastatic tumors in the lungs of mice after i.v.
error on token alignment
token: ., current:229
[(0, 4), (6, 16), (18, 21), (23, 32), (34, 41), (43, 43), (44, 52), (54, 56), (58, 67), (68, 68), (70, 73), (75, 78), (80, 89), (91, 94), (96, 104), (106, 108), (110, 125), (127, 131), (133, 137), (138, 138), (140, 149), (151, 163), (165, 168), (170, 178), (180, 189), (191, 196), (198, 199), (201, 203), (205, 209), (211, 212), (214, 217), (219, 223), (225, 228)]
[u'Cells', u'transfected', u'with', u'secretable', u'IL-1beta', u'-LRB-', u'mIL-1beta', u'and', u'ssIL-1beta', u'-RRB-', u'were', u'more', u'aggressive', u'than', u'wild-type', u'and', u'mock-transfected', u'tumor', u'cells', u';', u'ssIL-1beta', u'transfectants', u'even', u'exhibited', u'metastatic', u'tumors', u'in', u'the', u'lungs', u'of', u'mice', u'after', u'i.v.', u'.']
orignal sentence: Cells transfected with secretable IL-1beta (mIL-1beta and ssIL-1beta) were more aggressive than wild-type and mock-transfected tumor cells; ssIL-1beta transfectants even exhibited metastatic tumors in the lungs of mice after i.v.
error on token alignment
token: ., current:229
[(0, 4), (6, 16), (18, 21), (23, 32), (34, 41), (43, 43), (44, 52), (54, 56), (58, 67), (68, 68), (70, 73), (75, 78), (80, 89), (91, 94), (96, 104), (106, 108), (110, 125), (127, 131), (133, 137), (138, 138), (140, 149), (151, 163), (165, 168), (170, 178), (180, 189), (191, 196), (198, 199), (201, 203), (205, 209), (211, 212), (214, 217), (219, 223), (225, 228)]
[u'Cells', u'transfected', u'with', u'secretable', u'IL-1beta', u'-LRB-', u'mIL-1beta', u'and', u'ssIL-1beta', u'-RRB-', u'were', u'more', u'aggressive', u'than', u'wild-type', u'and', u'mock-transfected', u'tumor', u'cells', u';', u'ssIL-1beta', u'transfectants', u'even', u'exhibited', u'metastatic', u'tumors', u'in', u'the', u'lungs', u'of', u'mice', u'after', u'i.v.', u'.']
orignal sentence: Cells transfected with secretable IL-1beta (mIL-1beta and ssIL-1beta) were more aggressive than wild-type and mock-transfected tumor cells; ssIL-1beta transfectants even exhibited metastatic tumors in the lungs of mice after i.v.
error on token alignment
token: ., current:229
[(0, 4), (6, 16), (18, 21), (23, 32), (34, 41), (43, 43), (44, 52), (54, 56), (58, 67), (68, 68), (70, 73), (75, 78), (80, 89), (91, 94), (96, 104), (106, 108), (110, 125), (127, 131), (133, 137), (138, 138), (140, 149), (151, 163), (165, 168), (170, 178), (180, 189), (191, 196), (198, 199), (201, 203), (205, 209), (211, 212), (214, 217), (219, 223), (225, 228)]
[u'Cells', u'transfected', u'with', u'secretable', u'IL-1beta', u'-LRB-', u'mIL-1beta', u'and', u'ssIL-1beta', u'-RRB-', u'were', u'more', u'aggressive', u'than', u'wild-type', u'and', u'mock-transfected', u'tumor', u'cells', u';', u'ssIL-1beta', u'transfectants', u'even', u'exhibited', u'metastatic', u'tumors', u'in', u'the', u'lungs', u'of', u'mice', u'after', u'i.v.', u'.']
orignal sentence: Cells transfected with secretable IL-1beta (mIL-1beta and ssIL-1beta) were more aggressive than wild-type and mock-transfected tumor cells; ssIL-1beta transfectants even exhibited metastatic tumors in the lungs of mice after i.v.
error on token alignment
token: ., current:229
[(0, 4), (6, 16), (18, 21), (23, 32), (34, 41), (43, 43), (44, 52), (54, 56), (58, 67), (68, 68), (70, 73), (75, 78), (80, 89), (91, 94), (96, 104), (106, 108), (110, 125), (127, 131), (133, 137), (138, 138), (140, 149), (151, 163), (165, 168), (170, 178), (180, 189), (191, 196), (198, 199), (201, 203), (205, 209), (211, 212), (214, 217), (219, 223), (225, 228)]
[u'Cells', u'transfected', u'with', u'secretable', u'IL-1beta', u'-LRB-', u'mIL-1beta', u'and', u'ssIL-1beta', u'-RRB-', u'were', u'more', u'aggressive', u'than', u'wild-type', u'and', u'mock-transfected', u'tumor', u'cells', u';', u'ssIL-1beta', u'transfectants', u'even', u'exhibited', u'metastatic', u'tumors', u'in', u'the', u'lungs', u'of', u'mice', u'after', u'i.v.', u'.']
orignal sentence: Cells transfected with secretable IL-1beta (mIL-1beta and ssIL-1beta) were more aggressive than wild-type and mock-transfected tumor cells; ssIL-1beta transfectants even exhibited metastatic tumors in the lungs of mice after i.v.
error on token alignment
token: ., current:354
[(0, 1), (3, 6), (8, 18), (20, 22), (24, 32), (34, 37), (39, 43), (45, 46), (48, 55), (57, 61), (63, 66), (68, 68), (70, 77), (79, 84), (86, 86), (87, 90), (92, 103), (105, 111), (112, 112), (114, 115), (117, 122), (123, 123), (125, 127), (129, 133), (135, 142), (144, 146), (148, 151), (152, 152), (154, 158), (160, 163), (164, 164), (166, 167), (168, 168), (170, 171), (172, 172), (174, 176), (178, 183), (185, 189), (191, 194), (195, 195), (197, 202), (204, 205), (207, 209), (210, 210), (212, 213), (214, 214), (216, 217), (218, 218), (220, 222), (224, 232), (234, 238), (240, 243), (244, 244), (246, 250), (252, 255), (256, 256), (258, 259), (260, 260), (262, 263), (265, 267), (269, 271), (273, 278), (280, 281), (283, 287), (289, 292), (293, 293), (295, 298), (300, 308), (310, 316), (318, 319), (321, 329), (331, 333), (335, 339), (341, 344), (345, 345), (347, 348), (349, 349), (351, 353)]
[u'In', u'this', u'publication', u'are', u'presented', u'four', u'cases', u'of', u'pregnant', u'women', u'with', u'a', u'cervical', u'cancer', u'-LRB-', u'with', u'preoperative', u'staging', u'-RRB-', u'as', u'follow', u':', u'the', u'first', u'pregnant', u'6-7', u'g.w.', u',', u'stage', u'T1a1', u',', u'No', u',', u'Mo', u',', u'the', u'second', u'19-20', u'g.w.', u',', u'staged', u'as', u'T2a', u',', u'Nx', u',', u'Mo', u';', u'the', u'third--in', u'20-21', u'g.w.', u',', u'stage', u'T1b2', u',', u'Nx', u',', u'Mo', u'and', u'the', u'fourth', u'in', u'29-30', u'g.w.', u',', u'with', u'premature', u'rupture', u'of', u'membranes', u'and', u'stage', u'T1b2', u',', u'Nx', u',', u'Mo.', u'.']
orignal sentence: In this publication are presented four cases of pregnant women with a cervical cancer (with preoperative staging) as follow: the first pregnant 6-7 g.w., stage T1a1, No, Mo, the second 19-20 g.w., staged as T2a, Nx, Mo; the third--in 20-21 g.w., stage T1b2, Nx, Mo and the fourth in 29-30 g.w., with premature rupture of membranes and stage T1b2, Nx, Mo.
error on token alignment
token: ., current:194
[(0, 1), (3, 10), (12, 19), (21, 31), (33, 38), (40, 45), (47, 47), (48, 51), (52, 52), (54, 63), (65, 66), (68, 71), (73, 81), (83, 87), (89, 93), (94, 95), (97, 103), (105, 108), (110, 114), (116, 116), (117, 120), (121, 121), (123, 127), (128, 128), (130, 131), (132, 132), (134, 136), (138, 142), (143, 143), (145, 147), (149, 150), (152, 157), (159, 160), (162, 165), (167, 170), (172, 178), (180, 188), (190, 193)]
[u'We', u'assessed', u'vascular', u'endothelial', u'growth', u'factor', u'-LRB-', u'VEGF', u'-RRB-', u'expression', u'in', u'four', u'different', u'human', u'Ewing', u"'s", u'sarcoma', u'cell', u'lines', u'-LRB-', u'TC71', u',', u'SK-ES', u',', u'RD', u',', u'and', u'A4573', u'-RRB-', u'and', u'in', u'tumors', u'in', u'nude', u'mice', u'induced', u'following', u's.c.', u'.']
orignal sentence: We assessed vascular endothelial growth factor (VEGF) expression in four different human Ewing's sarcoma cell lines (TC71, SK-ES, RD, and A4573) and in tumors in nude mice induced following s.c.
error on token alignment
token: ., current:194
[(0, 1), (3, 10), (12, 19), (21, 31), (33, 38), (40, 45), (47, 47), (48, 51), (52, 52), (54, 63), (65, 66), (68, 71), (73, 81), (83, 87), (89, 93), (94, 95), (97, 103), (105, 108), (110, 114), (116, 116), (117, 120), (121, 121), (123, 127), (128, 128), (130, 131), (132, 132), (134, 136), (138, 142), (143, 143), (145, 147), (149, 150), (152, 157), (159, 160), (162, 165), (167, 170), (172, 178), (180, 188), (190, 193)]
[u'We', u'assessed', u'vascular', u'endothelial', u'growth', u'factor', u'-LRB-', u'VEGF', u'-RRB-', u'expression', u'in', u'four', u'different', u'human', u'Ewing', u"'s", u'sarcoma', u'cell', u'lines', u'-LRB-', u'TC71', u',', u'SK-ES', u',', u'RD', u',', u'and', u'A4573', u'-RRB-', u'and', u'in', u'tumors', u'in', u'nude', u'mice', u'induced', u'following', u's.c.', u'.']
orignal sentence: We assessed vascular endothelial growth factor (VEGF) expression in four different human Ewing's sarcoma cell lines (TC71, SK-ES, RD, and A4573) and in tumors in nude mice induced following s.c.
error on token alignment
token: ., current:194
[(0, 1), (3, 10), (12, 19), (21, 31), (33, 38), (40, 45), (47, 47), (48, 51), (52, 52), (54, 63), (65, 66), (68, 71), (73, 81), (83, 87), (89, 93), (94, 95), (97, 103), (105, 108), (110, 114), (116, 116), (117, 120), (121, 121), (123, 127), (128, 128), (130, 131), (132, 132), (134, 136), (138, 142), (143, 143), (145, 147), (149, 150), (152, 157), (159, 160), (162, 165), (167, 170), (172, 178), (180, 188), (190, 193)]
[u'We', u'assessed', u'vascular', u'endothelial', u'growth', u'factor', u'-LRB-', u'VEGF', u'-RRB-', u'expression', u'in', u'four', u'different', u'human', u'Ewing', u"'s", u'sarcoma', u'cell', u'lines', u'-LRB-', u'TC71', u',', u'SK-ES', u',', u'RD', u',', u'and', u'A4573', u'-RRB-', u'and', u'in', u'tumors', u'in', u'nude', u'mice', u'induced', u'following', u's.c.', u'.']
orignal sentence: We assessed vascular endothelial growth factor (VEGF) expression in four different human Ewing's sarcoma cell lines (TC71, SK-ES, RD, and A4573) and in tumors in nude mice induced following s.c.
error on token alignment
token: ., current:194
[(0, 1), (3, 10), (12, 19), (21, 31), (33, 38), (40, 45), (47, 47), (48, 51), (52, 52), (54, 63), (65, 66), (68, 71), (73, 81), (83, 87), (89, 93), (94, 95), (97, 103), (105, 108), (110, 114), (116, 116), (117, 120), (121, 121), (123, 127), (128, 128), (130, 131), (132, 132), (134, 136), (138, 142), (143, 143), (145, 147), (149, 150), (152, 157), (159, 160), (162, 165), (167, 170), (172, 178), (180, 188), (190, 193)]
[u'We', u'assessed', u'vascular', u'endothelial', u'growth', u'factor', u'-LRB-', u'VEGF', u'-RRB-', u'expression', u'in', u'four', u'different', u'human', u'Ewing', u"'s", u'sarcoma', u'cell', u'lines', u'-LRB-', u'TC71', u',', u'SK-ES', u',', u'RD', u',', u'and', u'A4573', u'-RRB-', u'and', u'in', u'tumors', u'in', u'nude', u'mice', u'induced', u'following', u's.c.', u'.']
orignal sentence: We assessed vascular endothelial growth factor (VEGF) expression in four different human Ewing's sarcoma cell lines (TC71, SK-ES, RD, and A4573) and in tumors in nude mice induced following s.c.
error on token alignment
token: ., current:110
[(0, 1), (3, 10), (11, 11), (13, 16), (18, 20), (22, 24), (26, 28), (30, 39), (41, 43), (45, 49), (51, 52), (54, 61), (63, 65), (67, 75), (77, 78), (80, 86), (88, 94), (96, 104), (106, 109)]
[u'In', u'contrast', u',', u'only', u'6.7', u'+/-', u'3.6', u'micrograms', u'B/g', u'tumor', u'of', u'G5-B1100', u'was', u'localized', u'in', u'F98EGFR', u'gliomas', u'following', u'i.t.', u'.']
orignal sentence: In contrast, only 6.7 +/- 3.6 micrograms B/g tumor of G5-B1100 was localized in F98EGFR gliomas following i.t.
error on token alignment
token: ., current:110
[(0, 1), (3, 10), (11, 11), (13, 16), (18, 20), (22, 24), (26, 28), (30, 39), (41, 43), (45, 49), (51, 52), (54, 61), (63, 65), (67, 75), (77, 78), (80, 86), (88, 94), (96, 104), (106, 109)]
[u'In', u'contrast', u',', u'only', u'6.7', u'+/-', u'3.6', u'micrograms', u'B/g', u'tumor', u'of', u'G5-B1100', u'was', u'localized', u'in', u'F98EGFR', u'gliomas', u'following', u'i.t.', u'.']
orignal sentence: In contrast, only 6.7 +/- 3.6 micrograms B/g tumor of G5-B1100 was localized in F98EGFR gliomas following i.t.
error on token alignment
token: ., current:122
[(0, 9), (11, 19), (21, 22), (24, 31), (33, 35), (37, 39), (41, 48), (50, 52), (54, 56), (58, 64), (66, 68), (70, 84), (86, 87), (89, 96), (98, 103), (105, 109), (111, 112), (114, 116), (118, 121)]
[u'Widespread', u'screening', u'of', u'American', u'men', u'for', u'elevated', u'PSA', u'has', u'changed', u'the', u'characteristics', u'of', u'prostate', u'cancer', u'cases', u'in', u'the', u'U.S.', u'.']
orignal sentence: Widespread screening of American men for elevated PSA has changed the characteristics of prostate cancer cases in the U.S.
error on token alignment
token: ., current:102
[(0, 1), (3, 4), (6, 15), (17, 26), (28, 33), (35, 48), (50, 54), (56, 57), (59, 62), (63, 63), (65, 75), (77, 78), (80, 83), (85, 93), (95, 96), (98, 101)]
[u'In', u'an', u'orthotopic', u'pancreatic', u'ductal', u'adenocarcinoma', u'model', u'in', u'mice', u',', u'suppression', u'of', u'EphA', u'signaling', u'by', u'i.p.', u'.']
orignal sentence: In an orthotopic pancreatic ductal adenocarcinoma model in mice, suppression of EphA signaling by i.p.
error on token alignment
token: ., current:161
[(0, 3), (5, 7), (9, 15), (17, 35), (37, 46), (48, 53), (55, 58), (60, 63), (65, 68), (70, 72), (74, 77), (79, 85), (87, 90), (92, 107), (109, 117), (119, 125), (127, 142), (144, 146), (148, 155), (157, 160)]
[u'When', u'the', u'EG-VEGF', u'gene-overexpressing', u'colorectal', u'cancer', u'cell', u'line', u'that', u'had', u'been', u'treated', u'with', u'phosphorothioate', u'antisense', u'EG-VEGF', u'oligonucleotides', u'was', u'injected', u's.c.', u'.']
orignal sentence: When the EG-VEGF gene-overexpressing colorectal cancer cell line that had been treated with phosphorothioate antisense EG-VEGF oligonucleotides was injected s.c.
error on token alignment
token: ., current:161
[(0, 3), (5, 7), (9, 15), (17, 35), (37, 46), (48, 53), (55, 58), (60, 63), (65, 68), (70, 72), (74, 77), (79, 85), (87, 90), (92, 107), (109, 117), (119, 125), (127, 142), (144, 146), (148, 155), (157, 160)]
[u'When', u'the', u'EG-VEGF', u'gene-overexpressing', u'colorectal', u'cancer', u'cell', u'line', u'that', u'had', u'been', u'treated', u'with', u'phosphorothioate', u'antisense', u'EG-VEGF', u'oligonucleotides', u'was', u'injected', u's.c.', u'.']
orignal sentence: When the EG-VEGF gene-overexpressing colorectal cancer cell line that had been treated with phosphorothioate antisense EG-VEGF oligonucleotides was injected s.c.
error on token alignment
token: ., current:238
[(0, 2), (4, 11), (13, 14), (16, 26), (28, 36), (38, 39), (41, 45), (47, 55), (56, 56), (58, 64), (65, 65), (67, 69), (71, 74), (76, 85), (87, 88), (90, 96), (98, 104), (106, 109), (111, 114), (116, 117), (119, 129), (131, 140), (142, 142), (143, 145), (147, 150), (152, 153), (155, 159), (160, 160), (162, 163), (165, 167), (169, 172), (174, 184), (186, 193), (194, 194), (196, 201), (203, 206), (208, 217), (218, 218), (220, 222), (224, 229), (231, 232), (234, 237)]
[u'The', u'function', u'of', u'alphaVbeta3', u'complexes', u'in', u'tumor', u'formation', u',', u'however', u',', u'has', u'been', u'challenged', u'by', u'studies', u'showing', u'that', u'loss', u'of', u'alphaVbeta3', u'expression', u'-LRB-', u'via', u'loss', u'of', u'beta3', u'-RRB-', u'in', u'the', u'host', u'vasculature', u'enhances', u',', u'rather', u'than', u'suppresses', u',', u'the', u'growth', u'of', u's.c.', u'.']
orignal sentence: The function of alphaVbeta3 complexes in tumor formation, however, has been challenged by studies showing that loss of alphaVbeta3 expression (via loss of beta3) in the host vasculature enhances, rather than suppresses, the growth of s.c.
error on token alignment
token: ., current:108
[(0, 2), (4, 7), (9, 13), (15, 18), (20, 32), (34, 45), (47, 56), (58, 62), (64, 75), (77, 79), (81, 85), (87, 92), (94, 95), (97, 97), (99, 102), (104, 107)]
[u'The', u'VEGF', u'siRNA', u'with', u'atelocollagen', u'dramatically', u'suppressed', u'tumor', u'angiogenesis', u'and', u'tumor', u'growth', u'in', u'a', u'PC-3', u's.c.', u'.']
orignal sentence: The VEGF siRNA with atelocollagen dramatically suppressed tumor angiogenesis and tumor growth in a PC-3 s.c.
error on token alignment
token: ., current:139
[(0, 2), (4, 15), (17, 19), (21, 29), (31, 42), (44, 46), (48, 50), (52, 60), (62, 66), (68, 76), (78, 86), (88, 94), (96, 100), (102, 107), (109, 111), (113, 122), (124, 130), (132, 133), (135, 138)]
[u'The', u'nonselective', u'COX', u'inhibitor', u'indomethacin', u'and', u'the', u'selective', u'COX-2', u'inhibitor', u'celecoxib', u'reduced', u'tumor', u'growth', u'and', u'metastasis', u'outcome', u'in', u's.c.', u'.']
orignal sentence: The nonselective COX inhibitor indomethacin and the selective COX-2 inhibitor celecoxib reduced tumor growth and metastasis outcome in s.c.
error on token alignment
token: ., current:89
[(0, 3), (5, 15), (16, 16), (18, 42), (44, 48), (50, 55), (57, 69), (71, 74), (76, 83), (85, 88)]
[u'Very', u'importantly', u',', u'MLTK-alpha-overexpressing', u'cells', u'formed', u'fibrosarcomas', u'when', u'injected', u's.c.', u'.']
orignal sentence: Very importantly, MLTK-alpha-overexpressing cells formed fibrosarcomas when injected s.c.
error on token alignment
token: ., current:211
[(0, 1), (3, 11), (13, 19), (21, 25), (27, 31), (33, 36), (38, 38), (40, 43), (45, 46), (48, 57), (59, 60), (62, 66), (68, 72), (74, 74), (75, 77), (78, 78), (79, 79), (81, 82), (84, 94), (96, 101), (103, 107), (109, 112), (114, 120), (122, 126), (128, 137), (139, 140), (142, 150), (152, 154), (156, 158), (160, 171), (173, 177), (179, 188), (190, 199), (201, 205), (207, 210)]
[u'To', u'determine', u'whether', u'CXCR3', u'could', u'play', u'a', u'role', u'in', u'metastasis', u'to', u'lymph', u'nodes', u'-LRB-', u'LNs', u'-RRB-', u',', u'we', u'constructed', u'B16F10', u'cells', u'with', u'reduced', u'CXCR3', u'expression', u'by', u'antisense', u'RNA', u'and', u'investigated', u'their', u'metastatic', u'activities', u'after', u's.c.', u'.']
orignal sentence: To determine whether CXCR3 could play a role in metastasis to lymph nodes (LNs), we constructed B16F10 cells with reduced CXCR3 expression by antisense RNA and investigated their metastatic activities after s.c.
error on token alignment
token: ., current:211
[(0, 1), (3, 11), (13, 19), (21, 25), (27, 31), (33, 36), (38, 38), (40, 43), (45, 46), (48, 57), (59, 60), (62, 66), (68, 72), (74, 74), (75, 77), (78, 78), (79, 79), (81, 82), (84, 94), (96, 101), (103, 107), (109, 112), (114, 120), (122, 126), (128, 137), (139, 140), (142, 150), (152, 154), (156, 158), (160, 171), (173, 177), (179, 188), (190, 199), (201, 205), (207, 210)]
[u'To', u'determine', u'whether', u'CXCR3', u'could', u'play', u'a', u'role', u'in', u'metastasis', u'to', u'lymph', u'nodes', u'-LRB-', u'LNs', u'-RRB-', u',', u'we', u'constructed', u'B16F10', u'cells', u'with', u'reduced', u'CXCR3', u'expression', u'by', u'antisense', u'RNA', u'and', u'investigated', u'their', u'metastatic', u'activities', u'after', u's.c.', u'.']
orignal sentence: To determine whether CXCR3 could play a role in metastasis to lymph nodes (LNs), we constructed B16F10 cells with reduced CXCR3 expression by antisense RNA and investigated their metastatic activities after s.c.
error on token alignment
token: ., current:230
[(0, 6), (7, 7), (9, 9), (11, 15), (17, 36), (38, 45), (47, 48), (50, 72), (73, 73), (75, 77), (79, 82), (84, 89), (91, 93), (95, 103), (105, 112), (114, 115), (117, 117), (119, 123), (125, 126), (128, 139), (141, 145), (147, 151), (153, 159), (161, 163), (165, 167), (169, 172), (174, 178), (180, 181), (183, 184), (186, 191), (193, 196), (198, 209), (211, 214), (215, 215), (217, 220), (221, 221), (223, 224), (226, 229)]
[u'SC33428', u',', u'a', u'novel', u'bishydrazone-bridged', u'analogue', u'of', u'4-demethoxydaunorubicin', u',', u'has', u'been', u'tested', u'for', u'antitumor', u'activity', u'in', u'a', u'range', u'of', u'experimental', u'mouse', u'tumor', u'systems', u'and', u'has', u'been', u'found', u'to', u'be', u'active', u'when', u'administered', u'i.p.', u',', u'i.v.', u',', u'or', u'p.o.', u'.']
orignal sentence: SC33428, a novel bishydrazone-bridged analogue of 4-demethoxydaunorubicin, has been tested for antitumor activity in a range of experimental mouse tumor systems and has been found to be active when administered i.p., i.v., or p.o.
error on token alignment
token: ., current:230
[(0, 6), (7, 7), (9, 9), (11, 15), (17, 36), (38, 45), (47, 48), (50, 72), (73, 73), (75, 77), (79, 82), (84, 89), (91, 93), (95, 103), (105, 112), (114, 115), (117, 117), (119, 123), (125, 126), (128, 139), (141, 145), (147, 151), (153, 159), (161, 163), (165, 167), (169, 172), (174, 178), (180, 181), (183, 184), (186, 191), (193, 196), (198, 209), (211, 214), (215, 215), (217, 220), (221, 221), (223, 224), (226, 229)]
[u'SC33428', u',', u'a', u'novel', u'bishydrazone-bridged', u'analogue', u'of', u'4-demethoxydaunorubicin', u',', u'has', u'been', u'tested', u'for', u'antitumor', u'activity', u'in', u'a', u'range', u'of', u'experimental', u'mouse', u'tumor', u'systems', u'and', u'has', u'been', u'found', u'to', u'be', u'active', u'when', u'administered', u'i.p.', u',', u'i.v.', u',', u'or', u'p.o.', u'.']
orignal sentence: SC33428, a novel bishydrazone-bridged analogue of 4-demethoxydaunorubicin, has been tested for antitumor activity in a range of experimental mouse tumor systems and has been found to be active when administered i.p., i.v., or p.o.
error on token alignment
token: ., current:85
[(0, 3), (5, 12), (14, 17), (19, 25), (27, 35), (37, 43), (45, 52), (54, 62), (64, 73), (75, 75), (76, 78), (79, 79), (81, 84)]
[u'Nine', u'patients', u'with', u'mid-gut', u'carcinoid', u'tumours', u'received', u'leucocyte', u'interferon', u'-LRB-', u'IFN', u'-RRB-', u'i.m.', u'.']
orignal sentence: Nine patients with mid-gut carcinoid tumours received leucocyte interferon (IFN) i.m.
error on token alignment
token: ., current:85
[(0, 3), (5, 12), (14, 17), (19, 25), (27, 35), (37, 43), (45, 52), (54, 62), (64, 73), (75, 75), (76, 78), (79, 79), (81, 84)]
[u'Nine', u'patients', u'with', u'mid-gut', u'carcinoid', u'tumours', u'received', u'leucocyte', u'interferon', u'-LRB-', u'IFN', u'-RRB-', u'i.m.', u'.']
orignal sentence: Nine patients with mid-gut carcinoid tumours received leucocyte interferon (IFN) i.m.
error on token alignment
token: ., current:257
[(0, 9), (11, 19), (21, 23), (25, 34), (36, 42), (44, 46), (48, 57), (59, 60), (62, 64), (66, 72), (74, 83), (85, 87), (89, 91), (93, 97), (99, 107), (109, 110), (112, 114), (116, 125), (127, 132), (133, 133), (135, 136), (138, 143), (145, 147), (149, 157), (159, 160), (162, 164), (166, 169), (171, 174), (176, 184), (186, 193), (195, 207), (209, 214), (215, 215), (217, 224), (226, 230), (232, 234), (236, 242), (244, 250), (251, 251), (253, 256)]
[u'Especially', u'analysing', u'the', u'diagnostic', u'ability', u'and', u'limitation', u'of', u'the', u'imaging', u'techniques', u'for', u'the', u'early', u'detection', u'of', u'the', u'pancreatic', u'cancer', u',', u'we', u'needed', u'the', u'selection', u'of', u'the', u'high', u'risk', u'patients-', u'elevated', u'hepatobiliary', u'enzyme', u',', u'abnormal', u'serum', u'and', u'urinary', u'amylase', u',', u'D.M.', u'.']
orignal sentence: Especially analysing the diagnostic ability and limitation of the imaging techniques for the early detection of the pancreatic cancer, we needed the selection of the high risk patients- elevated hepatobiliary enzyme, abnormal serum and urinary amylase, D.M.
error on token alignment
token: ., current:164
[(0, 6), (8, 18), (20, 21), (23, 27), (29, 44), (46, 54), (56, 64), (66, 78), (80, 87), (89, 92), (94, 101), (103, 104), (106, 109), (111, 114), (116, 119), (121, 125), (127, 128), (130, 132), (134, 138), (140, 144), (146, 149), (151, 158), (160, 163)]
[u'Similar', u'alterations', u'of', u'tumor', u'promoter-induced', u'epidermal', u'ornithine', u'decarboxylase', u'activity', u'were', u'observed', u'in', u'vivo', u'when', u'62.5', u'mumol', u'of', u'the', u'amino', u'acids', u'were', u'injected', u'i.p.', u'.']
orignal sentence: Similar alterations of tumor promoter-induced epidermal ornithine decarboxylase activity were observed in vivo when 62.5 mumol of the amino acids were injected i.p.
error on token alignment
token: ., current:164
[(0, 6), (8, 18), (20, 21), (23, 27), (29, 44), (46, 54), (56, 64), (66, 78), (80, 87), (89, 92), (94, 101), (103, 104), (106, 109), (111, 114), (116, 119), (121, 125), (127, 128), (130, 132), (134, 138), (140, 144), (146, 149), (151, 158), (160, 163)]
[u'Similar', u'alterations', u'of', u'tumor', u'promoter-induced', u'epidermal', u'ornithine', u'decarboxylase', u'activity', u'were', u'observed', u'in', u'vivo', u'when', u'62.5', u'mumol', u'of', u'the', u'amino', u'acids', u'were', u'injected', u'i.p.', u'.']
orignal sentence: Similar alterations of tumor promoter-induced epidermal ornithine decarboxylase activity were observed in vivo when 62.5 mumol of the amino acids were injected i.p.
error on token alignment
token: ., current:154
[(0, 1), (3, 11), (13, 13), (15, 24), (26, 33), (34, 34), (36, 41), (43, 45), (46, 46), (48, 52), (54, 60), (62, 62), (64, 68), (70, 70), (72, 75), (77, 95), (97, 100), (102, 108), (110, 121), (122, 122), (124, 127), (128, 128), (130, 133), (135, 136), (138, 148), (150, 153)]
[u'We', u'generated', u'a', u'monoclonal', u'antibody', u',', u'termed', u'SN2', u',', u'which', u'defines', u'a', u'human', u'T', u'cell', u'leukemia-associated', u'cell', u'surface', u'glycoprotein', u',', u'GP37', u',', u'with', u'an', u'approximate', u'm.w.', u'.']
orignal sentence: We generated a monoclonal antibody, termed SN2, which defines a human T cell leukemia-associated cell surface glycoprotein, GP37, with an approximate m.w.
error on token alignment
token: ., current:154
[(0, 1), (3, 11), (13, 13), (15, 24), (26, 33), (34, 34), (36, 41), (43, 45), (46, 46), (48, 52), (54, 60), (62, 62), (64, 68), (70, 70), (72, 75), (77, 95), (97, 100), (102, 108), (110, 121), (122, 122), (124, 127), (128, 128), (130, 133), (135, 136), (138, 148), (150, 153)]
[u'We', u'generated', u'a', u'monoclonal', u'antibody', u',', u'termed', u'SN2', u',', u'which', u'defines', u'a', u'human', u'T', u'cell', u'leukemia-associated', u'cell', u'surface', u'glycoprotein', u',', u'GP37', u',', u'with', u'an', u'approximate', u'm.w.', u'.']
orignal sentence: We generated a monoclonal antibody, termed SN2, which defines a human T cell leukemia-associated cell surface glycoprotein, GP37, with an approximate m.w.
error on token alignment
token: ., current:100
[(0, 1), (3, 10), (11, 11), (13, 18), (20, 28), (30, 30), (31, 31), (32, 32), (33, 48), (50, 50), (51, 54), (55, 55), (57, 58), (60, 62), (64, 68), (70, 72), (74, 82), (84, 85), (87, 87), (89, 94), (96, 99)]
[u'In', u'SC-6-JCK', u',', u'cyclic', u'adenosine', u'3', u"'", u':', u"5'-monophosphate", u'-LRB-', u'cAMP', u'-RRB-', u'in', u'the', u'tumor', u'was', u'increased', u'by', u'a', u'single', u'i.p.', u'.']
orignal sentence: In SC-6-JCK, cyclic adenosine 3':5'-monophosphate (cAMP) in the tumor was increased by a single i.p.
error on token alignment
token: ., current:100
[(0, 1), (3, 10), (11, 11), (13, 18), (20, 28), (30, 30), (31, 31), (32, 32), (33, 48), (50, 50), (51, 54), (55, 55), (57, 58), (60, 62), (64, 68), (70, 72), (74, 82), (84, 85), (87, 87), (89, 94), (96, 99)]
[u'In', u'SC-6-JCK', u',', u'cyclic', u'adenosine', u'3', u"'", u':', u"5'-monophosphate", u'-LRB-', u'cAMP', u'-RRB-', u'in', u'the', u'tumor', u'was', u'increased', u'by', u'a', u'single', u'i.p.', u'.']
orignal sentence: In SC-6-JCK, cyclic adenosine 3':5'-monophosphate (cAMP) in the tumor was increased by a single i.p.
error on token alignment
token: ., current:182
[(0, 13), (15, 22), (24, 24), (25, 26), (27, 27), (29, 34), (36, 39), (41, 51), (53, 54), (56, 63), (65, 70), (72, 75), (77, 80), (82, 87), (89, 97), (99, 100), (102, 104), (106, 113), (115, 118), (120, 124), (126, 138), (140, 147), (149, 149), (150, 152), (153, 153), (155, 157), (159, 162), (164, 170), (172, 173), (175, 177), (179, 181)]
[u'Glucocorticoid', u'receptor', u'-LRB-', u'GR', u'-RRB-', u'levels', u'were', u'quantitated', u'in', u'leukemic', u'blasts', u'from', u'bone', u'marrow', u'aspirates', u'of', u'249', u'children', u'with', u'acute', u'lymphoblastic', u'leukemia', u'-LRB-', u'ALL', u'-RRB-', u'who', u'were', u'entered', u'on', u'two', u'St.', u'.']
orignal sentence: Glucocorticoid receptor (GR) levels were quantitated in leukemic blasts from bone marrow aspirates of 249 children with acute lymphoblastic leukemia (ALL) who were entered on two St.
error on token alignment
token: ., current:182
[(0, 13), (15, 22), (24, 24), (25, 26), (27, 27), (29, 34), (36, 39), (41, 51), (53, 54), (56, 63), (65, 70), (72, 75), (77, 80), (82, 87), (89, 97), (99, 100), (102, 104), (106, 113), (115, 118), (120, 124), (126, 138), (140, 147), (149, 149), (150, 152), (153, 153), (155, 157), (159, 162), (164, 170), (172, 173), (175, 177), (179, 181)]
[u'Glucocorticoid', u'receptor', u'-LRB-', u'GR', u'-RRB-', u'levels', u'were', u'quantitated', u'in', u'leukemic', u'blasts', u'from', u'bone', u'marrow', u'aspirates', u'of', u'249', u'children', u'with', u'acute', u'lymphoblastic', u'leukemia', u'-LRB-', u'ALL', u'-RRB-', u'who', u'were', u'entered', u'on', u'two', u'St.', u'.']
orignal sentence: Glucocorticoid receptor (GR) levels were quantitated in leukemic blasts from bone marrow aspirates of 249 children with acute lymphoblastic leukemia (ALL) who were entered on two St.
error on token alignment
token: ., current:352
[(0, 1), (3, 10), (12, 14), (16, 24), (26, 35), (37, 38), (40, 49), (51, 51), (52, 53), (54, 54), (56, 58), (60, 73), (75, 75), (76, 77), (78, 78), (80, 85), (87, 90), (91, 91), (93, 93), (94, 94), (96, 102), (104, 108), (110, 118), (120, 124), (126, 129), (130, 130), (132, 132), (133, 133), (135, 140), (142, 150), (152, 152), (153, 155), (156, 156), (158, 163), (165, 167), (169, 175), (177, 181), (183, 188), (190, 192), (194, 198), (200, 203), (204, 204), (206, 206), (207, 207), (209, 214), (216, 218), (220, 221), (223, 230), (232, 238), (240, 243), (245, 248), (250, 251), (253, 254), (256, 258), (260, 261), (263, 264), (266, 269), (271, 272), (274, 275), (277, 279), (281, 282), (283, 283), (285, 285), (286, 286), (288, 293), (295, 297), (299, 302), (304, 307), (309, 310), (312, 315), (317, 318), (320, 322), (324, 329), (331, 333), (335, 336), (338, 340), (342, 346), (348, 351)]
[u'We', u'compared', u'the', u'following', u'parameters', u'in', u'Long-Evans', u'-LRB-', u'LE', u'-RRB-', u'and', u'Sprague-Dawley', u'-LRB-', u'SD', u'-RRB-', u'female', u'rats', u':', u'1', u'-RRB-', u'mammary', u'tumor', u'incidence', u'after', u'DMBA', u',', u'2', u'-RRB-', u'plasma', u'prolactin', u'-LRB-', u'PRL', u'-RRB-', u'during', u'the', u'estrous', u'cycle', u'before', u'and', u'after', u'DMBA', u',', u'3', u'-RRB-', u'plasma', u'PRL', u'in', u'immature', u'females', u'from', u'0900', u'hr', u'on', u'day', u'29', u'to', u'0900', u'hr', u'on', u'day', u'30', u',', u'4', u'-RRB-', u'plasma', u'PRL', u'from', u'1200', u'to', u'1700', u'hr', u'and', u'before', u'and', u'10', u'min', u'after', u'i.p.', u'.']
orignal sentence: We compared the following parameters in Long-Evans (LE) and Sprague-Dawley (SD) female rats: 1) mammary tumor incidence after DMBA, 2) plasma prolactin (PRL) during the estrous cycle before and after DMBA, 3) plasma PRL in immature females from 0900 hr on day 29 to 0900 hr on day 30, 4) plasma PRL from 1200 to 1700 hr and before and 10 min after i.p.
error on token alignment
token: ., current:352
[(0, 1), (3, 10), (12, 14), (16, 24), (26, 35), (37, 38), (40, 49), (51, 51), (52, 53), (54, 54), (56, 58), (60, 73), (75, 75), (76, 77), (78, 78), (80, 85), (87, 90), (91, 91), (93, 93), (94, 94), (96, 102), (104, 108), (110, 118), (120, 124), (126, 129), (130, 130), (132, 132), (133, 133), (135, 140), (142, 150), (152, 152), (153, 155), (156, 156), (158, 163), (165, 167), (169, 175), (177, 181), (183, 188), (190, 192), (194, 198), (200, 203), (204, 204), (206, 206), (207, 207), (209, 214), (216, 218), (220, 221), (223, 230), (232, 238), (240, 243), (245, 248), (250, 251), (253, 254), (256, 258), (260, 261), (263, 264), (266, 269), (271, 272), (274, 275), (277, 279), (281, 282), (283, 283), (285, 285), (286, 286), (288, 293), (295, 297), (299, 302), (304, 307), (309, 310), (312, 315), (317, 318), (320, 322), (324, 329), (331, 333), (335, 336), (338, 340), (342, 346), (348, 351)]
[u'We', u'compared', u'the', u'following', u'parameters', u'in', u'Long-Evans', u'-LRB-', u'LE', u'-RRB-', u'and', u'Sprague-Dawley', u'-LRB-', u'SD', u'-RRB-', u'female', u'rats', u':', u'1', u'-RRB-', u'mammary', u'tumor', u'incidence', u'after', u'DMBA', u',', u'2', u'-RRB-', u'plasma', u'prolactin', u'-LRB-', u'PRL', u'-RRB-', u'during', u'the', u'estrous', u'cycle', u'before', u'and', u'after', u'DMBA', u',', u'3', u'-RRB-', u'plasma', u'PRL', u'in', u'immature', u'females', u'from', u'0900', u'hr', u'on', u'day', u'29', u'to', u'0900', u'hr', u'on', u'day', u'30', u',', u'4', u'-RRB-', u'plasma', u'PRL', u'from', u'1200', u'to', u'1700', u'hr', u'and', u'before', u'and', u'10', u'min', u'after', u'i.p.', u'.']
orignal sentence: We compared the following parameters in Long-Evans (LE) and Sprague-Dawley (SD) female rats: 1) mammary tumor incidence after DMBA, 2) plasma prolactin (PRL) during the estrous cycle before and after DMBA, 3) plasma PRL in immature females from 0900 hr on day 29 to 0900 hr on day 30, 4) plasma PRL from 1200 to 1700 hr and before and 10 min after i.p.
error on token alignment
token: ., current:352
[(0, 1), (3, 10), (12, 14), (16, 24), (26, 35), (37, 38), (40, 49), (51, 51), (52, 53), (54, 54), (56, 58), (60, 73), (75, 75), (76, 77), (78, 78), (80, 85), (87, 90), (91, 91), (93, 93), (94, 94), (96, 102), (104, 108), (110, 118), (120, 124), (126, 129), (130, 130), (132, 132), (133, 133), (135, 140), (142, 150), (152, 152), (153, 155), (156, 156), (158, 163), (165, 167), (169, 175), (177, 181), (183, 188), (190, 192), (194, 198), (200, 203), (204, 204), (206, 206), (207, 207), (209, 214), (216, 218), (220, 221), (223, 230), (232, 238), (240, 243), (245, 248), (250, 251), (253, 254), (256, 258), (260, 261), (263, 264), (266, 269), (271, 272), (274, 275), (277, 279), (281, 282), (283, 283), (285, 285), (286, 286), (288, 293), (295, 297), (299, 302), (304, 307), (309, 310), (312, 315), (317, 318), (320, 322), (324, 329), (331, 333), (335, 336), (338, 340), (342, 346), (348, 351)]
[u'We', u'compared', u'the', u'following', u'parameters', u'in', u'Long-Evans', u'-LRB-', u'LE', u'-RRB-', u'and', u'Sprague-Dawley', u'-LRB-', u'SD', u'-RRB-', u'female', u'rats', u':', u'1', u'-RRB-', u'mammary', u'tumor', u'incidence', u'after', u'DMBA', u',', u'2', u'-RRB-', u'plasma', u'prolactin', u'-LRB-', u'PRL', u'-RRB-', u'during', u'the', u'estrous', u'cycle', u'before', u'and', u'after', u'DMBA', u',', u'3', u'-RRB-', u'plasma', u'PRL', u'in', u'immature', u'females', u'from', u'0900', u'hr', u'on', u'day', u'29', u'to', u'0900', u'hr', u'on', u'day', u'30', u',', u'4', u'-RRB-', u'plasma', u'PRL', u'from', u'1200', u'to', u'1700', u'hr', u'and', u'before', u'and', u'10', u'min', u'after', u'i.p.', u'.']
orignal sentence: We compared the following parameters in Long-Evans (LE) and Sprague-Dawley (SD) female rats: 1) mammary tumor incidence after DMBA, 2) plasma prolactin (PRL) during the estrous cycle before and after DMBA, 3) plasma PRL in immature females from 0900 hr on day 29 to 0900 hr on day 30, 4) plasma PRL from 1200 to 1700 hr and before and 10 min after i.p.
error on token alignment
token: ., current:352
[(0, 1), (3, 10), (12, 14), (16, 24), (26, 35), (37, 38), (40, 49), (51, 51), (52, 53), (54, 54), (56, 58), (60, 73), (75, 75), (76, 77), (78, 78), (80, 85), (87, 90), (91, 91), (93, 93), (94, 94), (96, 102), (104, 108), (110, 118), (120, 124), (126, 129), (130, 130), (132, 132), (133, 133), (135, 140), (142, 150), (152, 152), (153, 155), (156, 156), (158, 163), (165, 167), (169, 175), (177, 181), (183, 188), (190, 192), (194, 198), (200, 203), (204, 204), (206, 206), (207, 207), (209, 214), (216, 218), (220, 221), (223, 230), (232, 238), (240, 243), (245, 248), (250, 251), (253, 254), (256, 258), (260, 261), (263, 264), (266, 269), (271, 272), (274, 275), (277, 279), (281, 282), (283, 283), (285, 285), (286, 286), (288, 293), (295, 297), (299, 302), (304, 307), (309, 310), (312, 315), (317, 318), (320, 322), (324, 329), (331, 333), (335, 336), (338, 340), (342, 346), (348, 351)]
[u'We', u'compared', u'the', u'following', u'parameters', u'in', u'Long-Evans', u'-LRB-', u'LE', u'-RRB-', u'and', u'Sprague-Dawley', u'-LRB-', u'SD', u'-RRB-', u'female', u'rats', u':', u'1', u'-RRB-', u'mammary', u'tumor', u'incidence', u'after', u'DMBA', u',', u'2', u'-RRB-', u'plasma', u'prolactin', u'-LRB-', u'PRL', u'-RRB-', u'during', u'the', u'estrous', u'cycle', u'before', u'and', u'after', u'DMBA', u',', u'3', u'-RRB-', u'plasma', u'PRL', u'in', u'immature', u'females', u'from', u'0900', u'hr', u'on', u'day', u'29', u'to', u'0900', u'hr', u'on', u'day', u'30', u',', u'4', u'-RRB-', u'plasma', u'PRL', u'from', u'1200', u'to', u'1700', u'hr', u'and', u'before', u'and', u'10', u'min', u'after', u'i.p.', u'.']
orignal sentence: We compared the following parameters in Long-Evans (LE) and Sprague-Dawley (SD) female rats: 1) mammary tumor incidence after DMBA, 2) plasma prolactin (PRL) during the estrous cycle before and after DMBA, 3) plasma PRL in immature females from 0900 hr on day 29 to 0900 hr on day 30, 4) plasma PRL from 1200 to 1700 hr and before and 10 min after i.p.
error on token alignment
token: ., current:352
[(0, 1), (3, 10), (12, 14), (16, 24), (26, 35), (37, 38), (40, 49), (51, 51), (52, 53), (54, 54), (56, 58), (60, 73), (75, 75), (76, 77), (78, 78), (80, 85), (87, 90), (91, 91), (93, 93), (94, 94), (96, 102), (104, 108), (110, 118), (120, 124), (126, 129), (130, 130), (132, 132), (133, 133), (135, 140), (142, 150), (152, 152), (153, 155), (156, 156), (158, 163), (165, 167), (169, 175), (177, 181), (183, 188), (190, 192), (194, 198), (200, 203), (204, 204), (206, 206), (207, 207), (209, 214), (216, 218), (220, 221), (223, 230), (232, 238), (240, 243), (245, 248), (250, 251), (253, 254), (256, 258), (260, 261), (263, 264), (266, 269), (271, 272), (274, 275), (277, 279), (281, 282), (283, 283), (285, 285), (286, 286), (288, 293), (295, 297), (299, 302), (304, 307), (309, 310), (312, 315), (317, 318), (320, 322), (324, 329), (331, 333), (335, 336), (338, 340), (342, 346), (348, 351)]
[u'We', u'compared', u'the', u'following', u'parameters', u'in', u'Long-Evans', u'-LRB-', u'LE', u'-RRB-', u'and', u'Sprague-Dawley', u'-LRB-', u'SD', u'-RRB-', u'female', u'rats', u':', u'1', u'-RRB-', u'mammary', u'tumor', u'incidence', u'after', u'DMBA', u',', u'2', u'-RRB-', u'plasma', u'prolactin', u'-LRB-', u'PRL', u'-RRB-', u'during', u'the', u'estrous', u'cycle', u'before', u'and', u'after', u'DMBA', u',', u'3', u'-RRB-', u'plasma', u'PRL', u'in', u'immature', u'females', u'from', u'0900', u'hr', u'on', u'day', u'29', u'to', u'0900', u'hr', u'on', u'day', u'30', u',', u'4', u'-RRB-', u'plasma', u'PRL', u'from', u'1200', u'to', u'1700', u'hr', u'and', u'before', u'and', u'10', u'min', u'after', u'i.p.', u'.']
orignal sentence: We compared the following parameters in Long-Evans (LE) and Sprague-Dawley (SD) female rats: 1) mammary tumor incidence after DMBA, 2) plasma prolactin (PRL) during the estrous cycle before and after DMBA, 3) plasma PRL in immature females from 0900 hr on day 29 to 0900 hr on day 30, 4) plasma PRL from 1200 to 1700 hr and before and 10 min after i.p.
error on token alignment
token: ., current:352
[(0, 1), (3, 10), (12, 14), (16, 24), (26, 35), (37, 38), (40, 49), (51, 51), (52, 53), (54, 54), (56, 58), (60, 73), (75, 75), (76, 77), (78, 78), (80, 85), (87, 90), (91, 91), (93, 93), (94, 94), (96, 102), (104, 108), (110, 118), (120, 124), (126, 129), (130, 130), (132, 132), (133, 133), (135, 140), (142, 150), (152, 152), (153, 155), (156, 156), (158, 163), (165, 167), (169, 175), (177, 181), (183, 188), (190, 192), (194, 198), (200, 203), (204, 204), (206, 206), (207, 207), (209, 214), (216, 218), (220, 221), (223, 230), (232, 238), (240, 243), (245, 248), (250, 251), (253, 254), (256, 258), (260, 261), (263, 264), (266, 269), (271, 272), (274, 275), (277, 279), (281, 282), (283, 283), (285, 285), (286, 286), (288, 293), (295, 297), (299, 302), (304, 307), (309, 310), (312, 315), (317, 318), (320, 322), (324, 329), (331, 333), (335, 336), (338, 340), (342, 346), (348, 351)]
[u'We', u'compared', u'the', u'following', u'parameters', u'in', u'Long-Evans', u'-LRB-', u'LE', u'-RRB-', u'and', u'Sprague-Dawley', u'-LRB-', u'SD', u'-RRB-', u'female', u'rats', u':', u'1', u'-RRB-', u'mammary', u'tumor', u'incidence', u'after', u'DMBA', u',', u'2', u'-RRB-', u'plasma', u'prolactin', u'-LRB-', u'PRL', u'-RRB-', u'during', u'the', u'estrous', u'cycle', u'before', u'and', u'after', u'DMBA', u',', u'3', u'-RRB-', u'plasma', u'PRL', u'in', u'immature', u'females', u'from', u'0900', u'hr', u'on', u'day', u'29', u'to', u'0900', u'hr', u'on', u'day', u'30', u',', u'4', u'-RRB-', u'plasma', u'PRL', u'from', u'1200', u'to', u'1700', u'hr', u'and', u'before', u'and', u'10', u'min', u'after', u'i.p.', u'.']
orignal sentence: We compared the following parameters in Long-Evans (LE) and Sprague-Dawley (SD) female rats: 1) mammary tumor incidence after DMBA, 2) plasma prolactin (PRL) during the estrous cycle before and after DMBA, 3) plasma PRL in immature females from 0900 hr on day 29 to 0900 hr on day 30, 4) plasma PRL from 1200 to 1700 hr and before and 10 min after i.p.
error on token alignment
token: ., current:352
[(0, 1), (3, 10), (12, 14), (16, 24), (26, 35), (37, 38), (40, 49), (51, 51), (52, 53), (54, 54), (56, 58), (60, 73), (75, 75), (76, 77), (78, 78), (80, 85), (87, 90), (91, 91), (93, 93), (94, 94), (96, 102), (104, 108), (110, 118), (120, 124), (126, 129), (130, 130), (132, 132), (133, 133), (135, 140), (142, 150), (152, 152), (153, 155), (156, 156), (158, 163), (165, 167), (169, 175), (177, 181), (183, 188), (190, 192), (194, 198), (200, 203), (204, 204), (206, 206), (207, 207), (209, 214), (216, 218), (220, 221), (223, 230), (232, 238), (240, 243), (245, 248), (250, 251), (253, 254), (256, 258), (260, 261), (263, 264), (266, 269), (271, 272), (274, 275), (277, 279), (281, 282), (283, 283), (285, 285), (286, 286), (288, 293), (295, 297), (299, 302), (304, 307), (309, 310), (312, 315), (317, 318), (320, 322), (324, 329), (331, 333), (335, 336), (338, 340), (342, 346), (348, 351)]
[u'We', u'compared', u'the', u'following', u'parameters', u'in', u'Long-Evans', u'-LRB-', u'LE', u'-RRB-', u'and', u'Sprague-Dawley', u'-LRB-', u'SD', u'-RRB-', u'female', u'rats', u':', u'1', u'-RRB-', u'mammary', u'tumor', u'incidence', u'after', u'DMBA', u',', u'2', u'-RRB-', u'plasma', u'prolactin', u'-LRB-', u'PRL', u'-RRB-', u'during', u'the', u'estrous', u'cycle', u'before', u'and', u'after', u'DMBA', u',', u'3', u'-RRB-', u'plasma', u'PRL', u'in', u'immature', u'females', u'from', u'0900', u'hr', u'on', u'day', u'29', u'to', u'0900', u'hr', u'on', u'day', u'30', u',', u'4', u'-RRB-', u'plasma', u'PRL', u'from', u'1200', u'to', u'1700', u'hr', u'and', u'before', u'and', u'10', u'min', u'after', u'i.p.', u'.']
orignal sentence: We compared the following parameters in Long-Evans (LE) and Sprague-Dawley (SD) female rats: 1) mammary tumor incidence after DMBA, 2) plasma prolactin (PRL) during the estrous cycle before and after DMBA, 3) plasma PRL in immature females from 0900 hr on day 29 to 0900 hr on day 30, 4) plasma PRL from 1200 to 1700 hr and before and 10 min after i.p.
error on token alignment
token: ., current:352
[(0, 1), (3, 10), (12, 14), (16, 24), (26, 35), (37, 38), (40, 49), (51, 51), (52, 53), (54, 54), (56, 58), (60, 73), (75, 75), (76, 77), (78, 78), (80, 85), (87, 90), (91, 91), (93, 93), (94, 94), (96, 102), (104, 108), (110, 118), (120, 124), (126, 129), (130, 130), (132, 132), (133, 133), (135, 140), (142, 150), (152, 152), (153, 155), (156, 156), (158, 163), (165, 167), (169, 175), (177, 181), (183, 188), (190, 192), (194, 198), (200, 203), (204, 204), (206, 206), (207, 207), (209, 214), (216, 218), (220, 221), (223, 230), (232, 238), (240, 243), (245, 248), (250, 251), (253, 254), (256, 258), (260, 261), (263, 264), (266, 269), (271, 272), (274, 275), (277, 279), (281, 282), (283, 283), (285, 285), (286, 286), (288, 293), (295, 297), (299, 302), (304, 307), (309, 310), (312, 315), (317, 318), (320, 322), (324, 329), (331, 333), (335, 336), (338, 340), (342, 346), (348, 351)]
[u'We', u'compared', u'the', u'following', u'parameters', u'in', u'Long-Evans', u'-LRB-', u'LE', u'-RRB-', u'and', u'Sprague-Dawley', u'-LRB-', u'SD', u'-RRB-', u'female', u'rats', u':', u'1', u'-RRB-', u'mammary', u'tumor', u'incidence', u'after', u'DMBA', u',', u'2', u'-RRB-', u'plasma', u'prolactin', u'-LRB-', u'PRL', u'-RRB-', u'during', u'the', u'estrous', u'cycle', u'before', u'and', u'after', u'DMBA', u',', u'3', u'-RRB-', u'plasma', u'PRL', u'in', u'immature', u'females', u'from', u'0900', u'hr', u'on', u'day', u'29', u'to', u'0900', u'hr', u'on', u'day', u'30', u',', u'4', u'-RRB-', u'plasma', u'PRL', u'from', u'1200', u'to', u'1700', u'hr', u'and', u'before', u'and', u'10', u'min', u'after', u'i.p.', u'.']
orignal sentence: We compared the following parameters in Long-Evans (LE) and Sprague-Dawley (SD) female rats: 1) mammary tumor incidence after DMBA, 2) plasma prolactin (PRL) during the estrous cycle before and after DMBA, 3) plasma PRL in immature females from 0900 hr on day 29 to 0900 hr on day 30, 4) plasma PRL from 1200 to 1700 hr and before and 10 min after i.p.
error on token alignment
token: ., current:352
[(0, 1), (3, 10), (12, 14), (16, 24), (26, 35), (37, 38), (40, 49), (51, 51), (52, 53), (54, 54), (56, 58), (60, 73), (75, 75), (76, 77), (78, 78), (80, 85), (87, 90), (91, 91), (93, 93), (94, 94), (96, 102), (104, 108), (110, 118), (120, 124), (126, 129), (130, 130), (132, 132), (133, 133), (135, 140), (142, 150), (152, 152), (153, 155), (156, 156), (158, 163), (165, 167), (169, 175), (177, 181), (183, 188), (190, 192), (194, 198), (200, 203), (204, 204), (206, 206), (207, 207), (209, 214), (216, 218), (220, 221), (223, 230), (232, 238), (240, 243), (245, 248), (250, 251), (253, 254), (256, 258), (260, 261), (263, 264), (266, 269), (271, 272), (274, 275), (277, 279), (281, 282), (283, 283), (285, 285), (286, 286), (288, 293), (295, 297), (299, 302), (304, 307), (309, 310), (312, 315), (317, 318), (320, 322), (324, 329), (331, 333), (335, 336), (338, 340), (342, 346), (348, 351)]
[u'We', u'compared', u'the', u'following', u'parameters', u'in', u'Long-Evans', u'-LRB-', u'LE', u'-RRB-', u'and', u'Sprague-Dawley', u'-LRB-', u'SD', u'-RRB-', u'female', u'rats', u':', u'1', u'-RRB-', u'mammary', u'tumor', u'incidence', u'after', u'DMBA', u',', u'2', u'-RRB-', u'plasma', u'prolactin', u'-LRB-', u'PRL', u'-RRB-', u'during', u'the', u'estrous', u'cycle', u'before', u'and', u'after', u'DMBA', u',', u'3', u'-RRB-', u'plasma', u'PRL', u'in', u'immature', u'females', u'from', u'0900', u'hr', u'on', u'day', u'29', u'to', u'0900', u'hr', u'on', u'day', u'30', u',', u'4', u'-RRB-', u'plasma', u'PRL', u'from', u'1200', u'to', u'1700', u'hr', u'and', u'before', u'and', u'10', u'min', u'after', u'i.p.', u'.']
orignal sentence: We compared the following parameters in Long-Evans (LE) and Sprague-Dawley (SD) female rats: 1) mammary tumor incidence after DMBA, 2) plasma prolactin (PRL) during the estrous cycle before and after DMBA, 3) plasma PRL in immature females from 0900 hr on day 29 to 0900 hr on day 30, 4) plasma PRL from 1200 to 1700 hr and before and 10 min after i.p.
error on token alignment
token: ., current:352
[(0, 1), (3, 10), (12, 14), (16, 24), (26, 35), (37, 38), (40, 49), (51, 51), (52, 53), (54, 54), (56, 58), (60, 73), (75, 75), (76, 77), (78, 78), (80, 85), (87, 90), (91, 91), (93, 93), (94, 94), (96, 102), (104, 108), (110, 118), (120, 124), (126, 129), (130, 130), (132, 132), (133, 133), (135, 140), (142, 150), (152, 152), (153, 155), (156, 156), (158, 163), (165, 167), (169, 175), (177, 181), (183, 188), (190, 192), (194, 198), (200, 203), (204, 204), (206, 206), (207, 207), (209, 214), (216, 218), (220, 221), (223, 230), (232, 238), (240, 243), (245, 248), (250, 251), (253, 254), (256, 258), (260, 261), (263, 264), (266, 269), (271, 272), (274, 275), (277, 279), (281, 282), (283, 283), (285, 285), (286, 286), (288, 293), (295, 297), (299, 302), (304, 307), (309, 310), (312, 315), (317, 318), (320, 322), (324, 329), (331, 333), (335, 336), (338, 340), (342, 346), (348, 351)]
[u'We', u'compared', u'the', u'following', u'parameters', u'in', u'Long-Evans', u'-LRB-', u'LE', u'-RRB-', u'and', u'Sprague-Dawley', u'-LRB-', u'SD', u'-RRB-', u'female', u'rats', u':', u'1', u'-RRB-', u'mammary', u'tumor', u'incidence', u'after', u'DMBA', u',', u'2', u'-RRB-', u'plasma', u'prolactin', u'-LRB-', u'PRL', u'-RRB-', u'during', u'the', u'estrous', u'cycle', u'before', u'and', u'after', u'DMBA', u',', u'3', u'-RRB-', u'plasma', u'PRL', u'in', u'immature', u'females', u'from', u'0900', u'hr', u'on', u'day', u'29', u'to', u'0900', u'hr', u'on', u'day', u'30', u',', u'4', u'-RRB-', u'plasma', u'PRL', u'from', u'1200', u'to', u'1700', u'hr', u'and', u'before', u'and', u'10', u'min', u'after', u'i.p.', u'.']
orignal sentence: We compared the following parameters in Long-Evans (LE) and Sprague-Dawley (SD) female rats: 1) mammary tumor incidence after DMBA, 2) plasma prolactin (PRL) during the estrous cycle before and after DMBA, 3) plasma PRL in immature females from 0900 hr on day 29 to 0900 hr on day 30, 4) plasma PRL from 1200 to 1700 hr and before and 10 min after i.p.
error on token alignment
token: ., current:352
[(0, 1), (3, 10), (12, 14), (16, 24), (26, 35), (37, 38), (40, 49), (51, 51), (52, 53), (54, 54), (56, 58), (60, 73), (75, 75), (76, 77), (78, 78), (80, 85), (87, 90), (91, 91), (93, 93), (94, 94), (96, 102), (104, 108), (110, 118), (120, 124), (126, 129), (130, 130), (132, 132), (133, 133), (135, 140), (142, 150), (152, 152), (153, 155), (156, 156), (158, 163), (165, 167), (169, 175), (177, 181), (183, 188), (190, 192), (194, 198), (200, 203), (204, 204), (206, 206), (207, 207), (209, 214), (216, 218), (220, 221), (223, 230), (232, 238), (240, 243), (245, 248), (250, 251), (253, 254), (256, 258), (260, 261), (263, 264), (266, 269), (271, 272), (274, 275), (277, 279), (281, 282), (283, 283), (285, 285), (286, 286), (288, 293), (295, 297), (299, 302), (304, 307), (309, 310), (312, 315), (317, 318), (320, 322), (324, 329), (331, 333), (335, 336), (338, 340), (342, 346), (348, 351)]
[u'We', u'compared', u'the', u'following', u'parameters', u'in', u'Long-Evans', u'-LRB-', u'LE', u'-RRB-', u'and', u'Sprague-Dawley', u'-LRB-', u'SD', u'-RRB-', u'female', u'rats', u':', u'1', u'-RRB-', u'mammary', u'tumor', u'incidence', u'after', u'DMBA', u',', u'2', u'-RRB-', u'plasma', u'prolactin', u'-LRB-', u'PRL', u'-RRB-', u'during', u'the', u'estrous', u'cycle', u'before', u'and', u'after', u'DMBA', u',', u'3', u'-RRB-', u'plasma', u'PRL', u'in', u'immature', u'females', u'from', u'0900', u'hr', u'on', u'day', u'29', u'to', u'0900', u'hr', u'on', u'day', u'30', u',', u'4', u'-RRB-', u'plasma', u'PRL', u'from', u'1200', u'to', u'1700', u'hr', u'and', u'before', u'and', u'10', u'min', u'after', u'i.p.', u'.']
orignal sentence: We compared the following parameters in Long-Evans (LE) and Sprague-Dawley (SD) female rats: 1) mammary tumor incidence after DMBA, 2) plasma prolactin (PRL) during the estrous cycle before and after DMBA, 3) plasma PRL in immature females from 0900 hr on day 29 to 0900 hr on day 30, 4) plasma PRL from 1200 to 1700 hr and before and 10 min after i.p.
error on token alignment
token: ., current:352
[(0, 1), (3, 10), (12, 14), (16, 24), (26, 35), (37, 38), (40, 49), (51, 51), (52, 53), (54, 54), (56, 58), (60, 73), (75, 75), (76, 77), (78, 78), (80, 85), (87, 90), (91, 91), (93, 93), (94, 94), (96, 102), (104, 108), (110, 118), (120, 124), (126, 129), (130, 130), (132, 132), (133, 133), (135, 140), (142, 150), (152, 152), (153, 155), (156, 156), (158, 163), (165, 167), (169, 175), (177, 181), (183, 188), (190, 192), (194, 198), (200, 203), (204, 204), (206, 206), (207, 207), (209, 214), (216, 218), (220, 221), (223, 230), (232, 238), (240, 243), (245, 248), (250, 251), (253, 254), (256, 258), (260, 261), (263, 264), (266, 269), (271, 272), (274, 275), (277, 279), (281, 282), (283, 283), (285, 285), (286, 286), (288, 293), (295, 297), (299, 302), (304, 307), (309, 310), (312, 315), (317, 318), (320, 322), (324, 329), (331, 333), (335, 336), (338, 340), (342, 346), (348, 351)]
[u'We', u'compared', u'the', u'following', u'parameters', u'in', u'Long-Evans', u'-LRB-', u'LE', u'-RRB-', u'and', u'Sprague-Dawley', u'-LRB-', u'SD', u'-RRB-', u'female', u'rats', u':', u'1', u'-RRB-', u'mammary', u'tumor', u'incidence', u'after', u'DMBA', u',', u'2', u'-RRB-', u'plasma', u'prolactin', u'-LRB-', u'PRL', u'-RRB-', u'during', u'the', u'estrous', u'cycle', u'before', u'and', u'after', u'DMBA', u',', u'3', u'-RRB-', u'plasma', u'PRL', u'in', u'immature', u'females', u'from', u'0900', u'hr', u'on', u'day', u'29', u'to', u'0900', u'hr', u'on', u'day', u'30', u',', u'4', u'-RRB-', u'plasma', u'PRL', u'from', u'1200', u'to', u'1700', u'hr', u'and', u'before', u'and', u'10', u'min', u'after', u'i.p.', u'.']
orignal sentence: We compared the following parameters in Long-Evans (LE) and Sprague-Dawley (SD) female rats: 1) mammary tumor incidence after DMBA, 2) plasma prolactin (PRL) during the estrous cycle before and after DMBA, 3) plasma PRL in immature females from 0900 hr on day 29 to 0900 hr on day 30, 4) plasma PRL from 1200 to 1700 hr and before and 10 min after i.p.
error on token alignment
token: ., current:352
[(0, 1), (3, 10), (12, 14), (16, 24), (26, 35), (37, 38), (40, 49), (51, 51), (52, 53), (54, 54), (56, 58), (60, 73), (75, 75), (76, 77), (78, 78), (80, 85), (87, 90), (91, 91), (93, 93), (94, 94), (96, 102), (104, 108), (110, 118), (120, 124), (126, 129), (130, 130), (132, 132), (133, 133), (135, 140), (142, 150), (152, 152), (153, 155), (156, 156), (158, 163), (165, 167), (169, 175), (177, 181), (183, 188), (190, 192), (194, 198), (200, 203), (204, 204), (206, 206), (207, 207), (209, 214), (216, 218), (220, 221), (223, 230), (232, 238), (240, 243), (245, 248), (250, 251), (253, 254), (256, 258), (260, 261), (263, 264), (266, 269), (271, 272), (274, 275), (277, 279), (281, 282), (283, 283), (285, 285), (286, 286), (288, 293), (295, 297), (299, 302), (304, 307), (309, 310), (312, 315), (317, 318), (320, 322), (324, 329), (331, 333), (335, 336), (338, 340), (342, 346), (348, 351)]
[u'We', u'compared', u'the', u'following', u'parameters', u'in', u'Long-Evans', u'-LRB-', u'LE', u'-RRB-', u'and', u'Sprague-Dawley', u'-LRB-', u'SD', u'-RRB-', u'female', u'rats', u':', u'1', u'-RRB-', u'mammary', u'tumor', u'incidence', u'after', u'DMBA', u',', u'2', u'-RRB-', u'plasma', u'prolactin', u'-LRB-', u'PRL', u'-RRB-', u'during', u'the', u'estrous', u'cycle', u'before', u'and', u'after', u'DMBA', u',', u'3', u'-RRB-', u'plasma', u'PRL', u'in', u'immature', u'females', u'from', u'0900', u'hr', u'on', u'day', u'29', u'to', u'0900', u'hr', u'on', u'day', u'30', u',', u'4', u'-RRB-', u'plasma', u'PRL', u'from', u'1200', u'to', u'1700', u'hr', u'and', u'before', u'and', u'10', u'min', u'after', u'i.p.', u'.']
orignal sentence: We compared the following parameters in Long-Evans (LE) and Sprague-Dawley (SD) female rats: 1) mammary tumor incidence after DMBA, 2) plasma prolactin (PRL) during the estrous cycle before and after DMBA, 3) plasma PRL in immature females from 0900 hr on day 29 to 0900 hr on day 30, 4) plasma PRL from 1200 to 1700 hr and before and 10 min after i.p.
error on token alignment
token: ., current:352
[(0, 1), (3, 10), (12, 14), (16, 24), (26, 35), (37, 38), (40, 49), (51, 51), (52, 53), (54, 54), (56, 58), (60, 73), (75, 75), (76, 77), (78, 78), (80, 85), (87, 90), (91, 91), (93, 93), (94, 94), (96, 102), (104, 108), (110, 118), (120, 124), (126, 129), (130, 130), (132, 132), (133, 133), (135, 140), (142, 150), (152, 152), (153, 155), (156, 156), (158, 163), (165, 167), (169, 175), (177, 181), (183, 188), (190, 192), (194, 198), (200, 203), (204, 204), (206, 206), (207, 207), (209, 214), (216, 218), (220, 221), (223, 230), (232, 238), (240, 243), (245, 248), (250, 251), (253, 254), (256, 258), (260, 261), (263, 264), (266, 269), (271, 272), (274, 275), (277, 279), (281, 282), (283, 283), (285, 285), (286, 286), (288, 293), (295, 297), (299, 302), (304, 307), (309, 310), (312, 315), (317, 318), (320, 322), (324, 329), (331, 333), (335, 336), (338, 340), (342, 346), (348, 351)]
[u'We', u'compared', u'the', u'following', u'parameters', u'in', u'Long-Evans', u'-LRB-', u'LE', u'-RRB-', u'and', u'Sprague-Dawley', u'-LRB-', u'SD', u'-RRB-', u'female', u'rats', u':', u'1', u'-RRB-', u'mammary', u'tumor', u'incidence', u'after', u'DMBA', u',', u'2', u'-RRB-', u'plasma', u'prolactin', u'-LRB-', u'PRL', u'-RRB-', u'during', u'the', u'estrous', u'cycle', u'before', u'and', u'after', u'DMBA', u',', u'3', u'-RRB-', u'plasma', u'PRL', u'in', u'immature', u'females', u'from', u'0900', u'hr', u'on', u'day', u'29', u'to', u'0900', u'hr', u'on', u'day', u'30', u',', u'4', u'-RRB-', u'plasma', u'PRL', u'from', u'1200', u'to', u'1700', u'hr', u'and', u'before', u'and', u'10', u'min', u'after', u'i.p.', u'.']
orignal sentence: We compared the following parameters in Long-Evans (LE) and Sprague-Dawley (SD) female rats: 1) mammary tumor incidence after DMBA, 2) plasma prolactin (PRL) during the estrous cycle before and after DMBA, 3) plasma PRL in immature females from 0900 hr on day 29 to 0900 hr on day 30, 4) plasma PRL from 1200 to 1700 hr and before and 10 min after i.p.
error on token alignment
token: ., current:352
[(0, 1), (3, 10), (12, 14), (16, 24), (26, 35), (37, 38), (40, 49), (51, 51), (52, 53), (54, 54), (56, 58), (60, 73), (75, 75), (76, 77), (78, 78), (80, 85), (87, 90), (91, 91), (93, 93), (94, 94), (96, 102), (104, 108), (110, 118), (120, 124), (126, 129), (130, 130), (132, 132), (133, 133), (135, 140), (142, 150), (152, 152), (153, 155), (156, 156), (158, 163), (165, 167), (169, 175), (177, 181), (183, 188), (190, 192), (194, 198), (200, 203), (204, 204), (206, 206), (207, 207), (209, 214), (216, 218), (220, 221), (223, 230), (232, 238), (240, 243), (245, 248), (250, 251), (253, 254), (256, 258), (260, 261), (263, 264), (266, 269), (271, 272), (274, 275), (277, 279), (281, 282), (283, 283), (285, 285), (286, 286), (288, 293), (295, 297), (299, 302), (304, 307), (309, 310), (312, 315), (317, 318), (320, 322), (324, 329), (331, 333), (335, 336), (338, 340), (342, 346), (348, 351)]
[u'We', u'compared', u'the', u'following', u'parameters', u'in', u'Long-Evans', u'-LRB-', u'LE', u'-RRB-', u'and', u'Sprague-Dawley', u'-LRB-', u'SD', u'-RRB-', u'female', u'rats', u':', u'1', u'-RRB-', u'mammary', u'tumor', u'incidence', u'after', u'DMBA', u',', u'2', u'-RRB-', u'plasma', u'prolactin', u'-LRB-', u'PRL', u'-RRB-', u'during', u'the', u'estrous', u'cycle', u'before', u'and', u'after', u'DMBA', u',', u'3', u'-RRB-', u'plasma', u'PRL', u'in', u'immature', u'females', u'from', u'0900', u'hr', u'on', u'day', u'29', u'to', u'0900', u'hr', u'on', u'day', u'30', u',', u'4', u'-RRB-', u'plasma', u'PRL', u'from', u'1200', u'to', u'1700', u'hr', u'and', u'before', u'and', u'10', u'min', u'after', u'i.p.', u'.']
orignal sentence: We compared the following parameters in Long-Evans (LE) and Sprague-Dawley (SD) female rats: 1) mammary tumor incidence after DMBA, 2) plasma prolactin (PRL) during the estrous cycle before and after DMBA, 3) plasma PRL in immature females from 0900 hr on day 29 to 0900 hr on day 30, 4) plasma PRL from 1200 to 1700 hr and before and 10 min after i.p.
error on token alignment
token: ., current:352
[(0, 1), (3, 10), (12, 14), (16, 24), (26, 35), (37, 38), (40, 49), (51, 51), (52, 53), (54, 54), (56, 58), (60, 73), (75, 75), (76, 77), (78, 78), (80, 85), (87, 90), (91, 91), (93, 93), (94, 94), (96, 102), (104, 108), (110, 118), (120, 124), (126, 129), (130, 130), (132, 132), (133, 133), (135, 140), (142, 150), (152, 152), (153, 155), (156, 156), (158, 163), (165, 167), (169, 175), (177, 181), (183, 188), (190, 192), (194, 198), (200, 203), (204, 204), (206, 206), (207, 207), (209, 214), (216, 218), (220, 221), (223, 230), (232, 238), (240, 243), (245, 248), (250, 251), (253, 254), (256, 258), (260, 261), (263, 264), (266, 269), (271, 272), (274, 275), (277, 279), (281, 282), (283, 283), (285, 285), (286, 286), (288, 293), (295, 297), (299, 302), (304, 307), (309, 310), (312, 315), (317, 318), (320, 322), (324, 329), (331, 333), (335, 336), (338, 340), (342, 346), (348, 351)]
[u'We', u'compared', u'the', u'following', u'parameters', u'in', u'Long-Evans', u'-LRB-', u'LE', u'-RRB-', u'and', u'Sprague-Dawley', u'-LRB-', u'SD', u'-RRB-', u'female', u'rats', u':', u'1', u'-RRB-', u'mammary', u'tumor', u'incidence', u'after', u'DMBA', u',', u'2', u'-RRB-', u'plasma', u'prolactin', u'-LRB-', u'PRL', u'-RRB-', u'during', u'the', u'estrous', u'cycle', u'before', u'and', u'after', u'DMBA', u',', u'3', u'-RRB-', u'plasma', u'PRL', u'in', u'immature', u'females', u'from', u'0900', u'hr', u'on', u'day', u'29', u'to', u'0900', u'hr', u'on', u'day', u'30', u',', u'4', u'-RRB-', u'plasma', u'PRL', u'from', u'1200', u'to', u'1700', u'hr', u'and', u'before', u'and', u'10', u'min', u'after', u'i.p.', u'.']
orignal sentence: We compared the following parameters in Long-Evans (LE) and Sprague-Dawley (SD) female rats: 1) mammary tumor incidence after DMBA, 2) plasma prolactin (PRL) during the estrous cycle before and after DMBA, 3) plasma PRL in immature females from 0900 hr on day 29 to 0900 hr on day 30, 4) plasma PRL from 1200 to 1700 hr and before and 10 min after i.p.
error on token alignment
token: ., current:352
[(0, 1), (3, 10), (12, 14), (16, 24), (26, 35), (37, 38), (40, 49), (51, 51), (52, 53), (54, 54), (56, 58), (60, 73), (75, 75), (76, 77), (78, 78), (80, 85), (87, 90), (91, 91), (93, 93), (94, 94), (96, 102), (104, 108), (110, 118), (120, 124), (126, 129), (130, 130), (132, 132), (133, 133), (135, 140), (142, 150), (152, 152), (153, 155), (156, 156), (158, 163), (165, 167), (169, 175), (177, 181), (183, 188), (190, 192), (194, 198), (200, 203), (204, 204), (206, 206), (207, 207), (209, 214), (216, 218), (220, 221), (223, 230), (232, 238), (240, 243), (245, 248), (250, 251), (253, 254), (256, 258), (260, 261), (263, 264), (266, 269), (271, 272), (274, 275), (277, 279), (281, 282), (283, 283), (285, 285), (286, 286), (288, 293), (295, 297), (299, 302), (304, 307), (309, 310), (312, 315), (317, 318), (320, 322), (324, 329), (331, 333), (335, 336), (338, 340), (342, 346), (348, 351)]
[u'We', u'compared', u'the', u'following', u'parameters', u'in', u'Long-Evans', u'-LRB-', u'LE', u'-RRB-', u'and', u'Sprague-Dawley', u'-LRB-', u'SD', u'-RRB-', u'female', u'rats', u':', u'1', u'-RRB-', u'mammary', u'tumor', u'incidence', u'after', u'DMBA', u',', u'2', u'-RRB-', u'plasma', u'prolactin', u'-LRB-', u'PRL', u'-RRB-', u'during', u'the', u'estrous', u'cycle', u'before', u'and', u'after', u'DMBA', u',', u'3', u'-RRB-', u'plasma', u'PRL', u'in', u'immature', u'females', u'from', u'0900', u'hr', u'on', u'day', u'29', u'to', u'0900', u'hr', u'on', u'day', u'30', u',', u'4', u'-RRB-', u'plasma', u'PRL', u'from', u'1200', u'to', u'1700', u'hr', u'and', u'before', u'and', u'10', u'min', u'after', u'i.p.', u'.']
orignal sentence: We compared the following parameters in Long-Evans (LE) and Sprague-Dawley (SD) female rats: 1) mammary tumor incidence after DMBA, 2) plasma prolactin (PRL) during the estrous cycle before and after DMBA, 3) plasma PRL in immature females from 0900 hr on day 29 to 0900 hr on day 30, 4) plasma PRL from 1200 to 1700 hr and before and 10 min after i.p.
error on token alignment
token: ., current:352
[(0, 1), (3, 10), (12, 14), (16, 24), (26, 35), (37, 38), (40, 49), (51, 51), (52, 53), (54, 54), (56, 58), (60, 73), (75, 75), (76, 77), (78, 78), (80, 85), (87, 90), (91, 91), (93, 93), (94, 94), (96, 102), (104, 108), (110, 118), (120, 124), (126, 129), (130, 130), (132, 132), (133, 133), (135, 140), (142, 150), (152, 152), (153, 155), (156, 156), (158, 163), (165, 167), (169, 175), (177, 181), (183, 188), (190, 192), (194, 198), (200, 203), (204, 204), (206, 206), (207, 207), (209, 214), (216, 218), (220, 221), (223, 230), (232, 238), (240, 243), (245, 248), (250, 251), (253, 254), (256, 258), (260, 261), (263, 264), (266, 269), (271, 272), (274, 275), (277, 279), (281, 282), (283, 283), (285, 285), (286, 286), (288, 293), (295, 297), (299, 302), (304, 307), (309, 310), (312, 315), (317, 318), (320, 322), (324, 329), (331, 333), (335, 336), (338, 340), (342, 346), (348, 351)]
[u'We', u'compared', u'the', u'following', u'parameters', u'in', u'Long-Evans', u'-LRB-', u'LE', u'-RRB-', u'and', u'Sprague-Dawley', u'-LRB-', u'SD', u'-RRB-', u'female', u'rats', u':', u'1', u'-RRB-', u'mammary', u'tumor', u'incidence', u'after', u'DMBA', u',', u'2', u'-RRB-', u'plasma', u'prolactin', u'-LRB-', u'PRL', u'-RRB-', u'during', u'the', u'estrous', u'cycle', u'before', u'and', u'after', u'DMBA', u',', u'3', u'-RRB-', u'plasma', u'PRL', u'in', u'immature', u'females', u'from', u'0900', u'hr', u'on', u'day', u'29', u'to', u'0900', u'hr', u'on', u'day', u'30', u',', u'4', u'-RRB-', u'plasma', u'PRL', u'from', u'1200', u'to', u'1700', u'hr', u'and', u'before', u'and', u'10', u'min', u'after', u'i.p.', u'.']
orignal sentence: We compared the following parameters in Long-Evans (LE) and Sprague-Dawley (SD) female rats: 1) mammary tumor incidence after DMBA, 2) plasma prolactin (PRL) during the estrous cycle before and after DMBA, 3) plasma PRL in immature females from 0900 hr on day 29 to 0900 hr on day 30, 4) plasma PRL from 1200 to 1700 hr and before and 10 min after i.p.
error on token alignment
token: ., current:352
[(0, 1), (3, 10), (12, 14), (16, 24), (26, 35), (37, 38), (40, 49), (51, 51), (52, 53), (54, 54), (56, 58), (60, 73), (75, 75), (76, 77), (78, 78), (80, 85), (87, 90), (91, 91), (93, 93), (94, 94), (96, 102), (104, 108), (110, 118), (120, 124), (126, 129), (130, 130), (132, 132), (133, 133), (135, 140), (142, 150), (152, 152), (153, 155), (156, 156), (158, 163), (165, 167), (169, 175), (177, 181), (183, 188), (190, 192), (194, 198), (200, 203), (204, 204), (206, 206), (207, 207), (209, 214), (216, 218), (220, 221), (223, 230), (232, 238), (240, 243), (245, 248), (250, 251), (253, 254), (256, 258), (260, 261), (263, 264), (266, 269), (271, 272), (274, 275), (277, 279), (281, 282), (283, 283), (285, 285), (286, 286), (288, 293), (295, 297), (299, 302), (304, 307), (309, 310), (312, 315), (317, 318), (320, 322), (324, 329), (331, 333), (335, 336), (338, 340), (342, 346), (348, 351)]
[u'We', u'compared', u'the', u'following', u'parameters', u'in', u'Long-Evans', u'-LRB-', u'LE', u'-RRB-', u'and', u'Sprague-Dawley', u'-LRB-', u'SD', u'-RRB-', u'female', u'rats', u':', u'1', u'-RRB-', u'mammary', u'tumor', u'incidence', u'after', u'DMBA', u',', u'2', u'-RRB-', u'plasma', u'prolactin', u'-LRB-', u'PRL', u'-RRB-', u'during', u'the', u'estrous', u'cycle', u'before', u'and', u'after', u'DMBA', u',', u'3', u'-RRB-', u'plasma', u'PRL', u'in', u'immature', u'females', u'from', u'0900', u'hr', u'on', u'day', u'29', u'to', u'0900', u'hr', u'on', u'day', u'30', u',', u'4', u'-RRB-', u'plasma', u'PRL', u'from', u'1200', u'to', u'1700', u'hr', u'and', u'before', u'and', u'10', u'min', u'after', u'i.p.', u'.']
orignal sentence: We compared the following parameters in Long-Evans (LE) and Sprague-Dawley (SD) female rats: 1) mammary tumor incidence after DMBA, 2) plasma prolactin (PRL) during the estrous cycle before and after DMBA, 3) plasma PRL in immature females from 0900 hr on day 29 to 0900 hr on day 30, 4) plasma PRL from 1200 to 1700 hr and before and 10 min after i.p.
error on token alignment
token: ., current:352
[(0, 1), (3, 10), (12, 14), (16, 24), (26, 35), (37, 38), (40, 49), (51, 51), (52, 53), (54, 54), (56, 58), (60, 73), (75, 75), (76, 77), (78, 78), (80, 85), (87, 90), (91, 91), (93, 93), (94, 94), (96, 102), (104, 108), (110, 118), (120, 124), (126, 129), (130, 130), (132, 132), (133, 133), (135, 140), (142, 150), (152, 152), (153, 155), (156, 156), (158, 163), (165, 167), (169, 175), (177, 181), (183, 188), (190, 192), (194, 198), (200, 203), (204, 204), (206, 206), (207, 207), (209, 214), (216, 218), (220, 221), (223, 230), (232, 238), (240, 243), (245, 248), (250, 251), (253, 254), (256, 258), (260, 261), (263, 264), (266, 269), (271, 272), (274, 275), (277, 279), (281, 282), (283, 283), (285, 285), (286, 286), (288, 293), (295, 297), (299, 302), (304, 307), (309, 310), (312, 315), (317, 318), (320, 322), (324, 329), (331, 333), (335, 336), (338, 340), (342, 346), (348, 351)]
[u'We', u'compared', u'the', u'following', u'parameters', u'in', u'Long-Evans', u'-LRB-', u'LE', u'-RRB-', u'and', u'Sprague-Dawley', u'-LRB-', u'SD', u'-RRB-', u'female', u'rats', u':', u'1', u'-RRB-', u'mammary', u'tumor', u'incidence', u'after', u'DMBA', u',', u'2', u'-RRB-', u'plasma', u'prolactin', u'-LRB-', u'PRL', u'-RRB-', u'during', u'the', u'estrous', u'cycle', u'before', u'and', u'after', u'DMBA', u',', u'3', u'-RRB-', u'plasma', u'PRL', u'in', u'immature', u'females', u'from', u'0900', u'hr', u'on', u'day', u'29', u'to', u'0900', u'hr', u'on', u'day', u'30', u',', u'4', u'-RRB-', u'plasma', u'PRL', u'from', u'1200', u'to', u'1700', u'hr', u'and', u'before', u'and', u'10', u'min', u'after', u'i.p.', u'.']
orignal sentence: We compared the following parameters in Long-Evans (LE) and Sprague-Dawley (SD) female rats: 1) mammary tumor incidence after DMBA, 2) plasma prolactin (PRL) during the estrous cycle before and after DMBA, 3) plasma PRL in immature females from 0900 hr on day 29 to 0900 hr on day 30, 4) plasma PRL from 1200 to 1700 hr and before and 10 min after i.p.
error on token alignment
token: ., current:352
[(0, 1), (3, 10), (12, 14), (16, 24), (26, 35), (37, 38), (40, 49), (51, 51), (52, 53), (54, 54), (56, 58), (60, 73), (75, 75), (76, 77), (78, 78), (80, 85), (87, 90), (91, 91), (93, 93), (94, 94), (96, 102), (104, 108), (110, 118), (120, 124), (126, 129), (130, 130), (132, 132), (133, 133), (135, 140), (142, 150), (152, 152), (153, 155), (156, 156), (158, 163), (165, 167), (169, 175), (177, 181), (183, 188), (190, 192), (194, 198), (200, 203), (204, 204), (206, 206), (207, 207), (209, 214), (216, 218), (220, 221), (223, 230), (232, 238), (240, 243), (245, 248), (250, 251), (253, 254), (256, 258), (260, 261), (263, 264), (266, 269), (271, 272), (274, 275), (277, 279), (281, 282), (283, 283), (285, 285), (286, 286), (288, 293), (295, 297), (299, 302), (304, 307), (309, 310), (312, 315), (317, 318), (320, 322), (324, 329), (331, 333), (335, 336), (338, 340), (342, 346), (348, 351)]
[u'We', u'compared', u'the', u'following', u'parameters', u'in', u'Long-Evans', u'-LRB-', u'LE', u'-RRB-', u'and', u'Sprague-Dawley', u'-LRB-', u'SD', u'-RRB-', u'female', u'rats', u':', u'1', u'-RRB-', u'mammary', u'tumor', u'incidence', u'after', u'DMBA', u',', u'2', u'-RRB-', u'plasma', u'prolactin', u'-LRB-', u'PRL', u'-RRB-', u'during', u'the', u'estrous', u'cycle', u'before', u'and', u'after', u'DMBA', u',', u'3', u'-RRB-', u'plasma', u'PRL', u'in', u'immature', u'females', u'from', u'0900', u'hr', u'on', u'day', u'29', u'to', u'0900', u'hr', u'on', u'day', u'30', u',', u'4', u'-RRB-', u'plasma', u'PRL', u'from', u'1200', u'to', u'1700', u'hr', u'and', u'before', u'and', u'10', u'min', u'after', u'i.p.', u'.']
orignal sentence: We compared the following parameters in Long-Evans (LE) and Sprague-Dawley (SD) female rats: 1) mammary tumor incidence after DMBA, 2) plasma prolactin (PRL) during the estrous cycle before and after DMBA, 3) plasma PRL in immature females from 0900 hr on day 29 to 0900 hr on day 30, 4) plasma PRL from 1200 to 1700 hr and before and 10 min after i.p.
error on token alignment
token: ., current:352
[(0, 1), (3, 10), (12, 14), (16, 24), (26, 35), (37, 38), (40, 49), (51, 51), (52, 53), (54, 54), (56, 58), (60, 73), (75, 75), (76, 77), (78, 78), (80, 85), (87, 90), (91, 91), (93, 93), (94, 94), (96, 102), (104, 108), (110, 118), (120, 124), (126, 129), (130, 130), (132, 132), (133, 133), (135, 140), (142, 150), (152, 152), (153, 155), (156, 156), (158, 163), (165, 167), (169, 175), (177, 181), (183, 188), (190, 192), (194, 198), (200, 203), (204, 204), (206, 206), (207, 207), (209, 214), (216, 218), (220, 221), (223, 230), (232, 238), (240, 243), (245, 248), (250, 251), (253, 254), (256, 258), (260, 261), (263, 264), (266, 269), (271, 272), (274, 275), (277, 279), (281, 282), (283, 283), (285, 285), (286, 286), (288, 293), (295, 297), (299, 302), (304, 307), (309, 310), (312, 315), (317, 318), (320, 322), (324, 329), (331, 333), (335, 336), (338, 340), (342, 346), (348, 351)]
[u'We', u'compared', u'the', u'following', u'parameters', u'in', u'Long-Evans', u'-LRB-', u'LE', u'-RRB-', u'and', u'Sprague-Dawley', u'-LRB-', u'SD', u'-RRB-', u'female', u'rats', u':', u'1', u'-RRB-', u'mammary', u'tumor', u'incidence', u'after', u'DMBA', u',', u'2', u'-RRB-', u'plasma', u'prolactin', u'-LRB-', u'PRL', u'-RRB-', u'during', u'the', u'estrous', u'cycle', u'before', u'and', u'after', u'DMBA', u',', u'3', u'-RRB-', u'plasma', u'PRL', u'in', u'immature', u'females', u'from', u'0900', u'hr', u'on', u'day', u'29', u'to', u'0900', u'hr', u'on', u'day', u'30', u',', u'4', u'-RRB-', u'plasma', u'PRL', u'from', u'1200', u'to', u'1700', u'hr', u'and', u'before', u'and', u'10', u'min', u'after', u'i.p.', u'.']
orignal sentence: We compared the following parameters in Long-Evans (LE) and Sprague-Dawley (SD) female rats: 1) mammary tumor incidence after DMBA, 2) plasma prolactin (PRL) during the estrous cycle before and after DMBA, 3) plasma PRL in immature females from 0900 hr on day 29 to 0900 hr on day 30, 4) plasma PRL from 1200 to 1700 hr and before and 10 min after i.p.
error on token alignment
token: ., current:352
[(0, 1), (3, 10), (12, 14), (16, 24), (26, 35), (37, 38), (40, 49), (51, 51), (52, 53), (54, 54), (56, 58), (60, 73), (75, 75), (76, 77), (78, 78), (80, 85), (87, 90), (91, 91), (93, 93), (94, 94), (96, 102), (104, 108), (110, 118), (120, 124), (126, 129), (130, 130), (132, 132), (133, 133), (135, 140), (142, 150), (152, 152), (153, 155), (156, 156), (158, 163), (165, 167), (169, 175), (177, 181), (183, 188), (190, 192), (194, 198), (200, 203), (204, 204), (206, 206), (207, 207), (209, 214), (216, 218), (220, 221), (223, 230), (232, 238), (240, 243), (245, 248), (250, 251), (253, 254), (256, 258), (260, 261), (263, 264), (266, 269), (271, 272), (274, 275), (277, 279), (281, 282), (283, 283), (285, 285), (286, 286), (288, 293), (295, 297), (299, 302), (304, 307), (309, 310), (312, 315), (317, 318), (320, 322), (324, 329), (331, 333), (335, 336), (338, 340), (342, 346), (348, 351)]
[u'We', u'compared', u'the', u'following', u'parameters', u'in', u'Long-Evans', u'-LRB-', u'LE', u'-RRB-', u'and', u'Sprague-Dawley', u'-LRB-', u'SD', u'-RRB-', u'female', u'rats', u':', u'1', u'-RRB-', u'mammary', u'tumor', u'incidence', u'after', u'DMBA', u',', u'2', u'-RRB-', u'plasma', u'prolactin', u'-LRB-', u'PRL', u'-RRB-', u'during', u'the', u'estrous', u'cycle', u'before', u'and', u'after', u'DMBA', u',', u'3', u'-RRB-', u'plasma', u'PRL', u'in', u'immature', u'females', u'from', u'0900', u'hr', u'on', u'day', u'29', u'to', u'0900', u'hr', u'on', u'day', u'30', u',', u'4', u'-RRB-', u'plasma', u'PRL', u'from', u'1200', u'to', u'1700', u'hr', u'and', u'before', u'and', u'10', u'min', u'after', u'i.p.', u'.']
orignal sentence: We compared the following parameters in Long-Evans (LE) and Sprague-Dawley (SD) female rats: 1) mammary tumor incidence after DMBA, 2) plasma prolactin (PRL) during the estrous cycle before and after DMBA, 3) plasma PRL in immature females from 0900 hr on day 29 to 0900 hr on day 30, 4) plasma PRL from 1200 to 1700 hr and before and 10 min after i.p.
error on token alignment
token: ., current:352
[(0, 1), (3, 10), (12, 14), (16, 24), (26, 35), (37, 38), (40, 49), (51, 51), (52, 53), (54, 54), (56, 58), (60, 73), (75, 75), (76, 77), (78, 78), (80, 85), (87, 90), (91, 91), (93, 93), (94, 94), (96, 102), (104, 108), (110, 118), (120, 124), (126, 129), (130, 130), (132, 132), (133, 133), (135, 140), (142, 150), (152, 152), (153, 155), (156, 156), (158, 163), (165, 167), (169, 175), (177, 181), (183, 188), (190, 192), (194, 198), (200, 203), (204, 204), (206, 206), (207, 207), (209, 214), (216, 218), (220, 221), (223, 230), (232, 238), (240, 243), (245, 248), (250, 251), (253, 254), (256, 258), (260, 261), (263, 264), (266, 269), (271, 272), (274, 275), (277, 279), (281, 282), (283, 283), (285, 285), (286, 286), (288, 293), (295, 297), (299, 302), (304, 307), (309, 310), (312, 315), (317, 318), (320, 322), (324, 329), (331, 333), (335, 336), (338, 340), (342, 346), (348, 351)]
[u'We', u'compared', u'the', u'following', u'parameters', u'in', u'Long-Evans', u'-LRB-', u'LE', u'-RRB-', u'and', u'Sprague-Dawley', u'-LRB-', u'SD', u'-RRB-', u'female', u'rats', u':', u'1', u'-RRB-', u'mammary', u'tumor', u'incidence', u'after', u'DMBA', u',', u'2', u'-RRB-', u'plasma', u'prolactin', u'-LRB-', u'PRL', u'-RRB-', u'during', u'the', u'estrous', u'cycle', u'before', u'and', u'after', u'DMBA', u',', u'3', u'-RRB-', u'plasma', u'PRL', u'in', u'immature', u'females', u'from', u'0900', u'hr', u'on', u'day', u'29', u'to', u'0900', u'hr', u'on', u'day', u'30', u',', u'4', u'-RRB-', u'plasma', u'PRL', u'from', u'1200', u'to', u'1700', u'hr', u'and', u'before', u'and', u'10', u'min', u'after', u'i.p.', u'.']
orignal sentence: We compared the following parameters in Long-Evans (LE) and Sprague-Dawley (SD) female rats: 1) mammary tumor incidence after DMBA, 2) plasma prolactin (PRL) during the estrous cycle before and after DMBA, 3) plasma PRL in immature females from 0900 hr on day 29 to 0900 hr on day 30, 4) plasma PRL from 1200 to 1700 hr and before and 10 min after i.p.
error on token alignment
token: ., current:352
[(0, 1), (3, 10), (12, 14), (16, 24), (26, 35), (37, 38), (40, 49), (51, 51), (52, 53), (54, 54), (56, 58), (60, 73), (75, 75), (76, 77), (78, 78), (80, 85), (87, 90), (91, 91), (93, 93), (94, 94), (96, 102), (104, 108), (110, 118), (120, 124), (126, 129), (130, 130), (132, 132), (133, 133), (135, 140), (142, 150), (152, 152), (153, 155), (156, 156), (158, 163), (165, 167), (169, 175), (177, 181), (183, 188), (190, 192), (194, 198), (200, 203), (204, 204), (206, 206), (207, 207), (209, 214), (216, 218), (220, 221), (223, 230), (232, 238), (240, 243), (245, 248), (250, 251), (253, 254), (256, 258), (260, 261), (263, 264), (266, 269), (271, 272), (274, 275), (277, 279), (281, 282), (283, 283), (285, 285), (286, 286), (288, 293), (295, 297), (299, 302), (304, 307), (309, 310), (312, 315), (317, 318), (320, 322), (324, 329), (331, 333), (335, 336), (338, 340), (342, 346), (348, 351)]
[u'We', u'compared', u'the', u'following', u'parameters', u'in', u'Long-Evans', u'-LRB-', u'LE', u'-RRB-', u'and', u'Sprague-Dawley', u'-LRB-', u'SD', u'-RRB-', u'female', u'rats', u':', u'1', u'-RRB-', u'mammary', u'tumor', u'incidence', u'after', u'DMBA', u',', u'2', u'-RRB-', u'plasma', u'prolactin', u'-LRB-', u'PRL', u'-RRB-', u'during', u'the', u'estrous', u'cycle', u'before', u'and', u'after', u'DMBA', u',', u'3', u'-RRB-', u'plasma', u'PRL', u'in', u'immature', u'females', u'from', u'0900', u'hr', u'on', u'day', u'29', u'to', u'0900', u'hr', u'on', u'day', u'30', u',', u'4', u'-RRB-', u'plasma', u'PRL', u'from', u'1200', u'to', u'1700', u'hr', u'and', u'before', u'and', u'10', u'min', u'after', u'i.p.', u'.']
orignal sentence: We compared the following parameters in Long-Evans (LE) and Sprague-Dawley (SD) female rats: 1) mammary tumor incidence after DMBA, 2) plasma prolactin (PRL) during the estrous cycle before and after DMBA, 3) plasma PRL in immature females from 0900 hr on day 29 to 0900 hr on day 30, 4) plasma PRL from 1200 to 1700 hr and before and 10 min after i.p.
error on token alignment
token: ., current:352
[(0, 1), (3, 10), (12, 14), (16, 24), (26, 35), (37, 38), (40, 49), (51, 51), (52, 53), (54, 54), (56, 58), (60, 73), (75, 75), (76, 77), (78, 78), (80, 85), (87, 90), (91, 91), (93, 93), (94, 94), (96, 102), (104, 108), (110, 118), (120, 124), (126, 129), (130, 130), (132, 132), (133, 133), (135, 140), (142, 150), (152, 152), (153, 155), (156, 156), (158, 163), (165, 167), (169, 175), (177, 181), (183, 188), (190, 192), (194, 198), (200, 203), (204, 204), (206, 206), (207, 207), (209, 214), (216, 218), (220, 221), (223, 230), (232, 238), (240, 243), (245, 248), (250, 251), (253, 254), (256, 258), (260, 261), (263, 264), (266, 269), (271, 272), (274, 275), (277, 279), (281, 282), (283, 283), (285, 285), (286, 286), (288, 293), (295, 297), (299, 302), (304, 307), (309, 310), (312, 315), (317, 318), (320, 322), (324, 329), (331, 333), (335, 336), (338, 340), (342, 346), (348, 351)]
[u'We', u'compared', u'the', u'following', u'parameters', u'in', u'Long-Evans', u'-LRB-', u'LE', u'-RRB-', u'and', u'Sprague-Dawley', u'-LRB-', u'SD', u'-RRB-', u'female', u'rats', u':', u'1', u'-RRB-', u'mammary', u'tumor', u'incidence', u'after', u'DMBA', u',', u'2', u'-RRB-', u'plasma', u'prolactin', u'-LRB-', u'PRL', u'-RRB-', u'during', u'the', u'estrous', u'cycle', u'before', u'and', u'after', u'DMBA', u',', u'3', u'-RRB-', u'plasma', u'PRL', u'in', u'immature', u'females', u'from', u'0900', u'hr', u'on', u'day', u'29', u'to', u'0900', u'hr', u'on', u'day', u'30', u',', u'4', u'-RRB-', u'plasma', u'PRL', u'from', u'1200', u'to', u'1700', u'hr', u'and', u'before', u'and', u'10', u'min', u'after', u'i.p.', u'.']
orignal sentence: We compared the following parameters in Long-Evans (LE) and Sprague-Dawley (SD) female rats: 1) mammary tumor incidence after DMBA, 2) plasma prolactin (PRL) during the estrous cycle before and after DMBA, 3) plasma PRL in immature females from 0900 hr on day 29 to 0900 hr on day 30, 4) plasma PRL from 1200 to 1700 hr and before and 10 min after i.p.
error on token alignment
token: ., current:352
[(0, 1), (3, 10), (12, 14), (16, 24), (26, 35), (37, 38), (40, 49), (51, 51), (52, 53), (54, 54), (56, 58), (60, 73), (75, 75), (76, 77), (78, 78), (80, 85), (87, 90), (91, 91), (93, 93), (94, 94), (96, 102), (104, 108), (110, 118), (120, 124), (126, 129), (130, 130), (132, 132), (133, 133), (135, 140), (142, 150), (152, 152), (153, 155), (156, 156), (158, 163), (165, 167), (169, 175), (177, 181), (183, 188), (190, 192), (194, 198), (200, 203), (204, 204), (206, 206), (207, 207), (209, 214), (216, 218), (220, 221), (223, 230), (232, 238), (240, 243), (245, 248), (250, 251), (253, 254), (256, 258), (260, 261), (263, 264), (266, 269), (271, 272), (274, 275), (277, 279), (281, 282), (283, 283), (285, 285), (286, 286), (288, 293), (295, 297), (299, 302), (304, 307), (309, 310), (312, 315), (317, 318), (320, 322), (324, 329), (331, 333), (335, 336), (338, 340), (342, 346), (348, 351)]
[u'We', u'compared', u'the', u'following', u'parameters', u'in', u'Long-Evans', u'-LRB-', u'LE', u'-RRB-', u'and', u'Sprague-Dawley', u'-LRB-', u'SD', u'-RRB-', u'female', u'rats', u':', u'1', u'-RRB-', u'mammary', u'tumor', u'incidence', u'after', u'DMBA', u',', u'2', u'-RRB-', u'plasma', u'prolactin', u'-LRB-', u'PRL', u'-RRB-', u'during', u'the', u'estrous', u'cycle', u'before', u'and', u'after', u'DMBA', u',', u'3', u'-RRB-', u'plasma', u'PRL', u'in', u'immature', u'females', u'from', u'0900', u'hr', u'on', u'day', u'29', u'to', u'0900', u'hr', u'on', u'day', u'30', u',', u'4', u'-RRB-', u'plasma', u'PRL', u'from', u'1200', u'to', u'1700', u'hr', u'and', u'before', u'and', u'10', u'min', u'after', u'i.p.', u'.']
orignal sentence: We compared the following parameters in Long-Evans (LE) and Sprague-Dawley (SD) female rats: 1) mammary tumor incidence after DMBA, 2) plasma prolactin (PRL) during the estrous cycle before and after DMBA, 3) plasma PRL in immature females from 0900 hr on day 29 to 0900 hr on day 30, 4) plasma PRL from 1200 to 1700 hr and before and 10 min after i.p.
error on token alignment
token: ., current:352
[(0, 1), (3, 10), (12, 14), (16, 24), (26, 35), (37, 38), (40, 49), (51, 51), (52, 53), (54, 54), (56, 58), (60, 73), (75, 75), (76, 77), (78, 78), (80, 85), (87, 90), (91, 91), (93, 93), (94, 94), (96, 102), (104, 108), (110, 118), (120, 124), (126, 129), (130, 130), (132, 132), (133, 133), (135, 140), (142, 150), (152, 152), (153, 155), (156, 156), (158, 163), (165, 167), (169, 175), (177, 181), (183, 188), (190, 192), (194, 198), (200, 203), (204, 204), (206, 206), (207, 207), (209, 214), (216, 218), (220, 221), (223, 230), (232, 238), (240, 243), (245, 248), (250, 251), (253, 254), (256, 258), (260, 261), (263, 264), (266, 269), (271, 272), (274, 275), (277, 279), (281, 282), (283, 283), (285, 285), (286, 286), (288, 293), (295, 297), (299, 302), (304, 307), (309, 310), (312, 315), (317, 318), (320, 322), (324, 329), (331, 333), (335, 336), (338, 340), (342, 346), (348, 351)]
[u'We', u'compared', u'the', u'following', u'parameters', u'in', u'Long-Evans', u'-LRB-', u'LE', u'-RRB-', u'and', u'Sprague-Dawley', u'-LRB-', u'SD', u'-RRB-', u'female', u'rats', u':', u'1', u'-RRB-', u'mammary', u'tumor', u'incidence', u'after', u'DMBA', u',', u'2', u'-RRB-', u'plasma', u'prolactin', u'-LRB-', u'PRL', u'-RRB-', u'during', u'the', u'estrous', u'cycle', u'before', u'and', u'after', u'DMBA', u',', u'3', u'-RRB-', u'plasma', u'PRL', u'in', u'immature', u'females', u'from', u'0900', u'hr', u'on', u'day', u'29', u'to', u'0900', u'hr', u'on', u'day', u'30', u',', u'4', u'-RRB-', u'plasma', u'PRL', u'from', u'1200', u'to', u'1700', u'hr', u'and', u'before', u'and', u'10', u'min', u'after', u'i.p.', u'.']
orignal sentence: We compared the following parameters in Long-Evans (LE) and Sprague-Dawley (SD) female rats: 1) mammary tumor incidence after DMBA, 2) plasma prolactin (PRL) during the estrous cycle before and after DMBA, 3) plasma PRL in immature females from 0900 hr on day 29 to 0900 hr on day 30, 4) plasma PRL from 1200 to 1700 hr and before and 10 min after i.p.
error on token alignment
token: ., current:352
[(0, 1), (3, 10), (12, 14), (16, 24), (26, 35), (37, 38), (40, 49), (51, 51), (52, 53), (54, 54), (56, 58), (60, 73), (75, 75), (76, 77), (78, 78), (80, 85), (87, 90), (91, 91), (93, 93), (94, 94), (96, 102), (104, 108), (110, 118), (120, 124), (126, 129), (130, 130), (132, 132), (133, 133), (135, 140), (142, 150), (152, 152), (153, 155), (156, 156), (158, 163), (165, 167), (169, 175), (177, 181), (183, 188), (190, 192), (194, 198), (200, 203), (204, 204), (206, 206), (207, 207), (209, 214), (216, 218), (220, 221), (223, 230), (232, 238), (240, 243), (245, 248), (250, 251), (253, 254), (256, 258), (260, 261), (263, 264), (266, 269), (271, 272), (274, 275), (277, 279), (281, 282), (283, 283), (285, 285), (286, 286), (288, 293), (295, 297), (299, 302), (304, 307), (309, 310), (312, 315), (317, 318), (320, 322), (324, 329), (331, 333), (335, 336), (338, 340), (342, 346), (348, 351)]
[u'We', u'compared', u'the', u'following', u'parameters', u'in', u'Long-Evans', u'-LRB-', u'LE', u'-RRB-', u'and', u'Sprague-Dawley', u'-LRB-', u'SD', u'-RRB-', u'female', u'rats', u':', u'1', u'-RRB-', u'mammary', u'tumor', u'incidence', u'after', u'DMBA', u',', u'2', u'-RRB-', u'plasma', u'prolactin', u'-LRB-', u'PRL', u'-RRB-', u'during', u'the', u'estrous', u'cycle', u'before', u'and', u'after', u'DMBA', u',', u'3', u'-RRB-', u'plasma', u'PRL', u'in', u'immature', u'females', u'from', u'0900', u'hr', u'on', u'day', u'29', u'to', u'0900', u'hr', u'on', u'day', u'30', u',', u'4', u'-RRB-', u'plasma', u'PRL', u'from', u'1200', u'to', u'1700', u'hr', u'and', u'before', u'and', u'10', u'min', u'after', u'i.p.', u'.']
orignal sentence: We compared the following parameters in Long-Evans (LE) and Sprague-Dawley (SD) female rats: 1) mammary tumor incidence after DMBA, 2) plasma prolactin (PRL) during the estrous cycle before and after DMBA, 3) plasma PRL in immature females from 0900 hr on day 29 to 0900 hr on day 30, 4) plasma PRL from 1200 to 1700 hr and before and 10 min after i.p.
error on token alignment
token: ., current:352
[(0, 1), (3, 10), (12, 14), (16, 24), (26, 35), (37, 38), (40, 49), (51, 51), (52, 53), (54, 54), (56, 58), (60, 73), (75, 75), (76, 77), (78, 78), (80, 85), (87, 90), (91, 91), (93, 93), (94, 94), (96, 102), (104, 108), (110, 118), (120, 124), (126, 129), (130, 130), (132, 132), (133, 133), (135, 140), (142, 150), (152, 152), (153, 155), (156, 156), (158, 163), (165, 167), (169, 175), (177, 181), (183, 188), (190, 192), (194, 198), (200, 203), (204, 204), (206, 206), (207, 207), (209, 214), (216, 218), (220, 221), (223, 230), (232, 238), (240, 243), (245, 248), (250, 251), (253, 254), (256, 258), (260, 261), (263, 264), (266, 269), (271, 272), (274, 275), (277, 279), (281, 282), (283, 283), (285, 285), (286, 286), (288, 293), (295, 297), (299, 302), (304, 307), (309, 310), (312, 315), (317, 318), (320, 322), (324, 329), (331, 333), (335, 336), (338, 340), (342, 346), (348, 351)]
[u'We', u'compared', u'the', u'following', u'parameters', u'in', u'Long-Evans', u'-LRB-', u'LE', u'-RRB-', u'and', u'Sprague-Dawley', u'-LRB-', u'SD', u'-RRB-', u'female', u'rats', u':', u'1', u'-RRB-', u'mammary', u'tumor', u'incidence', u'after', u'DMBA', u',', u'2', u'-RRB-', u'plasma', u'prolactin', u'-LRB-', u'PRL', u'-RRB-', u'during', u'the', u'estrous', u'cycle', u'before', u'and', u'after', u'DMBA', u',', u'3', u'-RRB-', u'plasma', u'PRL', u'in', u'immature', u'females', u'from', u'0900', u'hr', u'on', u'day', u'29', u'to', u'0900', u'hr', u'on', u'day', u'30', u',', u'4', u'-RRB-', u'plasma', u'PRL', u'from', u'1200', u'to', u'1700', u'hr', u'and', u'before', u'and', u'10', u'min', u'after', u'i.p.', u'.']
orignal sentence: We compared the following parameters in Long-Evans (LE) and Sprague-Dawley (SD) female rats: 1) mammary tumor incidence after DMBA, 2) plasma prolactin (PRL) during the estrous cycle before and after DMBA, 3) plasma PRL in immature females from 0900 hr on day 29 to 0900 hr on day 30, 4) plasma PRL from 1200 to 1700 hr and before and 10 min after i.p.
error on token alignment
token: ., current:352
[(0, 1), (3, 10), (12, 14), (16, 24), (26, 35), (37, 38), (40, 49), (51, 51), (52, 53), (54, 54), (56, 58), (60, 73), (75, 75), (76, 77), (78, 78), (80, 85), (87, 90), (91, 91), (93, 93), (94, 94), (96, 102), (104, 108), (110, 118), (120, 124), (126, 129), (130, 130), (132, 132), (133, 133), (135, 140), (142, 150), (152, 152), (153, 155), (156, 156), (158, 163), (165, 167), (169, 175), (177, 181), (183, 188), (190, 192), (194, 198), (200, 203), (204, 204), (206, 206), (207, 207), (209, 214), (216, 218), (220, 221), (223, 230), (232, 238), (240, 243), (245, 248), (250, 251), (253, 254), (256, 258), (260, 261), (263, 264), (266, 269), (271, 272), (274, 275), (277, 279), (281, 282), (283, 283), (285, 285), (286, 286), (288, 293), (295, 297), (299, 302), (304, 307), (309, 310), (312, 315), (317, 318), (320, 322), (324, 329), (331, 333), (335, 336), (338, 340), (342, 346), (348, 351)]
[u'We', u'compared', u'the', u'following', u'parameters', u'in', u'Long-Evans', u'-LRB-', u'LE', u'-RRB-', u'and', u'Sprague-Dawley', u'-LRB-', u'SD', u'-RRB-', u'female', u'rats', u':', u'1', u'-RRB-', u'mammary', u'tumor', u'incidence', u'after', u'DMBA', u',', u'2', u'-RRB-', u'plasma', u'prolactin', u'-LRB-', u'PRL', u'-RRB-', u'during', u'the', u'estrous', u'cycle', u'before', u'and', u'after', u'DMBA', u',', u'3', u'-RRB-', u'plasma', u'PRL', u'in', u'immature', u'females', u'from', u'0900', u'hr', u'on', u'day', u'29', u'to', u'0900', u'hr', u'on', u'day', u'30', u',', u'4', u'-RRB-', u'plasma', u'PRL', u'from', u'1200', u'to', u'1700', u'hr', u'and', u'before', u'and', u'10', u'min', u'after', u'i.p.', u'.']
orignal sentence: We compared the following parameters in Long-Evans (LE) and Sprague-Dawley (SD) female rats: 1) mammary tumor incidence after DMBA, 2) plasma prolactin (PRL) during the estrous cycle before and after DMBA, 3) plasma PRL in immature females from 0900 hr on day 29 to 0900 hr on day 30, 4) plasma PRL from 1200 to 1700 hr and before and 10 min after i.p.
error on token alignment
token: ., current:352
[(0, 1), (3, 10), (12, 14), (16, 24), (26, 35), (37, 38), (40, 49), (51, 51), (52, 53), (54, 54), (56, 58), (60, 73), (75, 75), (76, 77), (78, 78), (80, 85), (87, 90), (91, 91), (93, 93), (94, 94), (96, 102), (104, 108), (110, 118), (120, 124), (126, 129), (130, 130), (132, 132), (133, 133), (135, 140), (142, 150), (152, 152), (153, 155), (156, 156), (158, 163), (165, 167), (169, 175), (177, 181), (183, 188), (190, 192), (194, 198), (200, 203), (204, 204), (206, 206), (207, 207), (209, 214), (216, 218), (220, 221), (223, 230), (232, 238), (240, 243), (245, 248), (250, 251), (253, 254), (256, 258), (260, 261), (263, 264), (266, 269), (271, 272), (274, 275), (277, 279), (281, 282), (283, 283), (285, 285), (286, 286), (288, 293), (295, 297), (299, 302), (304, 307), (309, 310), (312, 315), (317, 318), (320, 322), (324, 329), (331, 333), (335, 336), (338, 340), (342, 346), (348, 351)]
[u'We', u'compared', u'the', u'following', u'parameters', u'in', u'Long-Evans', u'-LRB-', u'LE', u'-RRB-', u'and', u'Sprague-Dawley', u'-LRB-', u'SD', u'-RRB-', u'female', u'rats', u':', u'1', u'-RRB-', u'mammary', u'tumor', u'incidence', u'after', u'DMBA', u',', u'2', u'-RRB-', u'plasma', u'prolactin', u'-LRB-', u'PRL', u'-RRB-', u'during', u'the', u'estrous', u'cycle', u'before', u'and', u'after', u'DMBA', u',', u'3', u'-RRB-', u'plasma', u'PRL', u'in', u'immature', u'females', u'from', u'0900', u'hr', u'on', u'day', u'29', u'to', u'0900', u'hr', u'on', u'day', u'30', u',', u'4', u'-RRB-', u'plasma', u'PRL', u'from', u'1200', u'to', u'1700', u'hr', u'and', u'before', u'and', u'10', u'min', u'after', u'i.p.', u'.']
orignal sentence: We compared the following parameters in Long-Evans (LE) and Sprague-Dawley (SD) female rats: 1) mammary tumor incidence after DMBA, 2) plasma prolactin (PRL) during the estrous cycle before and after DMBA, 3) plasma PRL in immature females from 0900 hr on day 29 to 0900 hr on day 30, 4) plasma PRL from 1200 to 1700 hr and before and 10 min after i.p.
error on token alignment
token: ., current:352
[(0, 1), (3, 10), (12, 14), (16, 24), (26, 35), (37, 38), (40, 49), (51, 51), (52, 53), (54, 54), (56, 58), (60, 73), (75, 75), (76, 77), (78, 78), (80, 85), (87, 90), (91, 91), (93, 93), (94, 94), (96, 102), (104, 108), (110, 118), (120, 124), (126, 129), (130, 130), (132, 132), (133, 133), (135, 140), (142, 150), (152, 152), (153, 155), (156, 156), (158, 163), (165, 167), (169, 175), (177, 181), (183, 188), (190, 192), (194, 198), (200, 203), (204, 204), (206, 206), (207, 207), (209, 214), (216, 218), (220, 221), (223, 230), (232, 238), (240, 243), (245, 248), (250, 251), (253, 254), (256, 258), (260, 261), (263, 264), (266, 269), (271, 272), (274, 275), (277, 279), (281, 282), (283, 283), (285, 285), (286, 286), (288, 293), (295, 297), (299, 302), (304, 307), (309, 310), (312, 315), (317, 318), (320, 322), (324, 329), (331, 333), (335, 336), (338, 340), (342, 346), (348, 351)]
[u'We', u'compared', u'the', u'following', u'parameters', u'in', u'Long-Evans', u'-LRB-', u'LE', u'-RRB-', u'and', u'Sprague-Dawley', u'-LRB-', u'SD', u'-RRB-', u'female', u'rats', u':', u'1', u'-RRB-', u'mammary', u'tumor', u'incidence', u'after', u'DMBA', u',', u'2', u'-RRB-', u'plasma', u'prolactin', u'-LRB-', u'PRL', u'-RRB-', u'during', u'the', u'estrous', u'cycle', u'before', u'and', u'after', u'DMBA', u',', u'3', u'-RRB-', u'plasma', u'PRL', u'in', u'immature', u'females', u'from', u'0900', u'hr', u'on', u'day', u'29', u'to', u'0900', u'hr', u'on', u'day', u'30', u',', u'4', u'-RRB-', u'plasma', u'PRL', u'from', u'1200', u'to', u'1700', u'hr', u'and', u'before', u'and', u'10', u'min', u'after', u'i.p.', u'.']
orignal sentence: We compared the following parameters in Long-Evans (LE) and Sprague-Dawley (SD) female rats: 1) mammary tumor incidence after DMBA, 2) plasma prolactin (PRL) during the estrous cycle before and after DMBA, 3) plasma PRL in immature females from 0900 hr on day 29 to 0900 hr on day 30, 4) plasma PRL from 1200 to 1700 hr and before and 10 min after i.p.
error on token alignment
token: ., current:352
[(0, 1), (3, 10), (12, 14), (16, 24), (26, 35), (37, 38), (40, 49), (51, 51), (52, 53), (54, 54), (56, 58), (60, 73), (75, 75), (76, 77), (78, 78), (80, 85), (87, 90), (91, 91), (93, 93), (94, 94), (96, 102), (104, 108), (110, 118), (120, 124), (126, 129), (130, 130), (132, 132), (133, 133), (135, 140), (142, 150), (152, 152), (153, 155), (156, 156), (158, 163), (165, 167), (169, 175), (177, 181), (183, 188), (190, 192), (194, 198), (200, 203), (204, 204), (206, 206), (207, 207), (209, 214), (216, 218), (220, 221), (223, 230), (232, 238), (240, 243), (245, 248), (250, 251), (253, 254), (256, 258), (260, 261), (263, 264), (266, 269), (271, 272), (274, 275), (277, 279), (281, 282), (283, 283), (285, 285), (286, 286), (288, 293), (295, 297), (299, 302), (304, 307), (309, 310), (312, 315), (317, 318), (320, 322), (324, 329), (331, 333), (335, 336), (338, 340), (342, 346), (348, 351)]
[u'We', u'compared', u'the', u'following', u'parameters', u'in', u'Long-Evans', u'-LRB-', u'LE', u'-RRB-', u'and', u'Sprague-Dawley', u'-LRB-', u'SD', u'-RRB-', u'female', u'rats', u':', u'1', u'-RRB-', u'mammary', u'tumor', u'incidence', u'after', u'DMBA', u',', u'2', u'-RRB-', u'plasma', u'prolactin', u'-LRB-', u'PRL', u'-RRB-', u'during', u'the', u'estrous', u'cycle', u'before', u'and', u'after', u'DMBA', u',', u'3', u'-RRB-', u'plasma', u'PRL', u'in', u'immature', u'females', u'from', u'0900', u'hr', u'on', u'day', u'29', u'to', u'0900', u'hr', u'on', u'day', u'30', u',', u'4', u'-RRB-', u'plasma', u'PRL', u'from', u'1200', u'to', u'1700', u'hr', u'and', u'before', u'and', u'10', u'min', u'after', u'i.p.', u'.']
orignal sentence: We compared the following parameters in Long-Evans (LE) and Sprague-Dawley (SD) female rats: 1) mammary tumor incidence after DMBA, 2) plasma prolactin (PRL) during the estrous cycle before and after DMBA, 3) plasma PRL in immature females from 0900 hr on day 29 to 0900 hr on day 30, 4) plasma PRL from 1200 to 1700 hr and before and 10 min after i.p.
error on token alignment
token: ., current:352
[(0, 1), (3, 10), (12, 14), (16, 24), (26, 35), (37, 38), (40, 49), (51, 51), (52, 53), (54, 54), (56, 58), (60, 73), (75, 75), (76, 77), (78, 78), (80, 85), (87, 90), (91, 91), (93, 93), (94, 94), (96, 102), (104, 108), (110, 118), (120, 124), (126, 129), (130, 130), (132, 132), (133, 133), (135, 140), (142, 150), (152, 152), (153, 155), (156, 156), (158, 163), (165, 167), (169, 175), (177, 181), (183, 188), (190, 192), (194, 198), (200, 203), (204, 204), (206, 206), (207, 207), (209, 214), (216, 218), (220, 221), (223, 230), (232, 238), (240, 243), (245, 248), (250, 251), (253, 254), (256, 258), (260, 261), (263, 264), (266, 269), (271, 272), (274, 275), (277, 279), (281, 282), (283, 283), (285, 285), (286, 286), (288, 293), (295, 297), (299, 302), (304, 307), (309, 310), (312, 315), (317, 318), (320, 322), (324, 329), (331, 333), (335, 336), (338, 340), (342, 346), (348, 351)]
[u'We', u'compared', u'the', u'following', u'parameters', u'in', u'Long-Evans', u'-LRB-', u'LE', u'-RRB-', u'and', u'Sprague-Dawley', u'-LRB-', u'SD', u'-RRB-', u'female', u'rats', u':', u'1', u'-RRB-', u'mammary', u'tumor', u'incidence', u'after', u'DMBA', u',', u'2', u'-RRB-', u'plasma', u'prolactin', u'-LRB-', u'PRL', u'-RRB-', u'during', u'the', u'estrous', u'cycle', u'before', u'and', u'after', u'DMBA', u',', u'3', u'-RRB-', u'plasma', u'PRL', u'in', u'immature', u'females', u'from', u'0900', u'hr', u'on', u'day', u'29', u'to', u'0900', u'hr', u'on', u'day', u'30', u',', u'4', u'-RRB-', u'plasma', u'PRL', u'from', u'1200', u'to', u'1700', u'hr', u'and', u'before', u'and', u'10', u'min', u'after', u'i.p.', u'.']
orignal sentence: We compared the following parameters in Long-Evans (LE) and Sprague-Dawley (SD) female rats: 1) mammary tumor incidence after DMBA, 2) plasma prolactin (PRL) during the estrous cycle before and after DMBA, 3) plasma PRL in immature females from 0900 hr on day 29 to 0900 hr on day 30, 4) plasma PRL from 1200 to 1700 hr and before and 10 min after i.p.
error on token alignment
token: ., current:352
[(0, 1), (3, 10), (12, 14), (16, 24), (26, 35), (37, 38), (40, 49), (51, 51), (52, 53), (54, 54), (56, 58), (60, 73), (75, 75), (76, 77), (78, 78), (80, 85), (87, 90), (91, 91), (93, 93), (94, 94), (96, 102), (104, 108), (110, 118), (120, 124), (126, 129), (130, 130), (132, 132), (133, 133), (135, 140), (142, 150), (152, 152), (153, 155), (156, 156), (158, 163), (165, 167), (169, 175), (177, 181), (183, 188), (190, 192), (194, 198), (200, 203), (204, 204), (206, 206), (207, 207), (209, 214), (216, 218), (220, 221), (223, 230), (232, 238), (240, 243), (245, 248), (250, 251), (253, 254), (256, 258), (260, 261), (263, 264), (266, 269), (271, 272), (274, 275), (277, 279), (281, 282), (283, 283), (285, 285), (286, 286), (288, 293), (295, 297), (299, 302), (304, 307), (309, 310), (312, 315), (317, 318), (320, 322), (324, 329), (331, 333), (335, 336), (338, 340), (342, 346), (348, 351)]
[u'We', u'compared', u'the', u'following', u'parameters', u'in', u'Long-Evans', u'-LRB-', u'LE', u'-RRB-', u'and', u'Sprague-Dawley', u'-LRB-', u'SD', u'-RRB-', u'female', u'rats', u':', u'1', u'-RRB-', u'mammary', u'tumor', u'incidence', u'after', u'DMBA', u',', u'2', u'-RRB-', u'plasma', u'prolactin', u'-LRB-', u'PRL', u'-RRB-', u'during', u'the', u'estrous', u'cycle', u'before', u'and', u'after', u'DMBA', u',', u'3', u'-RRB-', u'plasma', u'PRL', u'in', u'immature', u'females', u'from', u'0900', u'hr', u'on', u'day', u'29', u'to', u'0900', u'hr', u'on', u'day', u'30', u',', u'4', u'-RRB-', u'plasma', u'PRL', u'from', u'1200', u'to', u'1700', u'hr', u'and', u'before', u'and', u'10', u'min', u'after', u'i.p.', u'.']
orignal sentence: We compared the following parameters in Long-Evans (LE) and Sprague-Dawley (SD) female rats: 1) mammary tumor incidence after DMBA, 2) plasma prolactin (PRL) during the estrous cycle before and after DMBA, 3) plasma PRL in immature females from 0900 hr on day 29 to 0900 hr on day 30, 4) plasma PRL from 1200 to 1700 hr and before and 10 min after i.p.
error on token alignment
token: ., current:352
[(0, 1), (3, 10), (12, 14), (16, 24), (26, 35), (37, 38), (40, 49), (51, 51), (52, 53), (54, 54), (56, 58), (60, 73), (75, 75), (76, 77), (78, 78), (80, 85), (87, 90), (91, 91), (93, 93), (94, 94), (96, 102), (104, 108), (110, 118), (120, 124), (126, 129), (130, 130), (132, 132), (133, 133), (135, 140), (142, 150), (152, 152), (153, 155), (156, 156), (158, 163), (165, 167), (169, 175), (177, 181), (183, 188), (190, 192), (194, 198), (200, 203), (204, 204), (206, 206), (207, 207), (209, 214), (216, 218), (220, 221), (223, 230), (232, 238), (240, 243), (245, 248), (250, 251), (253, 254), (256, 258), (260, 261), (263, 264), (266, 269), (271, 272), (274, 275), (277, 279), (281, 282), (283, 283), (285, 285), (286, 286), (288, 293), (295, 297), (299, 302), (304, 307), (309, 310), (312, 315), (317, 318), (320, 322), (324, 329), (331, 333), (335, 336), (338, 340), (342, 346), (348, 351)]
[u'We', u'compared', u'the', u'following', u'parameters', u'in', u'Long-Evans', u'-LRB-', u'LE', u'-RRB-', u'and', u'Sprague-Dawley', u'-LRB-', u'SD', u'-RRB-', u'female', u'rats', u':', u'1', u'-RRB-', u'mammary', u'tumor', u'incidence', u'after', u'DMBA', u',', u'2', u'-RRB-', u'plasma', u'prolactin', u'-LRB-', u'PRL', u'-RRB-', u'during', u'the', u'estrous', u'cycle', u'before', u'and', u'after', u'DMBA', u',', u'3', u'-RRB-', u'plasma', u'PRL', u'in', u'immature', u'females', u'from', u'0900', u'hr', u'on', u'day', u'29', u'to', u'0900', u'hr', u'on', u'day', u'30', u',', u'4', u'-RRB-', u'plasma', u'PRL', u'from', u'1200', u'to', u'1700', u'hr', u'and', u'before', u'and', u'10', u'min', u'after', u'i.p.', u'.']
orignal sentence: We compared the following parameters in Long-Evans (LE) and Sprague-Dawley (SD) female rats: 1) mammary tumor incidence after DMBA, 2) plasma prolactin (PRL) during the estrous cycle before and after DMBA, 3) plasma PRL in immature females from 0900 hr on day 29 to 0900 hr on day 30, 4) plasma PRL from 1200 to 1700 hr and before and 10 min after i.p.
error on token alignment
token: ., current:352
[(0, 1), (3, 10), (12, 14), (16, 24), (26, 35), (37, 38), (40, 49), (51, 51), (52, 53), (54, 54), (56, 58), (60, 73), (75, 75), (76, 77), (78, 78), (80, 85), (87, 90), (91, 91), (93, 93), (94, 94), (96, 102), (104, 108), (110, 118), (120, 124), (126, 129), (130, 130), (132, 132), (133, 133), (135, 140), (142, 150), (152, 152), (153, 155), (156, 156), (158, 163), (165, 167), (169, 175), (177, 181), (183, 188), (190, 192), (194, 198), (200, 203), (204, 204), (206, 206), (207, 207), (209, 214), (216, 218), (220, 221), (223, 230), (232, 238), (240, 243), (245, 248), (250, 251), (253, 254), (256, 258), (260, 261), (263, 264), (266, 269), (271, 272), (274, 275), (277, 279), (281, 282), (283, 283), (285, 285), (286, 286), (288, 293), (295, 297), (299, 302), (304, 307), (309, 310), (312, 315), (317, 318), (320, 322), (324, 329), (331, 333), (335, 336), (338, 340), (342, 346), (348, 351)]
[u'We', u'compared', u'the', u'following', u'parameters', u'in', u'Long-Evans', u'-LRB-', u'LE', u'-RRB-', u'and', u'Sprague-Dawley', u'-LRB-', u'SD', u'-RRB-', u'female', u'rats', u':', u'1', u'-RRB-', u'mammary', u'tumor', u'incidence', u'after', u'DMBA', u',', u'2', u'-RRB-', u'plasma', u'prolactin', u'-LRB-', u'PRL', u'-RRB-', u'during', u'the', u'estrous', u'cycle', u'before', u'and', u'after', u'DMBA', u',', u'3', u'-RRB-', u'plasma', u'PRL', u'in', u'immature', u'females', u'from', u'0900', u'hr', u'on', u'day', u'29', u'to', u'0900', u'hr', u'on', u'day', u'30', u',', u'4', u'-RRB-', u'plasma', u'PRL', u'from', u'1200', u'to', u'1700', u'hr', u'and', u'before', u'and', u'10', u'min', u'after', u'i.p.', u'.']
orignal sentence: We compared the following parameters in Long-Evans (LE) and Sprague-Dawley (SD) female rats: 1) mammary tumor incidence after DMBA, 2) plasma prolactin (PRL) during the estrous cycle before and after DMBA, 3) plasma PRL in immature females from 0900 hr on day 29 to 0900 hr on day 30, 4) plasma PRL from 1200 to 1700 hr and before and 10 min after i.p.
error on token alignment
token: ., current:352
[(0, 1), (3, 10), (12, 14), (16, 24), (26, 35), (37, 38), (40, 49), (51, 51), (52, 53), (54, 54), (56, 58), (60, 73), (75, 75), (76, 77), (78, 78), (80, 85), (87, 90), (91, 91), (93, 93), (94, 94), (96, 102), (104, 108), (110, 118), (120, 124), (126, 129), (130, 130), (132, 132), (133, 133), (135, 140), (142, 150), (152, 152), (153, 155), (156, 156), (158, 163), (165, 167), (169, 175), (177, 181), (183, 188), (190, 192), (194, 198), (200, 203), (204, 204), (206, 206), (207, 207), (209, 214), (216, 218), (220, 221), (223, 230), (232, 238), (240, 243), (245, 248), (250, 251), (253, 254), (256, 258), (260, 261), (263, 264), (266, 269), (271, 272), (274, 275), (277, 279), (281, 282), (283, 283), (285, 285), (286, 286), (288, 293), (295, 297), (299, 302), (304, 307), (309, 310), (312, 315), (317, 318), (320, 322), (324, 329), (331, 333), (335, 336), (338, 340), (342, 346), (348, 351)]
[u'We', u'compared', u'the', u'following', u'parameters', u'in', u'Long-Evans', u'-LRB-', u'LE', u'-RRB-', u'and', u'Sprague-Dawley', u'-LRB-', u'SD', u'-RRB-', u'female', u'rats', u':', u'1', u'-RRB-', u'mammary', u'tumor', u'incidence', u'after', u'DMBA', u',', u'2', u'-RRB-', u'plasma', u'prolactin', u'-LRB-', u'PRL', u'-RRB-', u'during', u'the', u'estrous', u'cycle', u'before', u'and', u'after', u'DMBA', u',', u'3', u'-RRB-', u'plasma', u'PRL', u'in', u'immature', u'females', u'from', u'0900', u'hr', u'on', u'day', u'29', u'to', u'0900', u'hr', u'on', u'day', u'30', u',', u'4', u'-RRB-', u'plasma', u'PRL', u'from', u'1200', u'to', u'1700', u'hr', u'and', u'before', u'and', u'10', u'min', u'after', u'i.p.', u'.']
orignal sentence: We compared the following parameters in Long-Evans (LE) and Sprague-Dawley (SD) female rats: 1) mammary tumor incidence after DMBA, 2) plasma prolactin (PRL) during the estrous cycle before and after DMBA, 3) plasma PRL in immature females from 0900 hr on day 29 to 0900 hr on day 30, 4) plasma PRL from 1200 to 1700 hr and before and 10 min after i.p.
error on token alignment
token: ., current:352
[(0, 1), (3, 10), (12, 14), (16, 24), (26, 35), (37, 38), (40, 49), (51, 51), (52, 53), (54, 54), (56, 58), (60, 73), (75, 75), (76, 77), (78, 78), (80, 85), (87, 90), (91, 91), (93, 93), (94, 94), (96, 102), (104, 108), (110, 118), (120, 124), (126, 129), (130, 130), (132, 132), (133, 133), (135, 140), (142, 150), (152, 152), (153, 155), (156, 156), (158, 163), (165, 167), (169, 175), (177, 181), (183, 188), (190, 192), (194, 198), (200, 203), (204, 204), (206, 206), (207, 207), (209, 214), (216, 218), (220, 221), (223, 230), (232, 238), (240, 243), (245, 248), (250, 251), (253, 254), (256, 258), (260, 261), (263, 264), (266, 269), (271, 272), (274, 275), (277, 279), (281, 282), (283, 283), (285, 285), (286, 286), (288, 293), (295, 297), (299, 302), (304, 307), (309, 310), (312, 315), (317, 318), (320, 322), (324, 329), (331, 333), (335, 336), (338, 340), (342, 346), (348, 351)]
[u'We', u'compared', u'the', u'following', u'parameters', u'in', u'Long-Evans', u'-LRB-', u'LE', u'-RRB-', u'and', u'Sprague-Dawley', u'-LRB-', u'SD', u'-RRB-', u'female', u'rats', u':', u'1', u'-RRB-', u'mammary', u'tumor', u'incidence', u'after', u'DMBA', u',', u'2', u'-RRB-', u'plasma', u'prolactin', u'-LRB-', u'PRL', u'-RRB-', u'during', u'the', u'estrous', u'cycle', u'before', u'and', u'after', u'DMBA', u',', u'3', u'-RRB-', u'plasma', u'PRL', u'in', u'immature', u'females', u'from', u'0900', u'hr', u'on', u'day', u'29', u'to', u'0900', u'hr', u'on', u'day', u'30', u',', u'4', u'-RRB-', u'plasma', u'PRL', u'from', u'1200', u'to', u'1700', u'hr', u'and', u'before', u'and', u'10', u'min', u'after', u'i.p.', u'.']
orignal sentence: We compared the following parameters in Long-Evans (LE) and Sprague-Dawley (SD) female rats: 1) mammary tumor incidence after DMBA, 2) plasma prolactin (PRL) during the estrous cycle before and after DMBA, 3) plasma PRL in immature females from 0900 hr on day 29 to 0900 hr on day 30, 4) plasma PRL from 1200 to 1700 hr and before and 10 min after i.p.
error on token alignment
token: ., current:352
[(0, 1), (3, 10), (12, 14), (16, 24), (26, 35), (37, 38), (40, 49), (51, 51), (52, 53), (54, 54), (56, 58), (60, 73), (75, 75), (76, 77), (78, 78), (80, 85), (87, 90), (91, 91), (93, 93), (94, 94), (96, 102), (104, 108), (110, 118), (120, 124), (126, 129), (130, 130), (132, 132), (133, 133), (135, 140), (142, 150), (152, 152), (153, 155), (156, 156), (158, 163), (165, 167), (169, 175), (177, 181), (183, 188), (190, 192), (194, 198), (200, 203), (204, 204), (206, 206), (207, 207), (209, 214), (216, 218), (220, 221), (223, 230), (232, 238), (240, 243), (245, 248), (250, 251), (253, 254), (256, 258), (260, 261), (263, 264), (266, 269), (271, 272), (274, 275), (277, 279), (281, 282), (283, 283), (285, 285), (286, 286), (288, 293), (295, 297), (299, 302), (304, 307), (309, 310), (312, 315), (317, 318), (320, 322), (324, 329), (331, 333), (335, 336), (338, 340), (342, 346), (348, 351)]
[u'We', u'compared', u'the', u'following', u'parameters', u'in', u'Long-Evans', u'-LRB-', u'LE', u'-RRB-', u'and', u'Sprague-Dawley', u'-LRB-', u'SD', u'-RRB-', u'female', u'rats', u':', u'1', u'-RRB-', u'mammary', u'tumor', u'incidence', u'after', u'DMBA', u',', u'2', u'-RRB-', u'plasma', u'prolactin', u'-LRB-', u'PRL', u'-RRB-', u'during', u'the', u'estrous', u'cycle', u'before', u'and', u'after', u'DMBA', u',', u'3', u'-RRB-', u'plasma', u'PRL', u'in', u'immature', u'females', u'from', u'0900', u'hr', u'on', u'day', u'29', u'to', u'0900', u'hr', u'on', u'day', u'30', u',', u'4', u'-RRB-', u'plasma', u'PRL', u'from', u'1200', u'to', u'1700', u'hr', u'and', u'before', u'and', u'10', u'min', u'after', u'i.p.', u'.']
orignal sentence: We compared the following parameters in Long-Evans (LE) and Sprague-Dawley (SD) female rats: 1) mammary tumor incidence after DMBA, 2) plasma prolactin (PRL) during the estrous cycle before and after DMBA, 3) plasma PRL in immature females from 0900 hr on day 29 to 0900 hr on day 30, 4) plasma PRL from 1200 to 1700 hr and before and 10 min after i.p.
error on token alignment
token: ., current:352
[(0, 1), (3, 10), (12, 14), (16, 24), (26, 35), (37, 38), (40, 49), (51, 51), (52, 53), (54, 54), (56, 58), (60, 73), (75, 75), (76, 77), (78, 78), (80, 85), (87, 90), (91, 91), (93, 93), (94, 94), (96, 102), (104, 108), (110, 118), (120, 124), (126, 129), (130, 130), (132, 132), (133, 133), (135, 140), (142, 150), (152, 152), (153, 155), (156, 156), (158, 163), (165, 167), (169, 175), (177, 181), (183, 188), (190, 192), (194, 198), (200, 203), (204, 204), (206, 206), (207, 207), (209, 214), (216, 218), (220, 221), (223, 230), (232, 238), (240, 243), (245, 248), (250, 251), (253, 254), (256, 258), (260, 261), (263, 264), (266, 269), (271, 272), (274, 275), (277, 279), (281, 282), (283, 283), (285, 285), (286, 286), (288, 293), (295, 297), (299, 302), (304, 307), (309, 310), (312, 315), (317, 318), (320, 322), (324, 329), (331, 333), (335, 336), (338, 340), (342, 346), (348, 351)]
[u'We', u'compared', u'the', u'following', u'parameters', u'in', u'Long-Evans', u'-LRB-', u'LE', u'-RRB-', u'and', u'Sprague-Dawley', u'-LRB-', u'SD', u'-RRB-', u'female', u'rats', u':', u'1', u'-RRB-', u'mammary', u'tumor', u'incidence', u'after', u'DMBA', u',', u'2', u'-RRB-', u'plasma', u'prolactin', u'-LRB-', u'PRL', u'-RRB-', u'during', u'the', u'estrous', u'cycle', u'before', u'and', u'after', u'DMBA', u',', u'3', u'-RRB-', u'plasma', u'PRL', u'in', u'immature', u'females', u'from', u'0900', u'hr', u'on', u'day', u'29', u'to', u'0900', u'hr', u'on', u'day', u'30', u',', u'4', u'-RRB-', u'plasma', u'PRL', u'from', u'1200', u'to', u'1700', u'hr', u'and', u'before', u'and', u'10', u'min', u'after', u'i.p.', u'.']
orignal sentence: We compared the following parameters in Long-Evans (LE) and Sprague-Dawley (SD) female rats: 1) mammary tumor incidence after DMBA, 2) plasma prolactin (PRL) during the estrous cycle before and after DMBA, 3) plasma PRL in immature females from 0900 hr on day 29 to 0900 hr on day 30, 4) plasma PRL from 1200 to 1700 hr and before and 10 min after i.p.
error on token alignment
token: ., current:352
[(0, 1), (3, 10), (12, 14), (16, 24), (26, 35), (37, 38), (40, 49), (51, 51), (52, 53), (54, 54), (56, 58), (60, 73), (75, 75), (76, 77), (78, 78), (80, 85), (87, 90), (91, 91), (93, 93), (94, 94), (96, 102), (104, 108), (110, 118), (120, 124), (126, 129), (130, 130), (132, 132), (133, 133), (135, 140), (142, 150), (152, 152), (153, 155), (156, 156), (158, 163), (165, 167), (169, 175), (177, 181), (183, 188), (190, 192), (194, 198), (200, 203), (204, 204), (206, 206), (207, 207), (209, 214), (216, 218), (220, 221), (223, 230), (232, 238), (240, 243), (245, 248), (250, 251), (253, 254), (256, 258), (260, 261), (263, 264), (266, 269), (271, 272), (274, 275), (277, 279), (281, 282), (283, 283), (285, 285), (286, 286), (288, 293), (295, 297), (299, 302), (304, 307), (309, 310), (312, 315), (317, 318), (320, 322), (324, 329), (331, 333), (335, 336), (338, 340), (342, 346), (348, 351)]
[u'We', u'compared', u'the', u'following', u'parameters', u'in', u'Long-Evans', u'-LRB-', u'LE', u'-RRB-', u'and', u'Sprague-Dawley', u'-LRB-', u'SD', u'-RRB-', u'female', u'rats', u':', u'1', u'-RRB-', u'mammary', u'tumor', u'incidence', u'after', u'DMBA', u',', u'2', u'-RRB-', u'plasma', u'prolactin', u'-LRB-', u'PRL', u'-RRB-', u'during', u'the', u'estrous', u'cycle', u'before', u'and', u'after', u'DMBA', u',', u'3', u'-RRB-', u'plasma', u'PRL', u'in', u'immature', u'females', u'from', u'0900', u'hr', u'on', u'day', u'29', u'to', u'0900', u'hr', u'on', u'day', u'30', u',', u'4', u'-RRB-', u'plasma', u'PRL', u'from', u'1200', u'to', u'1700', u'hr', u'and', u'before', u'and', u'10', u'min', u'after', u'i.p.', u'.']
orignal sentence: We compared the following parameters in Long-Evans (LE) and Sprague-Dawley (SD) female rats: 1) mammary tumor incidence after DMBA, 2) plasma prolactin (PRL) during the estrous cycle before and after DMBA, 3) plasma PRL in immature females from 0900 hr on day 29 to 0900 hr on day 30, 4) plasma PRL from 1200 to 1700 hr and before and 10 min after i.p.
error on token alignment
token: ., current:352
[(0, 1), (3, 10), (12, 14), (16, 24), (26, 35), (37, 38), (40, 49), (51, 51), (52, 53), (54, 54), (56, 58), (60, 73), (75, 75), (76, 77), (78, 78), (80, 85), (87, 90), (91, 91), (93, 93), (94, 94), (96, 102), (104, 108), (110, 118), (120, 124), (126, 129), (130, 130), (132, 132), (133, 133), (135, 140), (142, 150), (152, 152), (153, 155), (156, 156), (158, 163), (165, 167), (169, 175), (177, 181), (183, 188), (190, 192), (194, 198), (200, 203), (204, 204), (206, 206), (207, 207), (209, 214), (216, 218), (220, 221), (223, 230), (232, 238), (240, 243), (245, 248), (250, 251), (253, 254), (256, 258), (260, 261), (263, 264), (266, 269), (271, 272), (274, 275), (277, 279), (281, 282), (283, 283), (285, 285), (286, 286), (288, 293), (295, 297), (299, 302), (304, 307), (309, 310), (312, 315), (317, 318), (320, 322), (324, 329), (331, 333), (335, 336), (338, 340), (342, 346), (348, 351)]
[u'We', u'compared', u'the', u'following', u'parameters', u'in', u'Long-Evans', u'-LRB-', u'LE', u'-RRB-', u'and', u'Sprague-Dawley', u'-LRB-', u'SD', u'-RRB-', u'female', u'rats', u':', u'1', u'-RRB-', u'mammary', u'tumor', u'incidence', u'after', u'DMBA', u',', u'2', u'-RRB-', u'plasma', u'prolactin', u'-LRB-', u'PRL', u'-RRB-', u'during', u'the', u'estrous', u'cycle', u'before', u'and', u'after', u'DMBA', u',', u'3', u'-RRB-', u'plasma', u'PRL', u'in', u'immature', u'females', u'from', u'0900', u'hr', u'on', u'day', u'29', u'to', u'0900', u'hr', u'on', u'day', u'30', u',', u'4', u'-RRB-', u'plasma', u'PRL', u'from', u'1200', u'to', u'1700', u'hr', u'and', u'before', u'and', u'10', u'min', u'after', u'i.p.', u'.']
orignal sentence: We compared the following parameters in Long-Evans (LE) and Sprague-Dawley (SD) female rats: 1) mammary tumor incidence after DMBA, 2) plasma prolactin (PRL) during the estrous cycle before and after DMBA, 3) plasma PRL in immature females from 0900 hr on day 29 to 0900 hr on day 30, 4) plasma PRL from 1200 to 1700 hr and before and 10 min after i.p.
error on token alignment
token: ., current:352
[(0, 1), (3, 10), (12, 14), (16, 24), (26, 35), (37, 38), (40, 49), (51, 51), (52, 53), (54, 54), (56, 58), (60, 73), (75, 75), (76, 77), (78, 78), (80, 85), (87, 90), (91, 91), (93, 93), (94, 94), (96, 102), (104, 108), (110, 118), (120, 124), (126, 129), (130, 130), (132, 132), (133, 133), (135, 140), (142, 150), (152, 152), (153, 155), (156, 156), (158, 163), (165, 167), (169, 175), (177, 181), (183, 188), (190, 192), (194, 198), (200, 203), (204, 204), (206, 206), (207, 207), (209, 214), (216, 218), (220, 221), (223, 230), (232, 238), (240, 243), (245, 248), (250, 251), (253, 254), (256, 258), (260, 261), (263, 264), (266, 269), (271, 272), (274, 275), (277, 279), (281, 282), (283, 283), (285, 285), (286, 286), (288, 293), (295, 297), (299, 302), (304, 307), (309, 310), (312, 315), (317, 318), (320, 322), (324, 329), (331, 333), (335, 336), (338, 340), (342, 346), (348, 351)]
[u'We', u'compared', u'the', u'following', u'parameters', u'in', u'Long-Evans', u'-LRB-', u'LE', u'-RRB-', u'and', u'Sprague-Dawley', u'-LRB-', u'SD', u'-RRB-', u'female', u'rats', u':', u'1', u'-RRB-', u'mammary', u'tumor', u'incidence', u'after', u'DMBA', u',', u'2', u'-RRB-', u'plasma', u'prolactin', u'-LRB-', u'PRL', u'-RRB-', u'during', u'the', u'estrous', u'cycle', u'before', u'and', u'after', u'DMBA', u',', u'3', u'-RRB-', u'plasma', u'PRL', u'in', u'immature', u'females', u'from', u'0900', u'hr', u'on', u'day', u'29', u'to', u'0900', u'hr', u'on', u'day', u'30', u',', u'4', u'-RRB-', u'plasma', u'PRL', u'from', u'1200', u'to', u'1700', u'hr', u'and', u'before', u'and', u'10', u'min', u'after', u'i.p.', u'.']
orignal sentence: We compared the following parameters in Long-Evans (LE) and Sprague-Dawley (SD) female rats: 1) mammary tumor incidence after DMBA, 2) plasma prolactin (PRL) during the estrous cycle before and after DMBA, 3) plasma PRL in immature females from 0900 hr on day 29 to 0900 hr on day 30, 4) plasma PRL from 1200 to 1700 hr and before and 10 min after i.p.
error on token alignment
token: ., current:352
[(0, 1), (3, 10), (12, 14), (16, 24), (26, 35), (37, 38), (40, 49), (51, 51), (52, 53), (54, 54), (56, 58), (60, 73), (75, 75), (76, 77), (78, 78), (80, 85), (87, 90), (91, 91), (93, 93), (94, 94), (96, 102), (104, 108), (110, 118), (120, 124), (126, 129), (130, 130), (132, 132), (133, 133), (135, 140), (142, 150), (152, 152), (153, 155), (156, 156), (158, 163), (165, 167), (169, 175), (177, 181), (183, 188), (190, 192), (194, 198), (200, 203), (204, 204), (206, 206), (207, 207), (209, 214), (216, 218), (220, 221), (223, 230), (232, 238), (240, 243), (245, 248), (250, 251), (253, 254), (256, 258), (260, 261), (263, 264), (266, 269), (271, 272), (274, 275), (277, 279), (281, 282), (283, 283), (285, 285), (286, 286), (288, 293), (295, 297), (299, 302), (304, 307), (309, 310), (312, 315), (317, 318), (320, 322), (324, 329), (331, 333), (335, 336), (338, 340), (342, 346), (348, 351)]
[u'We', u'compared', u'the', u'following', u'parameters', u'in', u'Long-Evans', u'-LRB-', u'LE', u'-RRB-', u'and', u'Sprague-Dawley', u'-LRB-', u'SD', u'-RRB-', u'female', u'rats', u':', u'1', u'-RRB-', u'mammary', u'tumor', u'incidence', u'after', u'DMBA', u',', u'2', u'-RRB-', u'plasma', u'prolactin', u'-LRB-', u'PRL', u'-RRB-', u'during', u'the', u'estrous', u'cycle', u'before', u'and', u'after', u'DMBA', u',', u'3', u'-RRB-', u'plasma', u'PRL', u'in', u'immature', u'females', u'from', u'0900', u'hr', u'on', u'day', u'29', u'to', u'0900', u'hr', u'on', u'day', u'30', u',', u'4', u'-RRB-', u'plasma', u'PRL', u'from', u'1200', u'to', u'1700', u'hr', u'and', u'before', u'and', u'10', u'min', u'after', u'i.p.', u'.']
orignal sentence: We compared the following parameters in Long-Evans (LE) and Sprague-Dawley (SD) female rats: 1) mammary tumor incidence after DMBA, 2) plasma prolactin (PRL) during the estrous cycle before and after DMBA, 3) plasma PRL in immature females from 0900 hr on day 29 to 0900 hr on day 30, 4) plasma PRL from 1200 to 1700 hr and before and 10 min after i.p.
error on token alignment
token: ., current:352
[(0, 1), (3, 10), (12, 14), (16, 24), (26, 35), (37, 38), (40, 49), (51, 51), (52, 53), (54, 54), (56, 58), (60, 73), (75, 75), (76, 77), (78, 78), (80, 85), (87, 90), (91, 91), (93, 93), (94, 94), (96, 102), (104, 108), (110, 118), (120, 124), (126, 129), (130, 130), (132, 132), (133, 133), (135, 140), (142, 150), (152, 152), (153, 155), (156, 156), (158, 163), (165, 167), (169, 175), (177, 181), (183, 188), (190, 192), (194, 198), (200, 203), (204, 204), (206, 206), (207, 207), (209, 214), (216, 218), (220, 221), (223, 230), (232, 238), (240, 243), (245, 248), (250, 251), (253, 254), (256, 258), (260, 261), (263, 264), (266, 269), (271, 272), (274, 275), (277, 279), (281, 282), (283, 283), (285, 285), (286, 286), (288, 293), (295, 297), (299, 302), (304, 307), (309, 310), (312, 315), (317, 318), (320, 322), (324, 329), (331, 333), (335, 336), (338, 340), (342, 346), (348, 351)]
[u'We', u'compared', u'the', u'following', u'parameters', u'in', u'Long-Evans', u'-LRB-', u'LE', u'-RRB-', u'and', u'Sprague-Dawley', u'-LRB-', u'SD', u'-RRB-', u'female', u'rats', u':', u'1', u'-RRB-', u'mammary', u'tumor', u'incidence', u'after', u'DMBA', u',', u'2', u'-RRB-', u'plasma', u'prolactin', u'-LRB-', u'PRL', u'-RRB-', u'during', u'the', u'estrous', u'cycle', u'before', u'and', u'after', u'DMBA', u',', u'3', u'-RRB-', u'plasma', u'PRL', u'in', u'immature', u'females', u'from', u'0900', u'hr', u'on', u'day', u'29', u'to', u'0900', u'hr', u'on', u'day', u'30', u',', u'4', u'-RRB-', u'plasma', u'PRL', u'from', u'1200', u'to', u'1700', u'hr', u'and', u'before', u'and', u'10', u'min', u'after', u'i.p.', u'.']
orignal sentence: We compared the following parameters in Long-Evans (LE) and Sprague-Dawley (SD) female rats: 1) mammary tumor incidence after DMBA, 2) plasma prolactin (PRL) during the estrous cycle before and after DMBA, 3) plasma PRL in immature females from 0900 hr on day 29 to 0900 hr on day 30, 4) plasma PRL from 1200 to 1700 hr and before and 10 min after i.p.
error on token alignment
token: ., current:352
[(0, 1), (3, 10), (12, 14), (16, 24), (26, 35), (37, 38), (40, 49), (51, 51), (52, 53), (54, 54), (56, 58), (60, 73), (75, 75), (76, 77), (78, 78), (80, 85), (87, 90), (91, 91), (93, 93), (94, 94), (96, 102), (104, 108), (110, 118), (120, 124), (126, 129), (130, 130), (132, 132), (133, 133), (135, 140), (142, 150), (152, 152), (153, 155), (156, 156), (158, 163), (165, 167), (169, 175), (177, 181), (183, 188), (190, 192), (194, 198), (200, 203), (204, 204), (206, 206), (207, 207), (209, 214), (216, 218), (220, 221), (223, 230), (232, 238), (240, 243), (245, 248), (250, 251), (253, 254), (256, 258), (260, 261), (263, 264), (266, 269), (271, 272), (274, 275), (277, 279), (281, 282), (283, 283), (285, 285), (286, 286), (288, 293), (295, 297), (299, 302), (304, 307), (309, 310), (312, 315), (317, 318), (320, 322), (324, 329), (331, 333), (335, 336), (338, 340), (342, 346), (348, 351)]
[u'We', u'compared', u'the', u'following', u'parameters', u'in', u'Long-Evans', u'-LRB-', u'LE', u'-RRB-', u'and', u'Sprague-Dawley', u'-LRB-', u'SD', u'-RRB-', u'female', u'rats', u':', u'1', u'-RRB-', u'mammary', u'tumor', u'incidence', u'after', u'DMBA', u',', u'2', u'-RRB-', u'plasma', u'prolactin', u'-LRB-', u'PRL', u'-RRB-', u'during', u'the', u'estrous', u'cycle', u'before', u'and', u'after', u'DMBA', u',', u'3', u'-RRB-', u'plasma', u'PRL', u'in', u'immature', u'females', u'from', u'0900', u'hr', u'on', u'day', u'29', u'to', u'0900', u'hr', u'on', u'day', u'30', u',', u'4', u'-RRB-', u'plasma', u'PRL', u'from', u'1200', u'to', u'1700', u'hr', u'and', u'before', u'and', u'10', u'min', u'after', u'i.p.', u'.']
orignal sentence: We compared the following parameters in Long-Evans (LE) and Sprague-Dawley (SD) female rats: 1) mammary tumor incidence after DMBA, 2) plasma prolactin (PRL) during the estrous cycle before and after DMBA, 3) plasma PRL in immature females from 0900 hr on day 29 to 0900 hr on day 30, 4) plasma PRL from 1200 to 1700 hr and before and 10 min after i.p.
error on token alignment
token: ., current:352
[(0, 1), (3, 10), (12, 14), (16, 24), (26, 35), (37, 38), (40, 49), (51, 51), (52, 53), (54, 54), (56, 58), (60, 73), (75, 75), (76, 77), (78, 78), (80, 85), (87, 90), (91, 91), (93, 93), (94, 94), (96, 102), (104, 108), (110, 118), (120, 124), (126, 129), (130, 130), (132, 132), (133, 133), (135, 140), (142, 150), (152, 152), (153, 155), (156, 156), (158, 163), (165, 167), (169, 175), (177, 181), (183, 188), (190, 192), (194, 198), (200, 203), (204, 204), (206, 206), (207, 207), (209, 214), (216, 218), (220, 221), (223, 230), (232, 238), (240, 243), (245, 248), (250, 251), (253, 254), (256, 258), (260, 261), (263, 264), (266, 269), (271, 272), (274, 275), (277, 279), (281, 282), (283, 283), (285, 285), (286, 286), (288, 293), (295, 297), (299, 302), (304, 307), (309, 310), (312, 315), (317, 318), (320, 322), (324, 329), (331, 333), (335, 336), (338, 340), (342, 346), (348, 351)]
[u'We', u'compared', u'the', u'following', u'parameters', u'in', u'Long-Evans', u'-LRB-', u'LE', u'-RRB-', u'and', u'Sprague-Dawley', u'-LRB-', u'SD', u'-RRB-', u'female', u'rats', u':', u'1', u'-RRB-', u'mammary', u'tumor', u'incidence', u'after', u'DMBA', u',', u'2', u'-RRB-', u'plasma', u'prolactin', u'-LRB-', u'PRL', u'-RRB-', u'during', u'the', u'estrous', u'cycle', u'before', u'and', u'after', u'DMBA', u',', u'3', u'-RRB-', u'plasma', u'PRL', u'in', u'immature', u'females', u'from', u'0900', u'hr', u'on', u'day', u'29', u'to', u'0900', u'hr', u'on', u'day', u'30', u',', u'4', u'-RRB-', u'plasma', u'PRL', u'from', u'1200', u'to', u'1700', u'hr', u'and', u'before', u'and', u'10', u'min', u'after', u'i.p.', u'.']
orignal sentence: We compared the following parameters in Long-Evans (LE) and Sprague-Dawley (SD) female rats: 1) mammary tumor incidence after DMBA, 2) plasma prolactin (PRL) during the estrous cycle before and after DMBA, 3) plasma PRL in immature females from 0900 hr on day 29 to 0900 hr on day 30, 4) plasma PRL from 1200 to 1700 hr and before and 10 min after i.p.
error on token alignment
token: ., current:352
[(0, 1), (3, 10), (12, 14), (16, 24), (26, 35), (37, 38), (40, 49), (51, 51), (52, 53), (54, 54), (56, 58), (60, 73), (75, 75), (76, 77), (78, 78), (80, 85), (87, 90), (91, 91), (93, 93), (94, 94), (96, 102), (104, 108), (110, 118), (120, 124), (126, 129), (130, 130), (132, 132), (133, 133), (135, 140), (142, 150), (152, 152), (153, 155), (156, 156), (158, 163), (165, 167), (169, 175), (177, 181), (183, 188), (190, 192), (194, 198), (200, 203), (204, 204), (206, 206), (207, 207), (209, 214), (216, 218), (220, 221), (223, 230), (232, 238), (240, 243), (245, 248), (250, 251), (253, 254), (256, 258), (260, 261), (263, 264), (266, 269), (271, 272), (274, 275), (277, 279), (281, 282), (283, 283), (285, 285), (286, 286), (288, 293), (295, 297), (299, 302), (304, 307), (309, 310), (312, 315), (317, 318), (320, 322), (324, 329), (331, 333), (335, 336), (338, 340), (342, 346), (348, 351)]
[u'We', u'compared', u'the', u'following', u'parameters', u'in', u'Long-Evans', u'-LRB-', u'LE', u'-RRB-', u'and', u'Sprague-Dawley', u'-LRB-', u'SD', u'-RRB-', u'female', u'rats', u':', u'1', u'-RRB-', u'mammary', u'tumor', u'incidence', u'after', u'DMBA', u',', u'2', u'-RRB-', u'plasma', u'prolactin', u'-LRB-', u'PRL', u'-RRB-', u'during', u'the', u'estrous', u'cycle', u'before', u'and', u'after', u'DMBA', u',', u'3', u'-RRB-', u'plasma', u'PRL', u'in', u'immature', u'females', u'from', u'0900', u'hr', u'on', u'day', u'29', u'to', u'0900', u'hr', u'on', u'day', u'30', u',', u'4', u'-RRB-', u'plasma', u'PRL', u'from', u'1200', u'to', u'1700', u'hr', u'and', u'before', u'and', u'10', u'min', u'after', u'i.p.', u'.']
orignal sentence: We compared the following parameters in Long-Evans (LE) and Sprague-Dawley (SD) female rats: 1) mammary tumor incidence after DMBA, 2) plasma prolactin (PRL) during the estrous cycle before and after DMBA, 3) plasma PRL in immature females from 0900 hr on day 29 to 0900 hr on day 30, 4) plasma PRL from 1200 to 1700 hr and before and 10 min after i.p.
error on token alignment
token: ., current:352
[(0, 1), (3, 10), (12, 14), (16, 24), (26, 35), (37, 38), (40, 49), (51, 51), (52, 53), (54, 54), (56, 58), (60, 73), (75, 75), (76, 77), (78, 78), (80, 85), (87, 90), (91, 91), (93, 93), (94, 94), (96, 102), (104, 108), (110, 118), (120, 124), (126, 129), (130, 130), (132, 132), (133, 133), (135, 140), (142, 150), (152, 152), (153, 155), (156, 156), (158, 163), (165, 167), (169, 175), (177, 181), (183, 188), (190, 192), (194, 198), (200, 203), (204, 204), (206, 206), (207, 207), (209, 214), (216, 218), (220, 221), (223, 230), (232, 238), (240, 243), (245, 248), (250, 251), (253, 254), (256, 258), (260, 261), (263, 264), (266, 269), (271, 272), (274, 275), (277, 279), (281, 282), (283, 283), (285, 285), (286, 286), (288, 293), (295, 297), (299, 302), (304, 307), (309, 310), (312, 315), (317, 318), (320, 322), (324, 329), (331, 333), (335, 336), (338, 340), (342, 346), (348, 351)]
[u'We', u'compared', u'the', u'following', u'parameters', u'in', u'Long-Evans', u'-LRB-', u'LE', u'-RRB-', u'and', u'Sprague-Dawley', u'-LRB-', u'SD', u'-RRB-', u'female', u'rats', u':', u'1', u'-RRB-', u'mammary', u'tumor', u'incidence', u'after', u'DMBA', u',', u'2', u'-RRB-', u'plasma', u'prolactin', u'-LRB-', u'PRL', u'-RRB-', u'during', u'the', u'estrous', u'cycle', u'before', u'and', u'after', u'DMBA', u',', u'3', u'-RRB-', u'plasma', u'PRL', u'in', u'immature', u'females', u'from', u'0900', u'hr', u'on', u'day', u'29', u'to', u'0900', u'hr', u'on', u'day', u'30', u',', u'4', u'-RRB-', u'plasma', u'PRL', u'from', u'1200', u'to', u'1700', u'hr', u'and', u'before', u'and', u'10', u'min', u'after', u'i.p.', u'.']
orignal sentence: We compared the following parameters in Long-Evans (LE) and Sprague-Dawley (SD) female rats: 1) mammary tumor incidence after DMBA, 2) plasma prolactin (PRL) during the estrous cycle before and after DMBA, 3) plasma PRL in immature females from 0900 hr on day 29 to 0900 hr on day 30, 4) plasma PRL from 1200 to 1700 hr and before and 10 min after i.p.
error on token alignment
token: ., current:352
[(0, 1), (3, 10), (12, 14), (16, 24), (26, 35), (37, 38), (40, 49), (51, 51), (52, 53), (54, 54), (56, 58), (60, 73), (75, 75), (76, 77), (78, 78), (80, 85), (87, 90), (91, 91), (93, 93), (94, 94), (96, 102), (104, 108), (110, 118), (120, 124), (126, 129), (130, 130), (132, 132), (133, 133), (135, 140), (142, 150), (152, 152), (153, 155), (156, 156), (158, 163), (165, 167), (169, 175), (177, 181), (183, 188), (190, 192), (194, 198), (200, 203), (204, 204), (206, 206), (207, 207), (209, 214), (216, 218), (220, 221), (223, 230), (232, 238), (240, 243), (245, 248), (250, 251), (253, 254), (256, 258), (260, 261), (263, 264), (266, 269), (271, 272), (274, 275), (277, 279), (281, 282), (283, 283), (285, 285), (286, 286), (288, 293), (295, 297), (299, 302), (304, 307), (309, 310), (312, 315), (317, 318), (320, 322), (324, 329), (331, 333), (335, 336), (338, 340), (342, 346), (348, 351)]
[u'We', u'compared', u'the', u'following', u'parameters', u'in', u'Long-Evans', u'-LRB-', u'LE', u'-RRB-', u'and', u'Sprague-Dawley', u'-LRB-', u'SD', u'-RRB-', u'female', u'rats', u':', u'1', u'-RRB-', u'mammary', u'tumor', u'incidence', u'after', u'DMBA', u',', u'2', u'-RRB-', u'plasma', u'prolactin', u'-LRB-', u'PRL', u'-RRB-', u'during', u'the', u'estrous', u'cycle', u'before', u'and', u'after', u'DMBA', u',', u'3', u'-RRB-', u'plasma', u'PRL', u'in', u'immature', u'females', u'from', u'0900', u'hr', u'on', u'day', u'29', u'to', u'0900', u'hr', u'on', u'day', u'30', u',', u'4', u'-RRB-', u'plasma', u'PRL', u'from', u'1200', u'to', u'1700', u'hr', u'and', u'before', u'and', u'10', u'min', u'after', u'i.p.', u'.']
orignal sentence: We compared the following parameters in Long-Evans (LE) and Sprague-Dawley (SD) female rats: 1) mammary tumor incidence after DMBA, 2) plasma prolactin (PRL) during the estrous cycle before and after DMBA, 3) plasma PRL in immature females from 0900 hr on day 29 to 0900 hr on day 30, 4) plasma PRL from 1200 to 1700 hr and before and 10 min after i.p.
error on token alignment
token: ., current:352
[(0, 1), (3, 10), (12, 14), (16, 24), (26, 35), (37, 38), (40, 49), (51, 51), (52, 53), (54, 54), (56, 58), (60, 73), (75, 75), (76, 77), (78, 78), (80, 85), (87, 90), (91, 91), (93, 93), (94, 94), (96, 102), (104, 108), (110, 118), (120, 124), (126, 129), (130, 130), (132, 132), (133, 133), (135, 140), (142, 150), (152, 152), (153, 155), (156, 156), (158, 163), (165, 167), (169, 175), (177, 181), (183, 188), (190, 192), (194, 198), (200, 203), (204, 204), (206, 206), (207, 207), (209, 214), (216, 218), (220, 221), (223, 230), (232, 238), (240, 243), (245, 248), (250, 251), (253, 254), (256, 258), (260, 261), (263, 264), (266, 269), (271, 272), (274, 275), (277, 279), (281, 282), (283, 283), (285, 285), (286, 286), (288, 293), (295, 297), (299, 302), (304, 307), (309, 310), (312, 315), (317, 318), (320, 322), (324, 329), (331, 333), (335, 336), (338, 340), (342, 346), (348, 351)]
[u'We', u'compared', u'the', u'following', u'parameters', u'in', u'Long-Evans', u'-LRB-', u'LE', u'-RRB-', u'and', u'Sprague-Dawley', u'-LRB-', u'SD', u'-RRB-', u'female', u'rats', u':', u'1', u'-RRB-', u'mammary', u'tumor', u'incidence', u'after', u'DMBA', u',', u'2', u'-RRB-', u'plasma', u'prolactin', u'-LRB-', u'PRL', u'-RRB-', u'during', u'the', u'estrous', u'cycle', u'before', u'and', u'after', u'DMBA', u',', u'3', u'-RRB-', u'plasma', u'PRL', u'in', u'immature', u'females', u'from', u'0900', u'hr', u'on', u'day', u'29', u'to', u'0900', u'hr', u'on', u'day', u'30', u',', u'4', u'-RRB-', u'plasma', u'PRL', u'from', u'1200', u'to', u'1700', u'hr', u'and', u'before', u'and', u'10', u'min', u'after', u'i.p.', u'.']
orignal sentence: We compared the following parameters in Long-Evans (LE) and Sprague-Dawley (SD) female rats: 1) mammary tumor incidence after DMBA, 2) plasma prolactin (PRL) during the estrous cycle before and after DMBA, 3) plasma PRL in immature females from 0900 hr on day 29 to 0900 hr on day 30, 4) plasma PRL from 1200 to 1700 hr and before and 10 min after i.p.
error on token alignment
token: ., current:352
[(0, 1), (3, 10), (12, 14), (16, 24), (26, 35), (37, 38), (40, 49), (51, 51), (52, 53), (54, 54), (56, 58), (60, 73), (75, 75), (76, 77), (78, 78), (80, 85), (87, 90), (91, 91), (93, 93), (94, 94), (96, 102), (104, 108), (110, 118), (120, 124), (126, 129), (130, 130), (132, 132), (133, 133), (135, 140), (142, 150), (152, 152), (153, 155), (156, 156), (158, 163), (165, 167), (169, 175), (177, 181), (183, 188), (190, 192), (194, 198), (200, 203), (204, 204), (206, 206), (207, 207), (209, 214), (216, 218), (220, 221), (223, 230), (232, 238), (240, 243), (245, 248), (250, 251), (253, 254), (256, 258), (260, 261), (263, 264), (266, 269), (271, 272), (274, 275), (277, 279), (281, 282), (283, 283), (285, 285), (286, 286), (288, 293), (295, 297), (299, 302), (304, 307), (309, 310), (312, 315), (317, 318), (320, 322), (324, 329), (331, 333), (335, 336), (338, 340), (342, 346), (348, 351)]
[u'We', u'compared', u'the', u'following', u'parameters', u'in', u'Long-Evans', u'-LRB-', u'LE', u'-RRB-', u'and', u'Sprague-Dawley', u'-LRB-', u'SD', u'-RRB-', u'female', u'rats', u':', u'1', u'-RRB-', u'mammary', u'tumor', u'incidence', u'after', u'DMBA', u',', u'2', u'-RRB-', u'plasma', u'prolactin', u'-LRB-', u'PRL', u'-RRB-', u'during', u'the', u'estrous', u'cycle', u'before', u'and', u'after', u'DMBA', u',', u'3', u'-RRB-', u'plasma', u'PRL', u'in', u'immature', u'females', u'from', u'0900', u'hr', u'on', u'day', u'29', u'to', u'0900', u'hr', u'on', u'day', u'30', u',', u'4', u'-RRB-', u'plasma', u'PRL', u'from', u'1200', u'to', u'1700', u'hr', u'and', u'before', u'and', u'10', u'min', u'after', u'i.p.', u'.']
orignal sentence: We compared the following parameters in Long-Evans (LE) and Sprague-Dawley (SD) female rats: 1) mammary tumor incidence after DMBA, 2) plasma prolactin (PRL) during the estrous cycle before and after DMBA, 3) plasma PRL in immature females from 0900 hr on day 29 to 0900 hr on day 30, 4) plasma PRL from 1200 to 1700 hr and before and 10 min after i.p.
error on token alignment
token: ., current:352
[(0, 1), (3, 10), (12, 14), (16, 24), (26, 35), (37, 38), (40, 49), (51, 51), (52, 53), (54, 54), (56, 58), (60, 73), (75, 75), (76, 77), (78, 78), (80, 85), (87, 90), (91, 91), (93, 93), (94, 94), (96, 102), (104, 108), (110, 118), (120, 124), (126, 129), (130, 130), (132, 132), (133, 133), (135, 140), (142, 150), (152, 152), (153, 155), (156, 156), (158, 163), (165, 167), (169, 175), (177, 181), (183, 188), (190, 192), (194, 198), (200, 203), (204, 204), (206, 206), (207, 207), (209, 214), (216, 218), (220, 221), (223, 230), (232, 238), (240, 243), (245, 248), (250, 251), (253, 254), (256, 258), (260, 261), (263, 264), (266, 269), (271, 272), (274, 275), (277, 279), (281, 282), (283, 283), (285, 285), (286, 286), (288, 293), (295, 297), (299, 302), (304, 307), (309, 310), (312, 315), (317, 318), (320, 322), (324, 329), (331, 333), (335, 336), (338, 340), (342, 346), (348, 351)]
[u'We', u'compared', u'the', u'following', u'parameters', u'in', u'Long-Evans', u'-LRB-', u'LE', u'-RRB-', u'and', u'Sprague-Dawley', u'-LRB-', u'SD', u'-RRB-', u'female', u'rats', u':', u'1', u'-RRB-', u'mammary', u'tumor', u'incidence', u'after', u'DMBA', u',', u'2', u'-RRB-', u'plasma', u'prolactin', u'-LRB-', u'PRL', u'-RRB-', u'during', u'the', u'estrous', u'cycle', u'before', u'and', u'after', u'DMBA', u',', u'3', u'-RRB-', u'plasma', u'PRL', u'in', u'immature', u'females', u'from', u'0900', u'hr', u'on', u'day', u'29', u'to', u'0900', u'hr', u'on', u'day', u'30', u',', u'4', u'-RRB-', u'plasma', u'PRL', u'from', u'1200', u'to', u'1700', u'hr', u'and', u'before', u'and', u'10', u'min', u'after', u'i.p.', u'.']
orignal sentence: We compared the following parameters in Long-Evans (LE) and Sprague-Dawley (SD) female rats: 1) mammary tumor incidence after DMBA, 2) plasma prolactin (PRL) during the estrous cycle before and after DMBA, 3) plasma PRL in immature females from 0900 hr on day 29 to 0900 hr on day 30, 4) plasma PRL from 1200 to 1700 hr and before and 10 min after i.p.
error on token alignment
token: ., current:352
[(0, 1), (3, 10), (12, 14), (16, 24), (26, 35), (37, 38), (40, 49), (51, 51), (52, 53), (54, 54), (56, 58), (60, 73), (75, 75), (76, 77), (78, 78), (80, 85), (87, 90), (91, 91), (93, 93), (94, 94), (96, 102), (104, 108), (110, 118), (120, 124), (126, 129), (130, 130), (132, 132), (133, 133), (135, 140), (142, 150), (152, 152), (153, 155), (156, 156), (158, 163), (165, 167), (169, 175), (177, 181), (183, 188), (190, 192), (194, 198), (200, 203), (204, 204), (206, 206), (207, 207), (209, 214), (216, 218), (220, 221), (223, 230), (232, 238), (240, 243), (245, 248), (250, 251), (253, 254), (256, 258), (260, 261), (263, 264), (266, 269), (271, 272), (274, 275), (277, 279), (281, 282), (283, 283), (285, 285), (286, 286), (288, 293), (295, 297), (299, 302), (304, 307), (309, 310), (312, 315), (317, 318), (320, 322), (324, 329), (331, 333), (335, 336), (338, 340), (342, 346), (348, 351)]
[u'We', u'compared', u'the', u'following', u'parameters', u'in', u'Long-Evans', u'-LRB-', u'LE', u'-RRB-', u'and', u'Sprague-Dawley', u'-LRB-', u'SD', u'-RRB-', u'female', u'rats', u':', u'1', u'-RRB-', u'mammary', u'tumor', u'incidence', u'after', u'DMBA', u',', u'2', u'-RRB-', u'plasma', u'prolactin', u'-LRB-', u'PRL', u'-RRB-', u'during', u'the', u'estrous', u'cycle', u'before', u'and', u'after', u'DMBA', u',', u'3', u'-RRB-', u'plasma', u'PRL', u'in', u'immature', u'females', u'from', u'0900', u'hr', u'on', u'day', u'29', u'to', u'0900', u'hr', u'on', u'day', u'30', u',', u'4', u'-RRB-', u'plasma', u'PRL', u'from', u'1200', u'to', u'1700', u'hr', u'and', u'before', u'and', u'10', u'min', u'after', u'i.p.', u'.']
orignal sentence: We compared the following parameters in Long-Evans (LE) and Sprague-Dawley (SD) female rats: 1) mammary tumor incidence after DMBA, 2) plasma prolactin (PRL) during the estrous cycle before and after DMBA, 3) plasma PRL in immature females from 0900 hr on day 29 to 0900 hr on day 30, 4) plasma PRL from 1200 to 1700 hr and before and 10 min after i.p.
error on token alignment
token: ., current:171
[(0, 9), (11, 12), (14, 23), (25, 30), (31, 31), (33, 34), (36, 41), (43, 44), (46, 50), (52, 57), (59, 67), (69, 70), (72, 87), (89, 94), (95, 95), (97, 98), (100, 103), (105, 108), (110, 121), (123, 134), (136, 144), (145, 145), (147, 150), (152, 159), (161, 165), (167, 170)]
[u'Inductions', u'of', u'monoclonal', u'tumors', u',', u'as', u'judged', u'by', u'their', u'single', u'phenotype', u'of', u'phosphoglycerate', u'kinase', u',', u'in', u'mice', u'with', u'X-chromosome', u'inactivation', u'mosaicism', u',', u'were', u'observed', u'after', u's.c.', u'.']
orignal sentence: Inductions of monoclonal tumors, as judged by their single phenotype of phosphoglycerate kinase, in mice with X-chromosome inactivation mosaicism, were observed after s.c.
error on token alignment
token: ., current:97
[(0, 8), (10, 10), (11, 13), (14, 14), (15, 24), (26, 28), (30, 38), (40, 45), (47, 50), (52, 58), (60, 61), (63, 68), (70, 75), (77, 83), (85, 88), (90, 91), (93, 96)]
[u'Prolactin', u'-LRB-', u'PRL', u'-RRB-', u'-secreting', u'rat', u'pituitary', u'tumors', u'were', u'induced', u'in', u'female', u'Fisher', u'344/Lis', u'rats', u'by', u's.c.', u'.']
orignal sentence: Prolactin (PRL)-secreting rat pituitary tumors were induced in female Fisher 344/Lis rats by s.c.
error on token alignment
token: ., current:97
[(0, 8), (10, 10), (11, 13), (14, 14), (15, 24), (26, 28), (30, 38), (40, 45), (47, 50), (52, 58), (60, 61), (63, 68), (70, 75), (77, 83), (85, 88), (90, 91), (93, 96)]
[u'Prolactin', u'-LRB-', u'PRL', u'-RRB-', u'-secreting', u'rat', u'pituitary', u'tumors', u'were', u'induced', u'in', u'female', u'Fisher', u'344/Lis', u'rats', u'by', u's.c.', u'.']
orignal sentence: Prolactin (PRL)-secreting rat pituitary tumors were induced in female Fisher 344/Lis rats by s.c.
error on token alignment
token: ., current:230
[(0, 1), (3, 7), (9, 10), (12, 19), (21, 27), (29, 30), (32, 41), (43, 43), (44, 46), (47, 47), (49, 51), (53, 55), (57, 64), (66, 67), (69, 78), (80, 88), (89, 89), (91, 100), (102, 118), (120, 120), (121, 123), (124, 124), (126, 128), (130, 136), (138, 139), (141, 142), (144, 151), (153, 159), (161, 164), (166, 168), (170, 170), (171, 175), (177, 190), (192, 201), (202, 202), (204, 206), (208, 208), (210, 211), (212, 212), (213, 213), (214, 214), (216, 224), (226, 229)]
[u'In', u'order', u'to', u'evaluate', u'effects', u'of', u'interferon', u'-LRB-', u'IFN', u'-RRB-', u'and', u'its', u'inducers', u'on', u'neutrophil', u'functions', u',', u'neutrophil', u'chemiluminescence', u'-LRB-', u'ChL', u'-RRB-', u'was', u'assayed', u'in', u'12', u'patients', u'treated', u'with', u'IFN', u'-LRB-', u'human', u'lymphoblastoid', u'interferon', u',', u'3.0', u'X', u'10', u'-LRB-', u'6', u'-RRB-', u'units/day', u'i.m.', u'.']
orignal sentence: In order to evaluate effects of interferon (IFN) and its inducers on neutrophil functions, neutrophil chemiluminescence (ChL) was assayed in 12 patients treated with IFN (human lymphoblastoid interferon, 3.0 X 10(6) units/day i.m.
error on token alignment
token: ., current:230
[(0, 1), (3, 7), (9, 10), (12, 19), (21, 27), (29, 30), (32, 41), (43, 43), (44, 46), (47, 47), (49, 51), (53, 55), (57, 64), (66, 67), (69, 78), (80, 88), (89, 89), (91, 100), (102, 118), (120, 120), (121, 123), (124, 124), (126, 128), (130, 136), (138, 139), (141, 142), (144, 151), (153, 159), (161, 164), (166, 168), (170, 170), (171, 175), (177, 190), (192, 201), (202, 202), (204, 206), (208, 208), (210, 211), (212, 212), (213, 213), (214, 214), (216, 224), (226, 229)]
[u'In', u'order', u'to', u'evaluate', u'effects', u'of', u'interferon', u'-LRB-', u'IFN', u'-RRB-', u'and', u'its', u'inducers', u'on', u'neutrophil', u'functions', u',', u'neutrophil', u'chemiluminescence', u'-LRB-', u'ChL', u'-RRB-', u'was', u'assayed', u'in', u'12', u'patients', u'treated', u'with', u'IFN', u'-LRB-', u'human', u'lymphoblastoid', u'interferon', u',', u'3.0', u'X', u'10', u'-LRB-', u'6', u'-RRB-', u'units/day', u'i.m.', u'.']
orignal sentence: In order to evaluate effects of interferon (IFN) and its inducers on neutrophil functions, neutrophil chemiluminescence (ChL) was assayed in 12 patients treated with IFN (human lymphoblastoid interferon, 3.0 X 10(6) units/day i.m.
error on token alignment
token: ., current:175
[(0, 11), (13, 18), (20, 22), (24, 33), (35, 35), (36, 38), (39, 39), (41, 43), (45, 48), (50, 51), (53, 59), (61, 70), (72, 77), (79, 81), (83, 88), (90, 101), (103, 104), (106, 109), (111, 111), (113, 115), (117, 120), (122, 123), (125, 131), (133, 133), (134, 137), (139, 142), (143, 143), (145, 154), (156, 162), (164, 165), (167, 169), (171, 174)]
[u'Radiolabeled', u'guinea', u'pig', u'fibrinogen', u'-LRB-', u'GPF', u'-RRB-', u'was', u'used', u'to', u'measure', u'fibrinogen', u'influx', u'and', u'fibrin', u'accumulation', u'in', u'line', u'1', u'and', u'line', u'10', u'hepato-', u'-LRB-', u'bile', u'duct', u'-RRB-', u'carcinomas', u'growing', u'in', u'the', u's.c.', u'.']
orignal sentence: Radiolabeled guinea pig fibrinogen (GPF) was used to measure fibrinogen influx and fibrin accumulation in line 1 and line 10 hepato- (bile duct) carcinomas growing in the s.c.
error on token alignment
token: ., current:206
[(0, 5), (7, 8), (10, 16), (18, 28), (30, 30), (31, 33), (34, 34), (36, 38), (40, 41), (42, 42), (43, 57), (58, 58), (59, 77), (79, 79), (80, 86), (87, 87), (89, 92), (94, 101), (103, 104), (106, 112), (114, 115), (117, 122), (124, 128), (130, 136), (138, 141), (143, 148), (150, 151), (153, 156), (158, 166), (168, 174), (176, 179), (181, 181), (183, 185), (187, 188), (190, 191), (193, 194), (196, 200), (202, 205)]
[u'Levels', u'of', u'reduced', u'glutathione', u'-LRB-', u'GSH', u'-RRB-', u'and', u'N-', u'-LRB-', u'2-mercaptoethyl', u'-RRB-', u'-1,3-diaminopropane', u'-LRB-', u'WR-1065', u'-RRB-', u'were', u'measured', u'in', u'tissues', u'of', u'Balb/c', u'mouse', u'bearing', u'EMT6', u'tumors', u'at', u'time', u'intervals', u'ranging', u'from', u'5', u'min', u'to', u'48', u'hr', u'after', u'i.v.', u'.']
orignal sentence: Levels of reduced glutathione (GSH) and N-(2-mercaptoethyl)-1,3-diaminopropane (WR-1065) were measured in tissues of Balb/c mouse bearing EMT6 tumors at time intervals ranging from 5 min to 48 hr after i.v.
error on token alignment
token: ., current:206
[(0, 5), (7, 8), (10, 16), (18, 28), (30, 30), (31, 33), (34, 34), (36, 38), (40, 41), (42, 42), (43, 57), (58, 58), (59, 77), (79, 79), (80, 86), (87, 87), (89, 92), (94, 101), (103, 104), (106, 112), (114, 115), (117, 122), (124, 128), (130, 136), (138, 141), (143, 148), (150, 151), (153, 156), (158, 166), (168, 174), (176, 179), (181, 181), (183, 185), (187, 188), (190, 191), (193, 194), (196, 200), (202, 205)]
[u'Levels', u'of', u'reduced', u'glutathione', u'-LRB-', u'GSH', u'-RRB-', u'and', u'N-', u'-LRB-', u'2-mercaptoethyl', u'-RRB-', u'-1,3-diaminopropane', u'-LRB-', u'WR-1065', u'-RRB-', u'were', u'measured', u'in', u'tissues', u'of', u'Balb/c', u'mouse', u'bearing', u'EMT6', u'tumors', u'at', u'time', u'intervals', u'ranging', u'from', u'5', u'min', u'to', u'48', u'hr', u'after', u'i.v.', u'.']
orignal sentence: Levels of reduced glutathione (GSH) and N-(2-mercaptoethyl)-1,3-diaminopropane (WR-1065) were measured in tissues of Balb/c mouse bearing EMT6 tumors at time intervals ranging from 5 min to 48 hr after i.v.
error on token alignment
token: ., current:174
[(0, 10), (12, 12), (13, 13), (15, 17), (18, 18), (20, 23), (25, 28), (30, 33), (35, 42), (44, 48), (50, 52), (54, 59), (61, 67), (69, 70), (72, 72), (73, 73), (74, 74), (76, 90), (92, 103), (105, 105), (106, 107), (108, 108), (110, 118), (119, 119), (121, 121), (122, 123), (124, 124), (126, 138), (140, 151), (153, 154), (156, 158), (159, 159), (161, 162), (164, 164), (165, 167), (168, 168), (170, 173)]
[u'Macrophages', u'-LRB-', u'M', u'phi', u'-RRB-', u'from', u'rats', u'with', u'elevated', u'serum', u'IgE', u'levels', u'induced', u'by', u'-LRB-', u'i', u'-RRB-', u'Nippostrongylus', u'brasiliensis', u'-LRB-', u'Nb', u'-RRB-', u'infection', u',', u'-LRB-', u'ii', u'-RRB-', u'IgE-secreting', u'plasmacytoma', u'IR', u'162', u',', u'or', u'-LRB-', u'iii', u'-RRB-', u'i.p.', u'.']
orignal sentence: Macrophages (M phi) from rats with elevated serum IgE levels induced by (i) Nippostrongylus brasiliensis (Nb) infection, (ii) IgE-secreting plasmacytoma IR 162, or (iii) i.p.
error on token alignment
token: ., current:174
[(0, 10), (12, 12), (13, 13), (15, 17), (18, 18), (20, 23), (25, 28), (30, 33), (35, 42), (44, 48), (50, 52), (54, 59), (61, 67), (69, 70), (72, 72), (73, 73), (74, 74), (76, 90), (92, 103), (105, 105), (106, 107), (108, 108), (110, 118), (119, 119), (121, 121), (122, 123), (124, 124), (126, 138), (140, 151), (153, 154), (156, 158), (159, 159), (161, 162), (164, 164), (165, 167), (168, 168), (170, 173)]
[u'Macrophages', u'-LRB-', u'M', u'phi', u'-RRB-', u'from', u'rats', u'with', u'elevated', u'serum', u'IgE', u'levels', u'induced', u'by', u'-LRB-', u'i', u'-RRB-', u'Nippostrongylus', u'brasiliensis', u'-LRB-', u'Nb', u'-RRB-', u'infection', u',', u'-LRB-', u'ii', u'-RRB-', u'IgE-secreting', u'plasmacytoma', u'IR', u'162', u',', u'or', u'-LRB-', u'iii', u'-RRB-', u'i.p.', u'.']
orignal sentence: Macrophages (M phi) from rats with elevated serum IgE levels induced by (i) Nippostrongylus brasiliensis (Nb) infection, (ii) IgE-secreting plasmacytoma IR 162, or (iii) i.p.
error on token alignment
token: ., current:37
[(0, 2), (4, 6), (8, 14), (16, 17), (19, 23), (25, 28), (30, 31), (33, 36)]
[u'AML', u'was', u'induced', u'in', u'C57B1', u'mice', u'by', u'i.v.', u'.']
orignal sentence: AML was induced in C57B1 mice by i.v.
error on token alignment
token: ., current:129
[(0, 9), (11, 12), (14, 17), (19, 24), (26, 33), (35, 40), (42, 44), (46, 56), (58, 58), (59, 60), (62, 79), (80, 80), (82, 83), (85, 87), (88, 88), (90, 93), (95, 102), (104, 104), (105, 110), (111, 111), (113, 117), (119, 119), (121, 123), (125, 128)]
[u'xenografts', u'of', u'this', u'cancer', u'received', u'either', u'CCK', u'octapeptide', u'-LRB-', u'50', u'micrograms/kg/dose', u'-RRB-', u'or', u'0.9', u'%', u'NaCl', u'solution', u'-LRB-', u'saline', u'-RRB-', u'twice', u'a', u'day', u'i.p.', u'.']
orignal sentence: xenografts of this cancer received either CCK octapeptide (50 micrograms/kg/dose) or 0.9% NaCl solution (saline) twice a day i.p.
error on token alignment
token: ., current:232
[(0, 3), (5, 14), (16, 17), (19, 23), (25, 25), (27, 34), (36, 38), (40, 44), (46, 47), (49, 49), (51, 54), (56, 65), (67, 68), (70, 73), (75, 81), (83, 85), (87, 96), (98, 103), (104, 104), (106, 112), (114, 115), (117, 119), (121, 123), (125, 130), (132, 132), (134, 144), (146, 154), (156, 156), (157, 160), (162, 162), (164, 165), (167, 168), (169, 169), (171, 172), (174, 178), (179, 179), (181, 182), (184, 193), (195, 198), (200, 201), (203, 209), (211, 213), (215, 216), (218, 227), (229, 231)]
[u'High', u'expression', u'of', u'class', u'I', u'antigens', u'was', u'found', u'in', u'a', u'high', u'percentage', u'of', u'both', u'primary', u'and', u'metastatic', u'tumors', u',', u'whereas', u'DR', u'and', u'MAA', u'showed', u'a', u'significant', u'variation', u'-LRB-', u'from', u'3', u'to', u'90', u'%', u'of', u'cells', u'-RRB-', u'in', u'expression', u'both', u'in', u'primary', u'and', u'in', u'metastatic', u'Me.', u'.']
orignal sentence: High expression of class I antigens was found in a high percentage of both primary and metastatic tumors, whereas DR and MAA showed a significant variation (from 3 to 90% of cells) in expression both in primary and in metastatic Me.
error on token alignment
token: ., current:85
[(0, 2), (4, 8), (10, 12), (14, 20), (22, 25), (27, 27), (29, 39), (41, 42), (44, 58), (60, 69), (71, 71), (72, 74), (75, 75), (77, 79), (81, 84)]
[u'The', u'tumor', u'was', u'treated', u'with', u'a', u'combination', u'of', u'hematoporphyrin', u'derivative', u'-LRB-', u'HPD', u'-RRB-', u'and', u'i.p.', u'.']
orignal sentence: The tumor was treated with a combination of hematoporphyrin derivative (HPD) and i.p.
error on token alignment
token: ., current:221
[(0, 7), (9, 16), (18, 21), (23, 32), (34, 43), (45, 51), (53, 58), (60, 69), (71, 72), (74, 79), (81, 84), (86, 95), (97, 101), (103, 113), (115, 126), (128, 131), (133, 139), (141, 144), (146, 148), (150, 155), (157, 158), (160, 176), (178, 187), (189, 189), (190, 199), (201, 201), (202, 202), (204, 215), (217, 220)]
[u'Fourteen', u'patients', u'with', u'persistent', u'epithelial', u'ovarian', u'cancer', u'documented', u'at', u'second', u'look', u'laparotomy', u'after', u'combination', u'chemotherapy', u'were', u'treated', u'with', u'146', u'cycles', u'of', u'alpha-recombinant', u'interferon', u'-LRB-', u'rIFN-alpha', u'2', u'-RRB-', u'administered', u'i.p.', u'.']
orignal sentence: Fourteen patients with persistent epithelial ovarian cancer documented at second look laparotomy after combination chemotherapy were treated with 146 cycles of alpha-recombinant interferon (rIFN-alpha 2) administered i.p.
error on token alignment
token: ., current:221
[(0, 7), (9, 16), (18, 21), (23, 32), (34, 43), (45, 51), (53, 58), (60, 69), (71, 72), (74, 79), (81, 84), (86, 95), (97, 101), (103, 113), (115, 126), (128, 131), (133, 139), (141, 144), (146, 148), (150, 155), (157, 158), (160, 176), (178, 187), (189, 189), (190, 199), (201, 201), (202, 202), (204, 215), (217, 220)]
[u'Fourteen', u'patients', u'with', u'persistent', u'epithelial', u'ovarian', u'cancer', u'documented', u'at', u'second', u'look', u'laparotomy', u'after', u'combination', u'chemotherapy', u'were', u'treated', u'with', u'146', u'cycles', u'of', u'alpha-recombinant', u'interferon', u'-LRB-', u'rIFN-alpha', u'2', u'-RRB-', u'administered', u'i.p.', u'.']
orignal sentence: Fourteen patients with persistent epithelial ovarian cancer documented at second look laparotomy after combination chemotherapy were treated with 146 cycles of alpha-recombinant interferon (rIFN-alpha 2) administered i.p.
error on token alignment
token: ., current:149
[(0, 2), (4, 11), (13, 16), (18, 22), (24, 27), (29, 36), (38, 40), (42, 46), (48, 54), (56, 57), (59, 61), (63, 73), (75, 78), (80, 80), (82, 92), (94, 101), (103, 104), (106, 110), (112, 112), (113, 113), (114, 114), (115, 115), (117, 126), (128, 128), (129, 129), (131, 131), (133, 134), (135, 135), (136, 136), (137, 137), (139, 143), (145, 148)]
[u'Ten', u'patients', u'with', u'hairy', u'cell', u'leukemia', u'are', u'being', u'treated', u'at', u'our', u'institution', u'with', u'a', u'therapeutic', u'schedule', u'of', u'alpha', u'2', u'-LRB-', u'r', u'-RRB-', u'interferon', u'-LRB-', u'2', u'X', u'10', u'-LRB-', u'6', u'-RRB-', u'IU/m2', u's.c.', u'.']
orignal sentence: Ten patients with hairy cell leukemia are being treated at our institution with a therapeutic schedule of alpha 2(r) interferon (2 X 10(6) IU/m2 s.c.
error on token alignment
token: ., current:171
[(0, 5), (7, 18), (20, 30), (32, 33), (35, 38), (40, 41), (43, 56), (58, 63), (65, 71), (73, 74), (76, 78), (80, 86), (88, 90), (92, 93), (95, 98), (100, 108), (110, 111), (113, 122), (124, 128), (130, 135), (137, 140), (142, 144), (146, 149), (151, 154), (156, 165), (167, 170)]
[u'Direct', u'intravesical', u'application', u'of', u'ABPP', u'to', u'transplantable', u'tumors', u'growing', u'in', u'the', u'bladder', u'may', u'be', u'more', u'effective', u'in', u'inhibiting', u'MBT-2', u'growth', u'than', u'the', u'same', u'dose', u'introduced', u'p.o.', u'.']
orignal sentence: Direct intravesical application of ABPP to transplantable tumors growing in the bladder may be more effective in inhibiting MBT-2 growth than the same dose introduced p.o.
error on token alignment
token: ., current:100
[(0, 1), (3, 6), (8, 12), (14, 18), (19, 19), (21, 22), (24, 31), (33, 36), (38, 45), (47, 55), (57, 64), (66, 73), (75, 79), (81, 84), (86, 87), (89, 90), (92, 94), (96, 99)]
[u'In', u'this', u'pilot', u'study', u',', u'12', u'patients', u'with', u'advanced', u'malignant', u'melanoma', u'received', u'HuIFN', u'beta', u'by', u'30', u'min', u'i.v.', u'.']
orignal sentence: In this pilot study, 12 patients with advanced malignant melanoma received HuIFN beta by 30 min i.v.
